- Staat
- TX
- Alter
- 85,0
- Geschlecht
- M
- Eingang
- 13.11.2023
- Impfdatum
- 06.05.2021
- Beginn
- 28.01.2022
- Tage bis Beginn
- 267,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
Asthenia
COVID-19
COVID-19 pneumonia
Decreased appetite
Dyspnoea
Metabolic encephalopathy
Myocardial ischaemia
Troponin increased
Symptomtext
Came to emergency room with generalized weakness, shortness of breath and poor appetite. Patient was admitted with acute hypoxemic respiratory failure due to COVID-19 pneumonia. Patient was treated with supplemental oxygen, zinc, vitamin-C, mucolytic, antitussive and empiric antibiotics. Patient also had acute metabolic encephalopathy due to COVID-19 and elevated troponin that was presumed from demand ischemia and type 2 MI. Patient was discharged to skilled nursing facility in a stable medical condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 69,0
- Geschlecht
- M
- Eingang
- 28.06.2023
- Impfdatum
- 07.07.2021
- Beginn
- 07.06.2023
- Tage bis Beginn
- 700,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
COVID-19
Chest discomfort
Chronic obstructive pulmonary disease
Condition aggravated
Confusional state
Cough
Dyspnoea
Oxygen saturation decreased
SARS-CoV-2 test positive
Tachycardia
Symptomtext
Patient arrives with chief complaint of shortness of breath and a cough. Patient has history of COPD. Patient has noted confusion as he arrives with his pants on backwards. Patient has had tachycardia as well as a low O2 sat at 84% today patient is here with his significant other who says that he has not been having any fevers. Patient reports very minimal chest discomfort. Patient has no history of CHF. Associated Symptoms: cough, shortness of breath
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 3,0
- Labordaten
- Patient to get a cardiac work-up as he does have mild chest discomfort. Patient to get steroids and albuterol. Since sepsis is in the differential with his tachycardia he will get a lactate and culture. Since pneumonia is in the differential he will get a chest x-ray. Patient also could have elevated CO2 as differential we will obtain venous blood gas. 2102 I did speak with dr., who will come down to eval pt. I did find out patient had prior covid home test positive about three weeks ago now and has not bounced back. today RA pulse ox was 84% per nursing and continues to require oxygen now. 1. acute hypoxic resp failure 2. recent covid diagnosis 3. copd 2140: dr. accepts
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- Heart failure, Afib, HTN, COPD
- Andere Medikamente
- unknown
- Allergien
- eliquis
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 75,0
- Geschlecht
- F
- Eingang
- 12.02.2023
- Impfdatum
- 15.11.2021
- Beginn
- 22.01.2023
- Tage bis Beginn
- 433,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute respiratory failure
Blood glucose increased
Blood potassium decreased
COVID-19
COVID-19 pneumonia
Computerised tomogram thorax abnormal
Diabetes mellitus inadequate control
Hyperglycaemia
Hypokalaemia
Insulin-requiring type 2 diabetes mellitus
Respiratory failure
SARS-CoV-2 test positive
Symptomtext
Assessment and Plan Patient is a 77 y.o. female patient with history of COPD, IDDM. presented to Hospital with Hypoxia and multifocal covid 19 pneumonia Covid-19 Virus Infection Date of onset of symptoms: 1/21/23 Symptoms present on admission: yes Date of covid positive test: 1/22/23 Vaccination status: vaccinated Imaging: Ct chest Oxygen requirements on admission: 2l Current oxygen requirements: 2l Medical therapy: remdesivir (given 2 doses prior to discharge) Consultants following: None Anticipated special isolation end date: TBD Acute on chronic hypoxic respiratory failure, Covid 19 pneumonia with hypoxia CT chest shows multifocal pneumonia without PE Start Remdesivir IV decadron x1 in ED, with no significant hypoxia or increased work of breathing, will avoid administration of additional steroids at this time Nasal oxygen to keep saturation above 92% Patient wears 3 L nasal cannula at night at home, and states that she has been consistently wearing this during the day over the last several months Continue bronchodilator inhalers Ambulatory home oxygen evaluation showed desaturation at lowest point to 89% with rapid recovery on room air to 93%, therefore does not qualify for home oxygen around-the-clock at this time Given improvement in symptoms, patient stable for discharge Recommend PCP follow-up in approximately 1 to 2 weeks Uncontrolled insulin-dependent type 2 diabetes mellitus with hyperglycemia On Lantus 35 unit BID, high-dose/resistant sliding scale coverage added while inpatient Likely secondary to previous administration of Decadron in emergency department Have changed patient's diet to diabetic, and did have regular diet this morning prior to change of diet Blood glucose levels improved at time of discharge COPD Albuterol Advair inhaler Hypokalemia (resolved) Mild, potassium 3.4 on admission KCL po ordered Potassium 3.8 (1/24) Essential hypertension Continue metoprolol, Aldactone
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 2,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 78,0
- Geschlecht
- M
- Eingang
- 06.02.2023
- Impfdatum
- 21.06.2021
- Beginn
- 28.12.2022
- Tage bis Beginn
- 555,0
- Dosis
- 2
- Route/Site
- - / -
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
Acute respiratory failure
Blood pressure decreased
COVID-19
Chest X-ray abnormal
Chest tube insertion
Death
Dyspnoea
Emphysema
Endotracheal intubation
Haemofiltration
Hypoxia
Lung infiltration
Metabolic encephalopathy
Pneumonia
Pneumothorax
Positive airway pressure therapy
Septic shock
Symptomtext
Patient is a 80 y.o. male patient of MD with a history of remote tobacco abuse who was admitted 12/28/2022 for COVID infection with superimposed multifocal pneumonia. Started on empiric antibiotics as well as Remdesivir and Decadron. He was given Tocilizumab 12/31/2022. Patient was initially on BiPAP but ultimately required intubation due to hypoxia and increased work of breath 1/01/23. Patient was also started on DEXA ARDS protocol 1/01/2023. On 1/03/23 nephrology was consulted due to acute renal failure. Patient was started on CRRT. Given increasing pressor requirements and renal failure, palliative care was consulted 1/05 to discuss goals of care. Patient's code status was changed to DNR-CCA. On the night of 1/05 CXR showed a 2.1 cm right apical pneumothorax. Chest tube was urgently placed. Unfortunately, blood pressure continued to decline despite maximum pressor support with 100 of Levophed, Vaso, and Neo-synephrine. Time of death was called 0021 on 1/06/2023. Discharge Diagnoses: Acute Hypoxemic Respiratory Failure Pulmonary Infiltrates COVID Infection Acute metabolic encephalopathy Septic Shock Emphysema History of Tobacco Abuse Elevated Troponin Acute Kidney Injury
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 6,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 31.08.2022
- Impfdatum
- 03.09.2021
- Beginn
- 16.08.2022
- Tage bis Beginn
- 347,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
Chronic gastritis
Diabetic hyperosmolar coma
Duodenitis
Dysphagia
Fatigue
Gastrointestinal tract biopsy
Haematemesis
Nausea
Odynophagia
Oesophagitis
Oesophagitis ulcerative
Oesophagogastroduodenoscopy abnormal
Oral candidiasis
Oropharyngeal pain
SARS-CoV-2 test positive
Vomiting
Symptomtext
Provider d/c note: "41 yo female who presented for nausea and vomiting that was bloody today. She was diagnosed with Covid 8 days ago. She complains of fatigue and nausea during these recent days. Since she wasn't able to keep things down, she has not been taking her medications including insulin. (HPI per Dr) Hospital Course: No notes on file patient is a 41yr old female with a history of HTN, DM, Asthma, Depression, Hyperthyroidism who presented with HONK, intractable N and V, oropharyngeal thrush. Today she is seen sitting in chair, says pain in throat is horrible. Intractable N/V/ hematemesis - resolved. Oropharyngeal thrush Dysphagia/Odynophagia secondary to Esophagitis, Gastritis and Duodenitis - on diflucan. EGD done 8/24/22 revealed esophagitis, gastritis, duodenitis but no candida like plaques appreciated. Patient is tolerating soft diet. Biopsy revealed Inactive mild chronic gastritis and Acute ulcerative esophagitis. GI recommends PPI BID x 6 wks. Continue PPI q12hrs x 6 weeks followed by once daily dosing, continue fluconazole to complete a two weeks course of treatment, f/up pathology, f/up in GI office to discuss repeat EGD to evaluate for healing of esophagitis. GI signed off. "
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diabetic hyperosmolar coma
- Hospital-Tage
- 11,0
- Labordaten
- COVID detected PCR on 08/09/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Type 2 diabetes mellitus with hyperglycemia (HCC) 11/11/2018 Severe episode of recurrent major depressive disorder 11/13/2018 Hypertension Asthma Severe protein-calorie malnutrition
- Andere Medikamente
- -
- Allergien
- Cephalexin
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 21.02.2022
- Impfdatum
- 07.07.2021
- Beginn
- 20.02.2022
- Tage bis Beginn
- 228,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
Acute kidney injury
Acute myocardial infarction
Asthenia
Blood creatinine increased
Blood culture
Blood lactic acid
Blood sodium decreased
Breath sounds abnormal
COVID-19
Chest X-ray normal
Computerised tomogram head normal
Confusional state
Cough
Fatigue
General physical health deterioration
Incontinence
Infection
Micturition urgency
Symptomtext
o ED Clinical Course Patient was seen immediately on arrival and plan of care discussed with patient and significant other at bedside. IV will be established blood work including blood cultures and lactic acid will be obtained. She will be hydrated in the emergency department. We will plan for chest x-ray as well as CT head and urinalysis. Chest x-ray is reviewed with no focal infiltrates. Her CT of the brain does not show any acute findings. Laboratory studies are reviewed. Patient's creatinine today is 3.2 with a baseline of 0.7. Sodium is 127. Patient's lactate 1.6. No elevation white blood cell count. We will continue aggressive fluid hydration in the emergency department awaiting urinalysis. Patient's troponin is 0.22 this is likely secondary to decreased renal clearance Urinalysis is reviewed. Findings are consistent with a UTI. Patient will be started on Rocephin. According to the family the patient usually requires Solu-Cortef due to her removal of her pituitary gland whenever she gets sick. She normally gets 100 mg this will be given IV as there oral solution expired in August 2020. Patient's presenting to the emergency department with positive criteria for systemic inflammatory response syndrome with an active infection meeting the diagnosis of sepsis. Patient with end organ dysfunction in combination with sepsis meeting the diagnosis of severe sepsis. Patient had blood cultures drawn, serial lactic acids ordered and received a saline bolus of 30 mg/kg based on ideal body weight. Reexamination reveals vital signs as detailed below, heart regular rate and rhythm without any murmur, lungs diminished at bases with no wheezing, rales, or rhonchi, skin warm and dry with no mottling or rashes, pulses 2+ and equal bilaterally with capillary refill under 2 seconds, no cyanosis, no pallor, neurologic status intact. Further sepsis care to be completed on inpatient admission. 2/20/2022 1429 Temperature: 99.3 ?F Blood pressure: 123/72 Heart rate: 78 Respiratory rate: 18 I, Dr. provided critical care. The failure to initiate these interventions on an urgent basis would likely (high probability) result in sudden, clinically significant or life-threatening deterioration in the patient's condition is acute septic state. All critical care time is in addition to any procedures, teaching, or physician assistant work performed. Critical care time was spent at the bedside, patient reevaluation, reviewing tests, care plan determination, and discussing care with staff, consultants, and admitting care providers in the acutely ill septic patient. Critical care time spent was 44 minutes. The organ systems/conditions impaired: Infectious disease, immunology, pulmonary, cardiology, nephrology. Contacted that Covid is positive. patient satturating well. I discussed the case with the facility who graciously excepts this admission for further care and treatment Admitting diagnosis Acute kidney injury UTI with severe sepsis NSTEMI secondary to decreased renal clearance COVID-19
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute myocardial infarction
- Hospital-Tage
- 1,0
- Labordaten
- Patient is a 67-year-old female who presents the emergency department via private automobile for confusion. According to the husband at bedside patient confusion started minimally last night and then this morning it got markedly worse. She has a history of hyponatremia secondary to pituitary issue however this has been removed. According to the husband she is also been incontinent over the last few hours. She has been breathing rapidly as well according to the husband. She is only answering questions with yes/no Associated Symptoms: cough, fatigue, fever, frequency, sputum, urgency, weakness
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- dementia, bipolar, schizophrenia, hypothyroidism, anxiety
- Andere Medikamente
- Current Home Medications 1. acetaminophen 325 mg oral tablet : 2 tab(s) orally every 4 hours, As needed, for mild pain (1-3) or fever > 101 2. hydrocortisone 10 mg oral tablet : 1 tab(s) orally 2 times a day 3. levothyroxine 75 mcg (0.075 m
- Allergien
- haldol, penicillin
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 17.02.2022
- Impfdatum
- 15.06.2021
- Beginn
- 03.01.2022
- Tage bis Beginn
- 202,0
- Dosis
- 2
- Route/Site
- IM / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal pain
Acute respiratory failure
Back pain
Blood culture
Blood lactate dehydrogenase normal
C-reactive protein increased
COVID-19
Chemotherapy
Chest X-ray abnormal
Chest pain
Cough
Emphysema
Fibrin D dimer increased
Gastrostomy
Influenza virus test negative
Loss of personal independence in daily activities
Lung disorder
Lymphopenia
Symptomtext
Patient is a 63-year-old female who presents the ED today for further evaluation of fever, and recent initiation of chemotherapy. Patient states that she was instructed to come in by her chemo physicians, states that she has been having mild cough, chest pain, back pain, abdominal pain. Patient states that she has had some nausea and vomiting as well, is fed primarily through her G-tube, states that she has been able to take care of herself at home. Acute hypoxic respiratory failure 2/2 COVID-19 infection with underlying emphysema -COVID+ test (12/31/21). Has lymphopenia on admission. CRP -47>>51, LDH-wnl. Ferritin 574, DDimer -1.1>>1.3 -CXR showing right lower lobe airspace disease. personally reviewed . Noted on prior CXR in 10/21. -RSV, flu-negative. -blood cultures from peripheral and port-NTD -01/03: started Remdesivir x 5 days and dexamethasone 6 mg PO daily x 10 days. Discharged with dexamethasone to finish total 10 days course. -procalcitonin - low, less likely bacterial infection. However, given immuno-compromised status, given IV ceftriazone and azithromycin until cultures result and discontinued on discharged. -on the day of discharge, she feels better. She required 2 L NC on exertion. Recommended to check home oxygen twice a day. Discharged with albuterol prn and tessalon prn for cough. Discharge Disposition/Condition Disposition: Home with Home Health Condition: Stable (s/sx potential problems absent or manageable)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- 4,0
- Labordaten
- COVID PCR positive on 12/31/21 and 01/03/22
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Past Medical History: Stage IV triple negative breast cancer h/o right medullary breast cancer s/p lumpectomy/chemo/radiation (1993) Anxiety/depression Reynaud's disease GERD
- Andere Medikamente
- fluoxetine lorazepam ondansetron levofloxacin
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 28.01.2022
- Impfdatum
- 09.08.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Embolism
Limb discomfort
Myocardial infarction
Thrombosis
Symptomtext
heart attack; platelets or blood blots in legs broke apart in legs , traveled up to the heart; blood clots in legs broke apart in legs and traveled up to the heart; problem with leg; This spontaneous case was reported by a consumer and describes the occurrence of MYOCARDIAL INFARCTION (heart attack), THROMBOSIS (platelets or blood blots in legs broke apart in legs , traveled up to the heart) and EMBOLISM (blood clots in legs broke apart in legs and traveled up to the heart) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020F21A and 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Surgery. Concurrent medical conditions included Diabetes and Hypertension. On 09-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced MYOCARDIAL INFARCTION (heart attack) (seriousness criteria hospitalization and medically significant), THROMBOSIS (platelets or blood blots in legs broke apart in legs , traveled up to the heart) (seriousness criteria hospitalization and medically significant), EMBOLISM (blood clots in legs broke apart in legs and traveled up to the heart) (seriousness criteria hospitalization and medically significant) and LIMB DISCOMFORT (problem with leg). At the time of the report, MYOCARDIAL INFARCTION (heart attack), THROMBOSIS (platelets or blood blots in legs broke apart in legs , traveled up to the heart) and EMBOLISM (blood clots in legs broke apart in legs and traveled up to the heart) outcome was unknown and LIMB DISCOMFORT (problem with leg) had not resolved. Concomitant products were not provided. Consumer stated after his 1st dose he did not feel as bad. Consumer added he felt worse with second dose. Consumer stated that went on till November. Consumer stated his platelets or blood blots in legs broke apart in legs, traveled up to the heart, and clogged up 10 arteries in heart.Following that event he had a heart attack.Consumer stated he had to get a surgery done at the hospital. For his first surgery they used balloon pump. Then the doctors were going to use stent, but were not able to. They took a vein out of his leg and put in the heart. Company comment: This spontaneous case concerns a 56-year-old male patient, with medical history of diabetes and hypertension, who experienced the serious (medically significant, hospitalization) events of MYOCARDIAL INFARCTION, THROMBOSIS and THROMBOEMBOLISM. The events occurred on an unknown date after receiving a second dose of mRNA-1273. According to source document narrative, patient experienced blood clots in legs that traveled up to the heart and clogged up to 10 arteries in the heart, causing a heart attack. He was treated with surgery. No further information regarding hospitalization or details on received treatment was provided. Patient's history of diabetes and hypertension remains as a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report. This case was linked to MOD-2022-460354 (Patient Link). Reporter did not allow further contact; Sender's Comments: This spontaneous case concerns a 56-year-old male patient, with medical history of diabetes and hypertension, who experienced the serious (medically significant, hospitalization) events of MYOCARDIAL INFARCTION, THROMBOSIS and THROMBOEMBOLISM. The events occurred on an unknown date after receiving a second dose of mRNA-1273. According to source document narrative, patient experienced blood clots in legs that traveled up to the heart and clogged up to 10 arteries in the heart, causing a heart attack. He was treated with surgery. No further information regarding hospitalization or details on received treatment was provided. Patient's history of diabetes and hypertension remains as a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocardial infarction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Diabetes; Hypertension
- Vorgeschichte
- Medical History/Concurrent Conditions: Surgery
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 41,0
- Geschlecht
- F
- Eingang
- 05.12.2021
- Impfdatum
- 23.07.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 10,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest pain
Confusional state
Fatigue
Full blood count
Hallucination
Headache
Influenza virus test
Near death experience
Neuralgia
Pain in extremity
SARS-CoV-2 test
Symptomtext
I seriously thought I was dying. Extreme fatigue, chest pain, nerve pain all over my body (chest, head, legs), hallucinations and confusion. No treatment. Lasted a few days.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Near death experience
- Hospital-Tage
- -
- Labordaten
- COVID-19, parainfluenza and CBC.
- Aktuelle Erkrankungen
- After the first vaccine, I had severe fatigue, mild hallucinations and excessive nerve pain.
- Vorgeschichte
- Asthma, cardiac arrhythmia, chronic pain
- Andere Medikamente
- Lyrica, Zyrtec, Singular, Famotidine, Ambien, Hydrocodone, Oxycodone, Sertraline, Baclofen, Zofran
- Allergien
- Penicillin
- Vorherige Impfungen
- After the first vaccine I had severe fatigue, mild hallucinations and excessive nerve pain.
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 09.08.2021
- Impfdatum
- 22.07.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Acute respiratory failure
COVID-19
COVID-19 pneumonia
Symptomtext
Patient hospitalized 8/9/21 with pneumonia due to COVID -19 with acute hypoxic respiratory failure.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Acute respiratory failure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- copd, cad, ckd III, lung mass, HTN, GOUT
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 29.06.2021
- Impfdatum
- 15.06.2021
- Beginn
- 19.06.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Death
Symptomtext
Patient received Moderna #1 on 4/20/21 and Moderna #2 on 6/15/21. Our office was notified on 6/19/21 that this patient was found deceased and appeared to have passed away several days prior due to level of decomposition. The cause of death is unknown at this time and is being evaluated by Medical Examiner due to recent Covid vaccination and recent drug overdose on 6/2/21. No foul play suspected.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Death
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Suspected drug overdose 6/2- left ER AMA
- Vorgeschichte
- Type 2 Diabetes Hyperlipidemia Hypertension GERD Seizure disorder
- Andere Medikamente
- Hydrochlorothiazide 25mg Basaglar KwikPen Suboxone 8mg-2mg film Aspirin 81mg Doxepin 10mg Chlorpromazine 100mg Olanzapine 10mg Keppra 750mg Atorvastatin 40mg Admelog Amitriptyline 50mg Gabapentin 800mg Lisinopril 40mg Metformin 1000mg Ci
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 22.01.2022
- Impfdatum
- 02.07.2021
- Beginn
- 30.07.2021
- Tage bis Beginn
- 28,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Cardiac stress test abnormal
Myocarditis
Testis cancer
Ultrasound scan abnormal
Symptomtext
Myocarditis; misdiagnosed of cancer in the testicle.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- -
- Labordaten
- Sonogram of heart and testicle; stress test.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 07.01.2022
- Impfdatum
- 17.08.2021
- Beginn
- 17.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Heavy menstrual bleeding
Thrombosis
Symptomtext
After having given me the first dose in August, my menstruation was delayed until December in that month I had twice the first little flow, the second time too much bleeding with extremely large blood clots, which I never used to have or a bleeding of that magnitude or such large clots, he had not had a delay of so many months.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- Vitamin C
- Allergien
- Penicillin
- Vorherige Impfungen
- Changes in menstruation.
- Staat
- FL
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 29.11.2021
- Impfdatum
- 29.09.2021
- Beginn
- 03.10.2021
- Tage bis Beginn
- 4,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Pericarditis
Symptomtext
In the week after getting my second dose I developed a weird sensation in my chest near my heart that I just maybe thought was my lungs. After about a month it got a bit worse and went to an urgent care where they said I had pericarditis. I have been on anti inflammatory medications for past 3 weeks and it?s just now finally starting to get better but symptoms still persist.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pericarditis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 19.10.2021
- Impfdatum
- 15.10.2021
- Beginn
- 19.10.2021
- Tage bis Beginn
- 4,0
- Dosis
- UNK
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Dehydration
Electrocardiogram
Pain
Syncope
Tremor
Symptomtext
At 9::00pm I felt chilled ,and achy and went to bed because I started to shake U.N. controllably. I took Tylenol at about 10:00pm and in about10 minutes the shaking stopped. Soon after I was able to take off extra pjs and covers. When I went to the bathroom at sometime around 7:00 am I felt hungry as I stood up and fainted. I fell on my back and was out for less than a minute. I was checked out by paramedics. My blood pressure was 119/49. They told me to drink Gatorade and water from being dehydrated. I had already started drinking before this. They got me in bed. I ate, rested and got through the day.feeling stronger. The next day felt stronger and stronger.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- EKG and oxygen levels and usual tests
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Coq10, calcium, multiple, magnesium,vit. c montelukast, Flonase loratadine, simvastin, b12,D3, omeprazole, chlorthalidone
- Allergien
- Bactria, cortisone and aspirin
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 28.09.2021
- Impfdatum
- 24.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood glucose
Body temperature
Chills
Feeling abnormal
Headache
Loss of consciousness
Pyrexia
Tremor
Symptomtext
went to answer a text and never sent it because he passed out and woke 2-3 hours later and had a 94.9 degrees F core temperature; Brain fog; Shaking; headache, chills and 99.1 fever; chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of LOSS OF CONSCIOUSNESS (went to answer a text and never sent it because he passed out and woke 2-3 hours later and had a 94.9 degrees F core temperature) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 020F21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concurrent medical conditions included Diabetic (preexisting diabetic). Concomitant products included INSULIN for an unknown indication. On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced LOSS OF CONSCIOUSNESS (went to answer a text and never sent it because he passed out and woke 2-3 hours later and had a 94.9 degrees F core temperature) (seriousness criterion medically significant), FEELING ABNORMAL (Brain fog), TREMOR (Shaking), HEADACHE (headache, chills and 99.1 fever), CHILLS (chills) and PYREXIA (Fever). At the time of the report, LOSS OF CONSCIOUSNESS (went to answer a text and never sent it because he passed out and woke 2-3 hours later and had a 94.9 degrees F core temperature) and TREMOR (Shaking) outcome was unknown, FEELING ABNORMAL (Brain fog) had not resolved and HEADACHE (headache, chills and 99.1 fever), CHILLS (chills) and PYREXIA (Fever) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood glucose: 49 (Low) 49. On an unknown date, Body temperature: 99.1 (High) 99.1 and 94.9 (Low) 94.9 degrees F. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. The Concomitant medications include vitamin gummies. The Treatment information was not provided. Company comment: This case concerns a 48-year-old, male patient with previous relevant medical history diabetes and use of concomitant medication insulin, who experienced the unexpected loss of consciousness. The event occurred on an unknown number of days after the first dose of mRNA-1273. The rechallenge was unknown, as the event happened after the first dose and have resolved, and no information about second dose was disclosed. The reporter assessed the events as possible. The medical history of diabetes and use of concomitant medication insulin remains a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report.; Sender's Comments: This case concerns a 48-year-old, male patient with previous relevant medical history diabetes and use of concomitant medication insulin, who experienced the unexpected loss of consciousness. The event occurred on an unknown number of days after the first dose of mRNA-1273. The rechallenge was unknown, as the event happened after the first dose and have resolved, and no information about second dose was disclosed. The reporter assessed the events as possible. The medical history of diabetes and use of concomitant medication insulin remains a confounder. The benefit-risk relationship of mRNA-1273 is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Test Name: Blood sugar; Result Unstructured Data: 49; Test Name: Body temperature; Result Unstructured Data: 99.1; Test Name: Body temperature; Result Unstructured Data: 94.9 degrees F
- Aktuelle Erkrankungen
- Diabetic (preexisting diabetic)
- Vorgeschichte
- -
- Andere Medikamente
- INSULIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 28.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dyspnoea
Fatigue
Myalgia
Pyrexia
Sleep paralysis
Symptomtext
Sleep Paralysis with Lucid dreaming; when he sleeps he has difficulty breathing; fatigue; mild fever; Horrible but bearable sore arm; This spontaneous case was reported by a consumer and describes the occurrence of SLEEP PARALYSIS (Sleep Paralysis with Lucid dreaming), DYSPNOEA (when he sleeps he has difficulty breathing), FATIGUE (fatigue), PYREXIA (mild fever) and MYALGIA (Horrible but bearable sore arm) in a 28-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 and Sleep paralysis. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced SLEEP PARALYSIS (Sleep Paralysis with Lucid dreaming), DYSPNOEA (when he sleeps he has difficulty breathing), FATIGUE (fatigue), PYREXIA (mild fever) and MYALGIA (Horrible but bearable sore arm). At the time of the report, SLEEP PARALYSIS (Sleep Paralysis with Lucid dreaming), DYSPNOEA (when he sleeps he has difficulty breathing), FATIGUE (fatigue), PYREXIA (mild fever) and MYALGIA (Horrible but bearable sore arm) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Patient says he has similar symptoms when he had Covid, its like he is having Covid again. Concomitant medication were not provided Treatment information was not provided This case was linked to MOD-2021-297642 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Sleep paralysis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19; Sleep paralysis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 31.08.2021
- Impfdatum
- 02.08.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Menometrorrhagia
Thrombosis
Symptomtext
I started my period very late that night into early the next morning and bled more than I have ever in my life and then it went to clots. Normally my cycle is like clockwork and never has anything like this happened to me in my life. I should have gotten my second shot today but won?t until I can have some explanation. I started my cycle again a few days ago. It isn?t as bad as the last but it?s not the same.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 20.08.2021
- Impfdatum
- 20.08.2021
- Beginn
- 20.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Head injury
Seizure
Symptomtext
Patient received vaccine at 10:30 am. Patient waiting in monitoring area and fell out of the chair to the floor hitting the R side of his head on the floor at 10:35am. O2 sats 78%, P-78 bpm Unable to obtain a bp. Patient alert and talking. Patient seized for 30 seconds after sitting up. O2 @ 2L per NC administered. 911 called at 10:43 am. Patient taken by ambulance to ER at 10:53am.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Seizure
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 12.08.2021
- Impfdatum
- 22.07.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Injection site muscle weakness
Injection site pruritus
Muscular weakness
Myalgia
Needle track marks
Pain
Pain in extremity
Pyrexia
Thrombosis
Visual impairment
Symptomtext
My right arm from the second shot continues to itch & I can still see the needle mark. After 2nd shot I notice that at times both upper arms feel weak in the area from the injection sites downwards. At times both arms still have a mildly stabbing achy pain deep in the muscle. After I've mowed my lawn with a push mower both arms feel weak, & I have to sometimes just sit down because I feel weak all over. I also still have itching at the right arm injection site. I don't know if these are typical this long after the shots. I guess since I actually had had covid my reactions to the vaccines were awful-fevers of 101? along with horrible body aches just like I had with covid. Or maybe this is normal. But I didn't think the arm pain & weakness would continue. I only took the vaccine because I was afraid my retinal vein occlusion could have something to do with covid blood clot issues, but I am aware there isn't enough research at this stage. But I did not want to get it again or the delta variant. Maybe my case can help with research, as I never noticed strange visual "spots" until after I had covid--they would come & go, & then in June became permanent unfortunately.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Thrombosis
- Hospital-Tage
- -
- Labordaten
- I have not had tests related to the bilateral arm pain, & intermittent weakness.
- Aktuelle Erkrankungen
- Diagnosed with central retinal vein occlusion on 6/24/2021. I had covid in December of 2020. I am not diabetic, no prior eye problems. Wasn't aware of hypertension before eye diagnosed--that's when losartan prescribed. I've also had 2 anti VEGF injections directly into my left eye since 6/24.
- Vorgeschichte
- Hypothyroidism since 1994, treated with levothyroxine. Depression treated with venlafaxine & anxiety treated with prn diazepam for 10 years. In January, 2020 sustained blunt force trauma resulting in right comminuted tibial plateau fracture requiring ORIF with a plate & 8 screws. Since then have chronic arthritic pain.
- Andere Medikamente
- multi vitamin, levothyroxine, losartan, venlafaxine, diazepam, ibuprofen.
- Allergien
- No drug or food allergies. Allergic to metals in costume jewelry such as nickel, which causes a blistering, red, itchy rash. Also allergic to whatever the metal is on watch backs. Can only use titanium framed eye glasses, or stainless steel metals.
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 24,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 10.06.2021
- Beginn
- 11.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: ja
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
ADAMTS13 activity assay
Apraxia
Bilirubin conjugated increased
Blood bilirubin increased
Blood creatinine increased
Asthenia
Blood lactate dehydrogenase increased
Computerised tomogram head normal
Drug screen negative
Encephalopathy
Blood urea increased
Computerised tomogram abdomen
Computerised tomogram abnormal
Electroencephalogram abnormal
Endotracheal intubation
Eye movement disorder
Facial paralysis
Fatigue
Symptomtext
Patient is a 24 y.o. male, with no known medical history, who received more than a vaccination few weeks ago the presented to the outside hospital for worsening general malaise since he received the COVID vaccine and acute neurological symptoms with focal deficit. Symptoms was noted by his mother around 10:00 p.m. on 06/19/2021 with right arm weakness, facial droop, tongue deviation. On presentation to the outside hospital emergency room patient was found to be severely encephalopathy with moaning, eyes deviation, unable to follow commands, diaphoretic but no focal deficit. He was intubated and sedated for airway protection. Initial workup with CT head without contrast was negative for acute finding. CT abdomen pelvis without contrast showed splenomegaly. Hemoglobin was 8.8, platelet 24, LDH 2856, creatinine 1.27, BUN 23, total bili 3.5, direct 0.5. UDS negative. Transferring provider suspicious for TTP. Patient is been transferred to Hospital for further care. Given high mortality associated with TTP, patient was initiated on plasma exchange on 6/20/2021.ADAMTS activity and inhibitor assay were ordered. He received second dose of Covid-19 vaccine ten days ago. 6/21/21: Trialysis catheter place and initiated plasmapheresis yesterday. CBC being followed closely with improvement in platelet count to 37K this AM, but down to 28K this afternoon. Hemoglobin low requiring transfusion support. 24-year-old man with no prior medical history and quit 19 vaccine about 10 days ago. On the morning of June 19, 2021 he presented to Hospital where he was intubated. Patient had been having progressive malaise and there was concern for focal neurological deficits. He was intubated in the emergency room and later on transferred to Hospital for further evaluation and treatment. He had a normal CT angiogram of head but found to have significant hemolysis and profound thrombocytopenia. MRI of the brain did not show any hemorrhage however it did show possible hypoxic brain damage in cortical and subcortical gray matter. Upon decreasing his sedation patient became significantly restless and agitated and had to be Re sedated heavily. Neurology consult was called. His initial labs showed hemoglobin 7.9, hematocrit 23.6, platelet count 16000, RBC was 2.73. Neutrophil predominance was seen. PT PTT INR were normal and fibrinogen was normal D-dimer was elevated 3574. Patient was given multiple units of platelet transfusion and later on started on steroids and started on plasmapheresis. Last 24 hours: His MRI of the brain was negative for any mass mass effect or or signs of infarct MR venogram did not show any cerebral venous sinus thrombosis. His EEG did show generalized background slowing which appeared to be moderate pointing to hours systemic/metabolic encephalopathy. Patient is continued on plasmapheresis and steroids and this is day 4 of plasmapheresis. 6/24/21: Day 5 of plasma exchange with platelet count stable at 75K, will await repeat CBC. Patient extubated and alert. No bleeding reported. 6/25/21: Day 6 of plasma exchange. ADAMTS 13 activity resulted <5 and inhibitor >8BU consistent with an acquired TTP picture with higher likelihood for refractory disease. Platelet count dropped to 40K this AM, concerning for refractory disease. Will initiate Rituxan following PEX today. 6/26/21: Received Rituxan overnight 6/25 - 6/26. Had some initial complications with elevation of HR. Treatment stopped and restarted/continued at slow rate for duration of infusion. 6/27/21: Plasma exchange held for 24 hours post Rituxan. Restarted without complications. 6/28/21: Day 8 plasma exchange. Tolerating without complications. Platelet count improved today to 39,000. No bleeding reported. Scheduled for plasma exchanged twice today. 6/29/21: Day 9 plasma exchange. Will move to daily exchanges starting today given increase in platelet count. 6/30/21: Day 10 plasma exchange. Tolerating without complication. ADAMTS 13 and inhibitor ordered, results pending. 7/1/21: Day 11 plasma exchange. Has been tolerating without complication. ADAMTS 13 activity/inhibitor levels redrawn early this morning. Plan for cycle #2 Rituxan tomorrow. Peripheral smear showing less schistocytes. 7/2/21: Day 12 plasma exchange held. Cycle #2 Rituxan given and with plans to restart PEX 24 hours after completion. Has tolerated plasma exchange without complications thus far. 7/3/21: Hgb 7.6 g. Platelets 289,000. LDH 223. Continues on daily plasma exchanges. 7/4/21: Hgb 9.7 g. Platelets 321,000. LDH 221. 7/5/21: Hgb 8.3 g. Platelets 318,000. LDH 175. 7/6/21: Hgb 9.1 g. Platelets 283,000. Haptoglobin up to 100. LDH 184. ADAMTS13 inhibitor and activity level sent off. 7/7/21: Hgb 9.2 g. Platelets 300,000. LDH 224. ADAMTS13 activity from 07/02 came back at 30%. 7/8/21: Hgb 9.1 g. Platelets 244,000. LDH 162. Began holding plasmapheresis. 7/9/21: Hgb 9.9 g. Platelets 254,000. Received Rituxan. Tolerated well. LDH 194. 7/10/21: Hgb 10.3 g. Platelets 249,000. Prednisone changed to 90 mg. LDH 199. 7/11/21: Hgb 10.2 g. Platelets 250,000. LDH 205. Plasmapheresis performed. Tolerated well. DISCHARGED 7/13 with #4 Rituxan scheduled for 7/16/21 as outpatient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Facial paralysis
- Hospital-Tage
- 25,0
- Labordaten
- 6/20/21 ADAMTS15 activity <5 and inhibitor >8, platelets 14
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- NONE
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 43,0
- Geschlecht
- M
- Eingang
- 31.07.2021
- Impfdatum
- 31.07.2021
- Beginn
- 31.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fall
Fear of injection
Headache
Hyperhidrosis
Loss of consciousness
Mastication disorder
Nausea
Pallor
Symptomtext
after sitting him to wait 15 min he passed out and fell out of his chair. Pale, sweaty and nauseated but did not throw up. Said it was his needle phobia. Called later after the episode was over and he drove home to tell me his head hurt when he chewed so he would assume his head hit the floor.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- I took blood pressure 107/77 pulse 78
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- Seizures but not in over 5 years
- Andere Medikamente
- no. not mentioned
- Allergien
- no. not mentioned
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 48,0
- Geschlecht
- M
- Eingang
- 30.07.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Loss of consciousness
Neck pain
Pain
Pain in extremity
Presyncope
Symptomtext
The patient experienced profound arm pain starting the day of the shot and has since gotten worse since the first dose. It has continued to radiate to his shoulder and neck. The morning after receiving his shot he completely blacked out and was carried to a couch where he came several minutes later with no recollection. He almost passed out again a few hours later the same day. It was recommended to contact his PCP to see if second dose is needed. The PCP called the pharmacy today, 07/30/21, stating they recommend holding vaccine until patient is seen in office
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 25.07.2021
- Impfdatum
- 23.07.2021
- Beginn
- 24.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Back pain
Blood 25-hydroxycholecalciferol
Chest X-ray
Computerised tomogram
Electrocardiogram
Headache
Loss of consciousness
Syncope
Symptomtext
Patient received his second Moderna shot in our location on 7/23/2021 around 3 pm. On Saturday, 7/24 around 1130 am his daughter called to inform that his dad had fainted, got unconscious for approximately 1-2 minutes and was being transported to ER by emergency personnel at that precise moment for which she believes was adverse effects to his second Covid shot. I told her to keep me posted on that once he is stable. Around 440pm on Saturday, 7/24/21, his wife and patient came over to pick up some medications that have been sent from the ER. That included diphenhydramine, prochlorperazine and naproxen. I asked them for more details previous to event, during event and what ER personnel had said. Wife explained that he started with a headache and back pain the day after his shot and that he had not done anything different that morning. Suddenly he fainted, his eyes turned white, his hands got twisted and he fell unconscious for 1 minute. She said that it looked like an epilepsy episode but he did not have history of epilepsy or had anything like this before, as he was a healthy 38 y/o male. She explained to me that the only time he has been sick previously was when he got Covid infection late last year. She explained that at the hospital he got CT scan test, blood work, chest X-Ray and EKG and everything was normal.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- CT scan test, blood work, chest X-Ray and EKG and everything was normal AS REPORTED BY PATIENT'S WIFE- Details to be obtained from Emergency Room
- Aktuelle Erkrankungen
- No other illnesses
- Vorgeschichte
- Approximately 7 months post Covid-19 infection. Otherwise, healthy 38 y/o male.
- Andere Medikamente
- None disclosed
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 22.07.2021
- Impfdatum
- 22.07.2021
- Beginn
- 22.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cooling therapy
Dizziness
Fall
Fear
Hyperhidrosis
Loss of consciousness
Pallor
Symptomtext
The patient was fine immediately following the injection. I left him for about 5 minutes to get his immunization card. When I returned he was very pale and sweating profusely. He said he felt very dizzy and was quite frightened. I reached out to hold his arms and ease him to the floor when he fell backwards unconscious in the chair. I was able to keep him from falling to the ground and I called for help. He returned to consciousness after about 10 seconds and I applied a cold compress to his head and neck. He began feeling better rapidly and was able to drink water and rest comfortably. He was able to leave the area without further issue or need for medical attention
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- Blood pressure: 113/92 Pulse: 85
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 20.07.2021
- Impfdatum
- -
- Beginn
- 20.07.2021
- Tage bis Beginn
- -
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Loss of consciousness
Symptomtext
PATIENT TOOK HER COVID-19 SHOT AND AFTER SEATING FOR 15 MINUTES; PATIENT WENT ACROSS THE PHARMACY TO SHOP WITH HER MOM WERE SHE PASSED OUT TO THE FLOOR . THE EMS CAME AND TOOK HER TO THE HOSPITAL FOR FURTHER EXAMINATION.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- NOT KNOWN
- Aktuelle Erkrankungen
- DID NOT DISCLOSE
- Vorgeschichte
- DID NOT DISCLOSE
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 20.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blood pressure decreased
Loss of consciousness
Malaise
Tremor
Symptomtext
A few moments after getting Moderna vaccination, patient reported not feeling well. After asking a few questions, patient stated that she had fainted after shots before and had a severe fear of needles. We recommended that she stay seated in the IMZ room rather than getting up to wait in the waiting area. Her hands began to quiver and her head started to slump. I held her shoulders so she would not fall and asked if she was ok. She said she wanted to lie down. Her friend and I were able to gently lower her to the ground. She appeared to pass out for a brief moment, then awoke and was able to answer questions but still did not feel well. We raised her feet and offered to call 911 for evaluation. Patient felt continually better over the next 30 minutes. We checked her blood pressure and it was low. We rechecked about every 5-7 minutes and it was climbing. After feeling better for awhile, we helped her into a chair to see if she was well enough to go home. She mentioned that she had started feeling ill again. We checked her blood pressure and it had dropped again. She started feeling better within a few seconds and 5 minutes later her blood pressure was back up. Eventually she felt well and headed home with her companion who was very attentive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- previous post immunization syncope episodes
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- syncope after previous vaccines. exact vaccines unknown.
- Staat
- DC
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 06.07.2021
- Impfdatum
- 25.06.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dyspnoea
Heart rate increased
Syncope
Vomiting
Symptomtext
During her observation time, patient complained of a rapid heart beat, shortness of breath, she had an episode of vomiting, and a syncopal episode. She was referred to a primary care physician for further evaluation. Her condition stabilized prior to discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Vitamin D deficiency
- Andere Medikamente
- Ergocalciferol 1.25 MG (50000 UT) Capsule 1 capsule Orally weekly
- Allergien
- beef, lamb, alcohol, pork, chicken
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 02.07.2021
- Impfdatum
- 02.07.2021
- Beginn
- 02.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Syncope
Symptomtext
Patient fainted, awoke, and was dizzy.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- Patient refused medical treatment.
- Aktuelle Erkrankungen
- N/A.
- Vorgeschichte
- N/A.
- Andere Medikamente
- N/A.
- Allergien
- N/A.
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 28.06.2021
- Impfdatum
- 02.06.2021
- Beginn
- 02.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Aphasia
Asthenia
Dysphagia
Dysphonia
Feeling abnormal
Gait disturbance
Heart rate increased
Oral discomfort
Peripheral coldness
Pharyngeal swelling
Presyncope
Rash macular
Swelling
Throat irritation
Throat tightness
Urticaria
Symptomtext
After 7 minutes of the shot, the following events/symptoms started and gradually developed within 25 minutes: Fast heart beat, change in eyesight and then a feeling of neck disappearing-non existent. Episodes similar to Vasovagal (3) Involuntary movement of arms and legs Extremely cold hands, but I did not feel cold Burning sensation inside the mouth Numbness of mouth and lips, similar as when the dentist applies anesthesia Mild Swelling of the mouth and tongue Tightness and feeling of swollen throat and neck Difficult to speak-speaking as in slow motion Trouble swallowing Trouble walking, legs weakness (continue in next paragraph) For approximately 45 minutes Healthcare personnel at the facility provided lots of fluids and assistance until there were neither episodes similar to Vasovagal nor involuntary movement of arms and legs, the hands had a normal temperature, some strength was regained, the symptoms remain mild (did not increase) and there were no new symptoms. Hives in forehead, and red blotches in right cheek, neck, chest Hoarseness and feather sensation in throat After 2 hours of the shot, the hives and red blotches in the right cheek, neck, chest and the hoarseness and feather sensation in the throat developed. The mouth, tongue and neck were still swollen and numb. At that time, 50mg of Benadryl were ingested, again at bedtime, and for the next 2 weeks.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Presyncope
- Hospital-Tage
- -
- Labordaten
- None.
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Asthma, Ankylosing Spondylitis.
- Andere Medikamente
- None during that day. Benadryl was taken for two weeks until the day before the vaccine appointment.
- Allergien
- FluzonePFS, Aspirin, Imitrex, Prilosec, Chemicals, Mold, Pineapple, Kiwi.
- Vorherige Impfungen
- Hives, Asthma, Red blotches, fast heart beat / 58yrs old / 11-05-2020 / Fluzone PFS 2020-21 INJ 0.5ML
- Staat
- OH
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 16.06.2021
- Impfdatum
- 16.06.2021
- Beginn
- 16.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Nausea
Syncope
Symptomtext
Patient reported to feeling nauseous right after receiving the vaccine, and then fainted. He was assessed by EMS and refused to be transported to the hospital. He walked out with his wife after the event.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Syncope
- Hospital-Tage
- -
- Labordaten
- BP 110/70 Refused blood sugar and pulse ox
- Aktuelle Erkrankungen
- None reported
- Vorgeschichte
- None reported
- Andere Medikamente
- -
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 15.06.2021
- Impfdatum
- 11.06.2021
- Beginn
- 12.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Angiogram pulmonary normal
Arteriogram coronary normal
Chest pain
Echocardiogram normal
Ejection fraction normal
Dyspnoea
Heart rate increased
Nausea
Pyrexia
Laboratory test
Myocarditis
Troponin
Symptomtext
Chest pain/Myocarditis, treated with colchicine and NSAIDS, required hospitalization
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myocarditis
- Hospital-Tage
- 2,0
- Labordaten
- Labs, troponin 4, echocardiogram with normal EF, Cardiac CTA showed- normal, chest CTA- negative for PE
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- ADHD, depression
- Andere Medikamente
- Ritalin 20 mg
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 25.07.2022
- Impfdatum
- 22.07.2021
- Beginn
- 24.07.2022
- Tage bis Beginn
- 367,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Angiogram pulmonary normal
COVID-19
Chills
Chronic obstructive pulmonary disease
Cough
Dyspnoea
Fibrin D dimer increased
Hypoxia
Pyrexia
SARS-CoV-2 test positive
Tachycardia
Viral sepsis
Symptomtext
Provider d/c note: "Patient had presented with fever, chills, dyspnea and cough. On presentation she had tachycardia with a heart rate as high as 140. She had signs of viral sepsis and was positive for COVID infection. She had a mildly elevated D-dimer so underwent computed tomography angiogram chest which was negative for pulmonary embolism and there was no evidence of pneumonia. She is suspected to have some degree of COPD but has not been formally diagnosed but is a current smoker and utilizes inhalers at home. She was initially hypoxic with activity so was started on steroids. The following day she was maintaining adequate oxygen saturation with activity on room air so steroids were not continued. With hydration her tachycardia resolved. Patient was evaluated and felt to be stable for discharge. "
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 2,0
- Labordaten
- COVID Detected PCR on 07/24/22.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Current smoker GERD (gastroesophageal reflux disease) Obesity (BMI 30.0-34.9) Bipolar 1 disorder (*) Anxiety Hyperglycemia
- Andere Medikamente
- Albuterol Ashwagandha Root Extract Temovate Drisdol Xopenex Claritin Multivitamin Naproxen Prilosec Kenalog cream
- Allergien
- Amoxicillin Depakote Divalproex Sodium Penicillins Saxenda Aspirin Ibuprofen Benadryl Fentanyl Hydroxyzine Morphine Amerge
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 20.07.2022
- Impfdatum
- 16.07.2021
- Beginn
- 01.04.2022
- Tage bis Beginn
- 259,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anxiety
Arteriogram normal
Blood cholesterol increased
Blood test abnormal
Chest discomfort
Gait disturbance
Hypoaesthesia oral
Hypothyroidism
Limb discomfort
Nausea
Speech disorder
Tremor
Symptomtext
I have had anxiety with uncontrollable body shakes, nausea, chest pressure, lips and tongue going numb, unable to speak clearly. My legs feel like tree trunks and doesn't help to walk. I take PROZAC, levothyroxine due to low Thyroid function. now. These acute symptoms started in April and the body shakes happened in June. I am doing really good now and I don't know if it was due to a low Thyroid for it but I have never been told to that is was low before but the doctor told me that it could increase the anxiety so the low dose of PROZAC and levothyroxine is helping me.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- Blood work- Low Thyroid and elevated Cholesterol 07/2022. Arterial study normal 7/12/22. .
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Doxycycline; black elderberry; vitamin D; fish oil; BRAVELLE; turmeric; cumin; omeprazole
- Allergien
- LEVAQUIN; CIPRO; CECLOR; quinine; sulfa
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 06.07.2022
- Impfdatum
- 20.05.2021
- Beginn
- 21.06.2022
- Tage bis Beginn
- 397,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Chest pain
SARS-CoV-2 test positive
Symptomtext
6/21 37y.o. female with a PMH significant for hypertension and generalized anxiety disorder. Who presented from home with a chief complaint of chest pain of 1 day duration
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- 6/21 SARS-CoV-2, Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 10.02.2022
- Beginn
- 08.05.2022
- Tage bis Beginn
- 87,0
- Dosis
- 3
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Arthralgia
Atelectasis
Atrial fibrillation
Back pain
Blood bicarbonate increased
Blood gases
Blood pH normal
COVID-19
COVID-19 pneumonia
Chest X-ray abnormal
Chest pain
Chronic respiratory failure
Confusional state
Cough
Dyspnoea
Electrocardiogram abnormal
Exposure to SARS-CoV-2
Fatigue
Symptomtext
ED visit (5.6.22); Hospitalized w/ COVID (5.8.22); COVID-19 positive (5.1.22 / 5.8.22); Fully vaccinated PLUS two boosters. BRIEF OVERVIEW: Discharge Provider: Primary Care Provider: Admission Date: 5/8/2022; Discharge Date: May 13, 2022; DETAILS OF HOSPITAL STAY:PRESENTING PROBLEM: Hypoxia [R09.02]; Pneumonia due to COVID-19 virus [U07.1, J12.82]; COVID-19 [U07.1]; HOSPITAL COURSE: Pt is a 78 yr old F with PMHx of chronic hypoxic respiratory failure on 8L via NC at baseline, COPD, CAD, CHF, A-Fib, HTN, HLD, depression, OSA and obesity, presented to the ER on 5/8 with c/o worsening dyspnea. She is fully vaccinated, tested positive on 5/1 for COVID-19 and received molnupiravir (an antiviral) on 5/3 as outpatient. However, she continued to experience fatigue, hypoxia which prompted her ED visit. In the ER, she was borderline febrile, normotensive, tachycardic and tachypneic, maintaining appropriate oxygen saturations on 15 L/min NRB mask. Initial venous gas showed normal serum pH with likely chronically elevated pCO2 of 56 and bicarbonate of 30. Other initial labs show stable renal dysfunction, elevated proBNP, normal procalcitonin, normocytic anemia, and her COVID-19 screen is again positive. EKG showed A-Fib with RVR. CXR shows patchy bibasilar opacities suggestive of atelectasis vs infiltrate/pneumonia without significant interval change from imaging 2 days ago. Admitted for further management - started on Decadron x 10 days, Remdesivir x 5 days for COVID-19 PNA. There was concern for superimposed bacterial infection - Pulmonary consulted and empiric IV Cefepime/Doxycycline initiated. Sputum cultured attempted but unsuccessful. Clinically - her symptoms improved with return to baseline of her oxygen demands. On 5/11 - patient had left shoulder pain while attempting to move in bed. X ray concerning for left shoulder dislocation. Ortho consulted - felt it was chronic left rotator cuff tear with plans for outpatient follow up. PT/OT recommend Home with assist and home health. She was transitioned to oral Ceftin/Doxycyline for 3 more days to complete a total of 7 days of Antibiotics, as well as Decadron for total of 10 days. We reviewed stopping Amlodipine and reducing Lisinopril to 10 mg once daily as blood pressures well controlled in the hospital. Also discussed resuming Azithromycin daily once completion of current antibiotics - patient and son voiced understanding. She is discharged on 05/13/2022 in stable condition.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 5,0
- Labordaten
- -
- Aktuelle Erkrankungen
- 4.22.22 - PCP appointment for med check - chronic respiratory failure, chronic low back pain, intermittent confusion; 5.1.22 - patient called nurse triage for yellow phlegm and cough, sort throat, burning chest, HA - son COVID positive; COVID positive 5.1.22; Told to contact monoclonal antibody clinic. Will prescribe Paxlovid if not a MAB candidate. 5.6.22 - clinically worsened, presented to ED.
- Vorgeschichte
- Atrial fibrillation (HCC); OSA (obstructive sleep apnea); Tobacco abuse- quit smoking July 2013; COPD (chronic obstructive pulmonary disease) (HCC); Essential hypertension; Depression; Hypercholesterolemia; Environmental allergies; Chronic pain of left knee CAD (coronary artery disease); Stage 3 chronic kidney disease (HCC); Obesity, morbid (HCC) Platelets decreased (HCC); Community acquired pneumonia of right lower lobe of lung Chronic low back pain without sciatica, unspecified back pain laterality; Chronic respiratory failure with hypoxia (HCC); Leg edema, right; Frequent urination at night; Atrial fibrillation, unspecified type (HCC).
- Andere Medikamente
- Albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA); inhaler;apixaban (ELIQUIS); Aspirin chewable tablet; atorvastatin (LIPITOR) 40 MG tablet; azithromycin (ZITHROMAX) 250 MG tablet; benzonatate (TESSALON) 100 MG capsule; budesonide/f
- Allergien
- Hydrochlorothiazide-Hives
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 27.04.2022
- Impfdatum
- 29.06.2021
- Beginn
- 04.04.2022
- Tage bis Beginn
- 279,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Condition aggravated
Headache
Nausea
SARS-CoV-2 test positive
Vomiting
Symptomtext
4/4/22 PMH: spinal cord injury from GSW, quadriplegia, colostomy, neurogenic bladder with suprapubic catheter, UTIs, kidney stones, decubitus ulcer, DVT s/p IVC on Xarelto, gastroparesis, hypotension on midodrine, chronic pain. Presents with a chief complaint of a worsening headache.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- 4/4/21 SARS-CoV-2 (COVID-19) and by Nucleic Acid Amplification, POC--Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 27.04.2022
- Impfdatum
- 29.06.2021
- Beginn
- 04.04.2022
- Tage bis Beginn
- 279,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Condition aggravated
Headache
Nausea
SARS-CoV-2 test positive
Vomiting
Symptomtext
4/4/22 PMH: spinal cord injury from GSW, quadriplegia, colostomy, neurogenic bladder with suprapubic catheter, UTIs, kidney stones, decubitus ulcer, DVT s/p IVC on Xarelto, gastroparesis, hypotension on midodrine, chronic pain. Presents with a chief complaint of a worsening headache.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- 4/4/21 SARS-CoV-2 (COVID-19) and by Nucleic Acid Amplification, POC--Detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 61,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 31.07.2021
- Beginn
- 31.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chest discomfort
Dyspnoea
Symptomtext
hard to get my breath for 3-4 hours/hard to breathe; a concrete block laying on my chest/chest discomfort; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (hard to get my breath for 3-4 hours/hard to breathe) and CHEST DISCOMFORT (a concrete block laying on my chest/chest discomfort) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 31-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jul-2021, the patient experienced DYSPNOEA (hard to get my breath for 3-4 hours/hard to breathe) and CHEST DISCOMFORT (a concrete block laying on my chest/chest discomfort). At the time of the report, DYSPNOEA (hard to get my breath for 3-4 hours/hard to breathe) and CHEST DISCOMFORT (a concrete block laying on my chest/chest discomfort) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were provided by the reporter No treatment information were provided by the reporter
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 22.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Condition aggravated
Insomnia
Pruritus
Symptomtext
itching in her body; very very itchy and keeps getting worse; She wakes up 28 times in the night, scratching; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching in her body), CONDITION AGGRAVATED (very very itchy and keeps getting worse) and INSOMNIA (She wakes up 28 times in the night, scratching) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching in her body), CONDITION AGGRAVATED (very very itchy and keeps getting worse) and INSOMNIA (She wakes up 28 times in the night, scratching). At the time of the report, PRURITUS (itching in her body), CONDITION AGGRAVATED (very very itchy and keeps getting worse) and INSOMNIA (She wakes up 28 times in the night, scratching) had not resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant product use was not provided. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 28.06.2021
- Beginn
- 28.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Asthenia
Blister
Blood pressure measurement
Body temperature
Burning sensation
Culture
Dyspnoea exertional
Grip strength
Pain in extremity
Pruritus
Pyrexia
Rash pruritic
SARS-CoV-2 test
Vaccination site erythema
Vaccination site induration
Vaccination site reaction
Vaccination site warmth
Symptomtext
Still has SOB with exertion; Itchy rash; Less strength in her left arm than before the vaccine; Itchy skin blisters; Arm hot below the injection site; Itchy skin blisters; Pain in her arm; Burning skin blisters; Covid arm; Arm hard below the injection site; Shoulder pain / worsening of left shoulder pain; Arm red below the injection site; Fever/fever fluctuated between these temperatures for 3 days; This spontaneous case was reported by a nurse and describes the occurrence of ASTHENIA (Less strength in her left arm than before the vaccine), PRURITUS (Itchy skin blisters), VACCINATION SITE WARMTH (Arm hot below the injection site), BLISTER (Itchy skin blisters) and PAIN IN EXTREMITY (Pain in her arm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19. Concomitant products included AMLODIPINE BESILATE (NORVASC) for Blood pressure high. On 28-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jun-2021, the patient experienced PYREXIA (Fever/fever fluctuated between these temperatures for 3 days). On 29-Jun-2021, the patient experienced PRURITUS (Itchy skin blisters), VACCINATION SITE WARMTH (Arm hot below the injection site), BLISTER (Itchy skin blisters), PAIN IN EXTREMITY (Pain in her arm), BURNING SENSATION (Burning skin blisters), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE INDURATION (Arm hard below the injection site), ARTHRALGIA (Shoulder pain / worsening of left shoulder pain) and VACCINATION SITE ERYTHEMA (Arm red below the injection site). On 06-Jul-2021, the patient experienced ASTHENIA (Less strength in her left arm than before the vaccine). On 09-Jul-2021, the patient experienced RASH PRURITIC (Itchy rash). On an unknown date, the patient experienced DYSPNOEA EXERTIONAL (Still has SOB with exertion). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at a dose of 1 dosage form; ACYCLOVIR [ACICLOVIR] on 29-Jun-2021 for Blister, at a dose of 800 milligram four times per day; TRIAMCINOLONE ACETONIDE (KENALOG ORABASE) on 07-Jul-2021 for Blister, at a dose of 1 dosage form and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) on 03-Jul-2021 for Itching, at a dose of 1 dosage form. On 01-Jul-2021, PYREXIA (Fever/fever fluctuated between these temperatures for 3 days) had resolved. On 09-Jul-2021, PRURITUS (Itchy skin blisters) and BURNING SENSATION (Burning skin blisters) had resolved, BLISTER (Itchy skin blisters) outcome was unknown. At the time of the report, ASTHENIA (Less strength in her left arm than before the vaccine), VACCINATION SITE WARMTH (Arm hot below the injection site), PAIN IN EXTREMITY (Pain in her arm), RASH PRURITIC (Itchy rash), DYSPNOEA EXERTIONAL (Still has SOB with exertion), VACCINATION SITE REACTION (Covid arm), VACCINATION SITE INDURATION (Arm hard below the injection site), ARTHRALGIA (Shoulder pain / worsening of left shoulder pain) and VACCINATION SITE ERYTHEMA (Arm red below the injection site) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In November 2020, SARS-CoV-2 test: positive (Positive) Positive. On 29-Jun-2021, Body temperature: 102.4 (High) 102.4 degree F . After taking Tylenol fever reduced to 99.4degree F. On 01-Jul-2021, Blood pressure measurement: 161/94 (High) 161/94mmHg. On 01-Jul-2021, X-ray: negative (Negative) Negative Shoulder x-ray was normal.. On 06-Jul-2021, Grip strength: abnormal (abnormal) abnormal less strength in her left arm than before the vaccine. On 07-Jul-2021, Culture: negative (Negative) Negative for Shingles or herpes. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Patient reported that her arm was red and hot for 6 x 3 inches. The patient also reported that she was not planning for second dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea exertional
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210701; Test Name: Blood pressure measurement; Result Unstructured Data: 161/94mmHg; Test Date: 20210629; Test Name: Body Temperature; Result Unstructured Data: 102.4 degree F . After taking Tylenol fever reduced to 99.4degree F; Test Date: 20210707; Test Name: Blister fluid test; Test Result: Negative ; Result Unstructured Data: Negative for Shingles or herpes; Test Date: 20210706; Test Name: Grip strength; Result Unstructured Data: abnormal less strength in her left arm than before the vaccine; Test Date: 202011; Test Name: SARS-CoV-2 test; Test Result: Positive ; Result Unstructured Data: Positive; Test Date: 20210701; Test Name: X-Ray; Test Result: Negative ; Result Unstructured Data: Negative Shoulder x-ray was normal.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19
- Andere Medikamente
- NORVASC
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 92,0
- Geschlecht
- F
- Eingang
- 31.01.2022
- Impfdatum
- 27.10.2021
- Beginn
- 30.01.2022
- Tage bis Beginn
- 95,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Dyspnoea
SARS-CoV-2 test positive
Symptomtext
Admitted with shortness of breath
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 2,0
- Labordaten
- 01/30/2022 - SARS-CoV-2 Antigen (++)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 07.09.2021
- Beginn
- 17.01.2022
- Tage bis Beginn
- 132,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: unbekannt
COVID-19
Chronic obstructive pulmonary disease
Dyspnoea
Positive airway pressure therapy
SARS-CoV-2 test positive
Tachypnoea
Symptomtext
72-year-old female with past medical history of non-insulin-dependent diabetes, hypertension, hyperlipidemia arrived to ED complaining of shortness of breath. She tested positive for COVID-19 and had increasing oxygenation requirements in the emergency department requiring BiPAP 40%. She was transferred to our facility for further care. ---------- Hospital course: 1/18: Patient appeared comfortable on BIPAP this AM. Transitioned to HHF but unable to tolerate due to tachypnea. Likely a COPD component more than oxygenation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- sulfa drugs
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 12.01.2022
- Impfdatum
- 23.06.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 196,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Chest X-ray normal
Chest pain
Cough
Nausea
Pain
SARS-CoV-2 test positive
Sleep disorder
Vomiting
Symptomtext
01/05/2022: Event occurred after 2nd vaccine. 55 y/o female with a PMH of COPD, asthma, HTN, left pneumothorax and right breast cancer who presents to the ED for chest pain, described as stabbing as well as on and off body aches and nausea vomiting. As well as coughing. Been going on for the past two weeks and usually starts in the morning occasionally waking her up from sleep. Pt states that the pain has been about the same for the past two weeks, but she did develop a cough yesterday. Pt also denies previous PE, DVT or any current nausea, vomiting, headache, changes in vision or hearing, abdominal pain, calf pain, diarrhea or blood in stool, dysuria or hematuria. Pt denies any known COVID positive or other sick contacts.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- 1,0
- Labordaten
- 01/05/2022: COVID positive. chest- IMPRESSION: No acute process
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- COPD, Asthma, HTN Rt breast cancer
- Andere Medikamente
- unknown
- Allergien
- morphine motrin, penicillin, tylenol
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 11.01.2022
- Impfdatum
- 08.06.2021
- Beginn
- 14.11.2021
- Tage bis Beginn
- 159,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Acute kidney injury
Anticoagulant therapy
Asthenia
Blood potassium decreased
COVID-19
COVID-19 pneumonia
Chest discomfort
Cough
Diarrhoea
Fatigue
Hypokalaemia
Hypoxia
Ileus
Malaise
SARS-CoV-2 test positive
Symptomtext
Pt fully vaccinated. COVID positive on 11/14/2021. Admitting dx: COVID-19 pneumonia, hypoxia, ileus, acute renal failure. The patient came because of severe diarrhea and cough with chest tightness, sharp in nature. The patient has been sick for the past 5 days. She was tested positive for COVID. She was having profuse diarrhea with generalized fatigue and weakness. Her potassium was very low that has been under a replacement. Denying any fever. No chills. No blood in the stool or the urine. Treatment: oxygen, steroids, Lovenox, hypokalemia correction, hydration. Discharged to home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- 4,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 27.12.2021
- Impfdatum
- 03.07.2021
- Beginn
- 24.12.2021
- Tage bis Beginn
- 174,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Body temperature increased
COVID-19
Cough
Dyspnoea
Fatigue
Myalgia
Pyrexia
SARS-CoV-2 antibody test
SARS-CoV-2 test positive
Symptomtext
This is a 55-year-old male patient Came into the ER with a complaint of cough shortness of breath and fever For last 24 hours T-max recorded in ER 100.9 Patient feels complain of myalgia and fatigue
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- 3,0
- Labordaten
- 12/25/2021 - SARS-CoV-2 Antigen (++) 12/25/2021 - SARS-CoV-2 IgM 0.05, IgG 0.02, IgG2 QT-SPIKE 1721.2
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Dyslipidemia, HTN. Significant Surg Hx None. Smoking Status Former Smoker.
- Andere Medikamente
- ascorbic acid (vitamin C) 1,000 mg Tablet Directions: 1 tablet oral daily (Active) atorvastatin 10 mg Tablet Directions: 1 tablet oral daily at bedtime (Active) cholecalciferol (vitamin D3) 1,000 unit Capsule Directions: 1 capsule oral
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 02.12.2021
- Impfdatum
- 02.11.2021
- Beginn
- 28.11.2021
- Tage bis Beginn
- 26,0
- Dosis
- 3
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Acute kidney injury
Asymptomatic COVID-19
Blood glucose increased
Chest X-ray normal
Dehydration
Diabetic ketoacidosis
Dysuria
Pancreatitis chronic
Pollakiuria
SARS-CoV-2 test positive
Type 1 diabetes mellitus
Vomiting
Symptomtext
11/28/21 ED note: "Patient is 63-year-old female history of diabetes, hypertension, hyperlipidemia presents with abdominal pain, emesis. She reports intermittent abdominal pain for the past 3 days. She reports episodes of emesis tonight. She denies diarrhea, constipation, melena, medic hematochezia. She denies fever, chills, chest pain, shortness of breath. Reports sugars have been elevated at home. "11/29/21 resident's note: '63 y.o. year-old female with history of T2DM, HTN, HLD, and Gout who presented with elevated blood sugars and DKA. Patient is sitting up in the bedside chair saturating 99% on RA. Spoke to patient over the phone. She is feeling better than yesterday and is ambulating well in her room. She endorses increased frequency in urination and pain with urination. She denies HA, CP, SOB, N/V, diarrhea, or leg pain. PCR was positive for COVID 19 upon admission, but asymptomatic". 11/29/21 ID's note: "Acute COVID 19 infection in vaccinated patient w/ Moderna, s/p booster 11/2/21 - mild sx for 3 days, possible household exposure 21. Decompensated IDDM w/ DKA - has not taken her insulin for the past 3 days 3. AKI - likely from dehydration 4. Chr pancreatitis 5. Multiple comorbidities including CHF s/ p AICD, gout, HTN, DM etc. mAbs w/ casi/imde 600 mg/600 mg iv x1 since pt w/ multiple comorbidities, and at risk for progression Discussed with patient re: investigational use of casirivimab/imdevimab, explained the rationale of blocking SARS-CoV2 at the onset of disease and the benefits observed with less progression of disease and need for hospitalization; also explained the risk of infusion allergic reactions and the need for monitoring. Pt agreed to proceed" .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dehydration
- Hospital-Tage
- 3,0
- Labordaten
- 11/29/21 Contains abnormal data SARS-COV-2 High Sens PCR w/Cycle No. Detected, Current CN Value 19.78. 11/28/21 XR chest: "Negative: No radiographic evidence of pneumonia. "
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- T2DM, HLD, insomnia, HTN, gout, GERD, and Asthma
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 15.11.2021
- Impfdatum
- 22.10.2021
- Beginn
- 07.11.2021
- Tage bis Beginn
- 16,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: nein
Blood pressure increased
Carditis
Palpitations
Symptomtext
On 11/07/2021, patient was feeling heart palpitations and drove himself to the hospital. They kept him from that Sun. until Tues. doing further testing. Hx. of anxiety, and they found elevated B/P. They ordered an event monitor to be worn x30 days after he receives it. Is not on any meds. Dr. mentioned his heart inflammation could be from the vaccine. Hx. smoking off and on.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- 2,0
- Labordaten
- None were brought to medical for us to review.
- Aktuelle Erkrankungen
- None known.
- Vorgeschichte
- Anxiety, takes no medication for it.
- Andere Medikamente
- None known
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 12.11.2021
- Impfdatum
- 30.12.2020
- Beginn
- 05.11.2021
- Tage bis Beginn
- 310,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain upper
Dizziness
Fatigue
Haemorrhage
Headache
Hypoaesthesia
Myalgia
Piloerection
Tremor
Vomiting
Symptomtext
bleeding; stomach pain; felt light-headed; legs start shaking; her legs were shaking so much she couldn't even feel them; goosebumps; headaches; body aches; vomiting; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of HAEMORRHAGE (bleeding) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A, 004M20A and 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR SR), PROPRANOLOL HYDROCHLORIDE (PROPRANOLOL [PROPRANOLOL HYDROCHLORIDE]) and HYDROXYZINE HYDROCHLORIDE (HYDROXYZINE [HYDROXYZINE HYDROCHLORIDE]) for an unknown indication. On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Nov-2021, the patient experienced HAEMORRHAGE (bleeding) (seriousness criterion medically significant), ABDOMINAL PAIN UPPER (stomach pain), DIZZINESS (felt light-headed), TREMOR (legs start shaking), PILOERECTION (goosebumps), HEADACHE (headaches), MYALGIA (body aches), VOMITING (vomiting) and FATIGUE (fatigue). 05-Nov-2021, the patient experienced HYPOAESTHESIA (her legs were shaking so much she couldn't even feel them). At the time of the report, HAEMORRHAGE (bleeding), HEADACHE (headaches) and MYALGIA (body aches) had not resolved and ABDOMINAL PAIN UPPER (stomach pain), DIZZINESS (felt light-headed), TREMOR (legs start shaking), HYPOAESTHESIA (her legs were shaking so much she couldn't even feel them), PILOERECTION (goosebumps), VOMITING (vomiting) and FATIGUE (fatigue) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Treatment medications was not provided. Company comment- This case concerns a 26-year-old female patient with no relevant medical history, who experienced the unexpected event of Hemorrhage. The event occurred the same day after receiving the third dose of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge was not applicable since only information about the third dose was disclosed. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report. This case was linked to MOD-2021-378037, MOD-2021-378042 (Patient Link).; Sender's Comments: This case concerns a 26-year-old female patient with no relevant medical history, who experienced the unexpected event of Hemorrhage. The event occurred the same day after receiving the third dose of mRNA-1273 (Moderna COVID-19 Vaccine). The rechallenge was not applicable since only information about the third dose was disclosed. The benefit-risk relationship of mRNA-1273 (Moderna COVID-19 Vaccine) is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tremor
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Effexor SR; Propranolol [Propranolol Hydrochloride]; Hydroxyzine [Hydroxyzine Hydrochloride]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 89,0
- Geschlecht
- M
- Eingang
- 26.10.2021
- Impfdatum
- 26.05.2021
- Beginn
- 22.10.2021
- Tage bis Beginn
- 149,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Failure to thrive
Pneumonia
Symptomtext
Pt admitted with LLL pneumonia as well as failure to thrive.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 29.09.2021
- Impfdatum
- 22.06.2021
- Beginn
- 30.08.2021
- Tage bis Beginn
- 69,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
Exposure to SARS-CoV-2
Feeling abnormal
Nasal congestion
Oropharyngeal pain
Palpitations
Pulmonary congestion
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
I went to visit my grandson and he wasn't well. The day I drove back home on the 30th is when I noticed I was feeling bad. He tested positive of COVID. The next day I had a stuffy nose and sore throat and weird heart palpitation and congested. I felt sick but not overwhelmed. I went to the Emergency Room and got a Covid test and it was positive. I felt sick and bad for 3-4 days and then felt fine. I was tired and felt like I had a really bad cold but without breathing or chest issues.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- COVID test - positive
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- I have arthritis
- Andere Medikamente
- I take Sertraline 50mg, Naproxen 100mg, Omeprazole 20mg
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 29.09.2021
- Impfdatum
- 25.08.2021
- Beginn
- 26.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure increased
Blood pressure measurement
Chills
Computerised tomogram
Confusional state
Dizziness
Dyspnoea
Headache
Hyperhidrosis
Pyrexia
Sleep deficit
Vaccination site pain
Symptomtext
sweating profusely from his palms and feet; dizziness; could not breathe; severe headache; Confusion; Sleep deprivation; High BP; chills; sore arm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (severe headache), CONFUSIONAL STATE (Confusion), SLEEP DEFICIT (Sleep deprivation), BLOOD PRESSURE INCREASED (High BP), HYPERHIDROSIS (sweating profusely from his palms and feet), DIZZINESS (dizziness) and DYSPNOEA (could not breathe) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 25-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Aug-2021, the patient experienced CHILLS (chills), VACCINATION SITE PAIN (sore arm) and PYREXIA (Fever). On 29-Aug-2021, the patient experienced HEADACHE (severe headache) (seriousness criterion hospitalization), CONFUSIONAL STATE (Confusion) (seriousness criterion hospitalization), SLEEP DEFICIT (Sleep deprivation) (seriousness criterion hospitalization), BLOOD PRESSURE INCREASED (High BP) (seriousness criterion hospitalization), DIZZINESS (dizziness) (seriousness criterion hospitalization) and DYSPNOEA (could not breathe) (seriousness criterion hospitalization). On 06-Sep-2021, the patient experienced HYPERHIDROSIS (sweating profusely from his palms and feet) (seriousness criterion hospitalization). The patient was hospitalized on 06-Sep-2021 due to BLOOD PRESSURE INCREASED, CONFUSIONAL STATE, DIZZINESS, DYSPNOEA, HEADACHE, HYPERHIDROSIS and SLEEP DEFICIT. At the time of the report, HEADACHE (severe headache), CONFUSIONAL STATE (Confusion), SLEEP DEFICIT (Sleep deprivation), BLOOD PRESSURE INCREASED (High BP), DIZZINESS (dizziness) and DYSPNOEA (could not breathe) outcome was unknown, HYPERHIDROSIS (sweating profusely from his palms and feet) and VACCINATION SITE PAIN (sore arm) had not resolved and CHILLS (chills) and PYREXIA (Fever) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 30-Aug-2021, Blood pressure measurement (97-166): 166/97 (High) High. On 30-Aug-2021, Computerised tomogram: abnormal (abnormal) Cat Scan were splotches showing on the white matter of his brain they released him. On 06-Sep-2021, Blood pressure measurement (97-166): 178/110 (High) High. Concomitant medication was not provided Treatment medication was not provided Company Comment: This case concerns a 51 year-old male patient, with no medical history reported, who experienced the unexpected adverse events of HEADACHE, DIZZINESS, DYSPNOEA, CONFUSIONAL STATE, SLEEP DEPRIVATION, BLOOD PRESSURE INCREASED and HYPERHIDROSIS. Events of headache, dizziness, dyspnoea, confusional state, sleep deprivation and blood pressure increased occurred 4 days after the second dose of Spikevax. Event of hyperhidrosis occurred approximately 12 days after the second dose of Spikevax. Negative rechallenge remains a confounder. The benefit-risk relation of Spikevax is not affected by this report. Further information is expected for assessment. This case was linked to MOD-2021-321038 (Patient Link).; Sender's Comments: This case concerns a 51 year-old male patient, with no medical history reported, who experienced the unexpected adverse events of HEADACHE, DIZZINESS, DYSPNOEA, CONFUSIONAL STATE, SLEEP DEPRIVATION, BLOOD PRESSURE INCREASED and HYPERHIDROSIS. Events of headache, dizziness, dyspnoea, confusional state, sleep deprivation and blood pressure increased occurred 4 days after the second dose of Spikevax. Event of hyperhidrosis occurred approximately 12 days after the second dose of Spikevax. Negative rechallenge remains a confounder. The benefit-risk relation of Spikevax is not affected by this report. Further information is expected for assessment.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210830; Test Name: blood pressure; Result Unstructured Data: High; Test Date: 20210906; Test Name: blood pressure; Result Unstructured Data: High; Test Date: 20210830; Test Name: CT Scan; Result Unstructured Data: Cat Scan were splotches showing on the white matter of his brain they released him
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 21.08.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Hypoaesthesia
Musculoskeletal stiffness
Myalgia
Nausea
Paraesthesia
Pyrexia
Symptomtext
had a lot of pain (cramping) with menstruation/pain (cramping) made her feel like she wanted to throw up; cold (chills); The next day she got hot; she had all over muscle pain; her left arm down to her hand was numb; her left arm down to her hand was limp/she dropped things in her left hand a lot; tingling in her left arm when she got up; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (her left arm down to her hand was numb), MUSCULOSKELETAL STIFFNESS (her left arm down to her hand was limp/she dropped things in her left hand a lot), PARAESTHESIA (tingling in her left arm when she got up), NAUSEA (had a lot of pain (cramping) with menstruation/pain (cramping) made her feel like she wanted to throw up) and CHILLS (cold (chills)) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No medical history was provided by the reporter. Concomitant products included IRON and BIOTIN for an unknown indication. On 21-Aug-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In August 2021, the patient experienced PARAESTHESIA (tingling in her left arm when she got up). On 21-Aug-2021, the patient experienced HYPOAESTHESIA (her left arm down to her hand was numb), MUSCULOSKELETAL STIFFNESS (her left arm down to her hand was limp/she dropped things in her left hand a lot) and MYALGIA (she had all over muscle pain). On 22-Aug-2021, the patient experienced CHILLS (cold (chills)) and PYREXIA (The next day she got hot). On 12-Sep-2021, the patient experienced NAUSEA (had a lot of pain (cramping) with menstruation/pain (cramping) made her feel like she wanted to throw up). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HYPOAESTHESIA (her left arm down to her hand was numb), MUSCULOSKELETAL STIFFNESS (her left arm down to her hand was limp/she dropped things in her left hand a lot), PARAESTHESIA (tingling in her left arm when she got up), NAUSEA (had a lot of pain (cramping) with menstruation/pain (cramping) made her feel like she wanted to throw up), CHILLS (cold (chills)), PYREXIA (The next day she got hot) and MYALGIA (she had all over muscle pain) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Comments: No medical history was provided by the reporter.
- Andere Medikamente
- IRON; BIOTIN
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 04.09.2021
- Impfdatum
- 24.06.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 35,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Abdominal discomfort
Abdominal pain upper
Cardiac discomfort
Chest pain
Chills
Cold sweat
Dizziness
Feeling abnormal
Nausea
Pain
Pyrexia
Vomiting
White blood cell count increased
Symptomtext
Slight white blood cell count increase; slight on and off stomach symptoms; pain; Nausea; vomiting; cold chills; Feverish; stomach pain and tender/sore and tender stomach; dizziness; He felt like he had some cardiac angina; chest pain; though he was going to die; cold sweats; This spontaneous case was reported by a consumer and describes the occurrence of WHITE BLOOD CELL COUNT INCREASED (Slight white blood cell count increase), ABDOMINAL DISCOMFORT (slight on and off stomach symptoms), ABDOMINAL PAIN UPPER (stomach pain and tender/sore and tender stomach), DIZZINESS (dizziness) and CARDIAC DISCOMFORT (He felt like he had some cardiac angina) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 24-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 29-Jul-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain and tender/sore and tender stomach), DIZZINESS (dizziness), CARDIAC DISCOMFORT (He felt like he had some cardiac angina), CHEST PAIN (chest pain), FEELING ABNORMAL (though he was going to die), COLD SWEAT (cold sweats), NAUSEA (Nausea), VOMITING (vomiting), CHILLS (cold chills) and PYREXIA (Feverish). On an unknown date, the patient experienced WHITE BLOOD CELL COUNT INCREASED (Slight white blood cell count increase), ABDOMINAL DISCOMFORT (slight on and off stomach symptoms) and PAIN (pain). The patient was treated with IBUPROFEN for Pain and Nausea, at an unspecified dose and frequency and SULFIRAM (intravenous) for Pain and Nausea, at an unspecified dose and frequency. At the time of the report, WHITE BLOOD CELL COUNT INCREASED (Slight white blood cell count increase), ABDOMINAL DISCOMFORT (slight on and off stomach symptoms), ABDOMINAL PAIN UPPER (stomach pain and tender/sore and tender stomach), DIZZINESS (dizziness), CARDIAC DISCOMFORT (He felt like he had some cardiac angina), CHEST PAIN (chest pain), FEELING ABNORMAL (though he was going to die), COLD SWEAT (cold sweats), PAIN (pain), NAUSEA (Nausea), VOMITING (vomiting), CHILLS (cold chills) and PYREXIA (Feverish) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Jul-2021, SARS-CoV-2 test: negative (Negative) Negative. On 29-Jul-2021, White blood cell count: increased (High) slight increased. No concomitant medications were provided by the reported. The Patient had no reactions with the first shot. Heart EKG, liver, chest x-ray and blood work were done at the emergency department. Results were not provided. The patient was treated with opioids, anti-nausea drugs and IV fluids. Most recent FOLLOW-UP information incorporated above includes: On 20-Aug-2021: Followup received, events slight on and off stomach symptoms and Slight white blood cell count increase added
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210729; Test Name: COVID-19; Test Result: Negative ; Result Unstructured Data: Negative; Test Date: 20210729; Test Name: White blood cells; Result Unstructured Data: slight increased
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 31.08.2021
- Impfdatum
- 12.08.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Herpes zoster
Hypertension
Rash
Symptomtext
Excruciating pain in shoulder blade and surrounding shoulder area front and back side of body. Eventually resulting in an outbreak of a rash. Diagnosed at urgent care 08-30-2021 as an outbreak of Shingles.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- 08-30-2021 Assessment: High Blood Pressure, Shingles. Doctor explained he had diagnosed 4 other patients with exact symptoms following the covid19 vaccination.
- Aktuelle Erkrankungen
- Mgus
- Vorgeschichte
- Mgus, history of clotting, Bilateral Embolism,
- Andere Medikamente
- Xarelto 20mg, Atorvastatin 80mg, Hair skin and nails, Tart Cherry extract, Tumeric, Peppermint extract,
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NV
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 31.08.2021
- Impfdatum
- 12.08.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Herpes zoster
Hypertension
Rash
Symptomtext
Excruciating pain in shoulder blade and surrounding shoulder area front and back side of body. Eventually resulting in an outbreak of a rash. Diagnosed at urgent care 08-30-2021 as an outbreak of Shingles.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypertension
- Hospital-Tage
- -
- Labordaten
- 08-30-2021 Assessment: High Blood Pressure, Shingles. Doctor explained he had diagnosed 4 other patients with exact symptoms following the covid19 vaccination.
- Aktuelle Erkrankungen
- Mgus
- Vorgeschichte
- Mgus, history of clotting, Bilateral Embolism,
- Andere Medikamente
- Xarelto 20mg, Atorvastatin 80mg, Hair skin and nails, Tart Cherry extract, Tumeric, Peppermint extract,
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 12.08.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Paraesthesia
Symptomtext
tingling in leg; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in leg) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 vaccination. No Medical History information was reported. On 12-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PARAESTHESIA (tingling in leg). At the time of the report, PARAESTHESIA (tingling in leg) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication was not provided. Treatment information was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 22.08.2021
- Impfdatum
- 25.06.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Heart rate increased
Injection site erythema
Injection site oedema
Injection site warmth
Migraine
Nausea
Vomiting
Symptomtext
Large red area with warmth and edema to injection site, migraine, nausea, vomiting, elevated heart rate and blood pressure, weakness
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Migraine
- Hospital-Tage
- -
- Labordaten
- Flu, strep, CBC, UA on 6-26-21
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- OSA, RA, Fibromyalgia
- Andere Medikamente
- Cymbalta , Cymbalta qam, Celebrex bid, iron, allegra qd
- Allergien
- Lyrica
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 20.08.2021
- Impfdatum
- 24.06.2021
- Beginn
- 24.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Injection site erythema
Injection site swelling
Injection site warmth
Palpitations
Symptomtext
I don't remember if I was at pharmacy at 4pm or 5pm exact. However, getting the shot, was easy. I was so shocked how easy it was. But the aftermath, became a different story. I had a few small items to purchase at the store. So, I got up and started walking from the pharmacy over to produce at a fast pace (for me). Within about 2 minutes, my heart was pounding fast. It scared me. I paused at flowers, took deep breathes, and started moving much slower. I felt a large, strong adrenaline rush in my body, but heart racing had slowed down. Since my heart slowed down, I thought, "Ok, I'll get my stuff." I did. However, each time I started moving a little faster, my heart would speed up, and that rush feeling would com. ...and that rush feeling would come back. That concerned me. Well, I methodically finished purchasing my few items walking slowly. I checked out and went back over to the pharmacy. The lady who gave me the injection saw me out of the corner of her eye. She was busy at one of the customer counters, so I walked over and sat down in the pharmacy chairs nearby. (I knew if something happened, she would see and help me). I sat for about 5 - 10 minutes. She stayed busy. I decided to drive slowly home. I got up, spoke with the lady (she said she was coming to check on me as soon as she finished with what she had in her hand). I told her I just wanted to let her know I was going home. She said ok. I left. I went home, arm looked fine. As long as I moved slowly, deliberately, I was ok. I went to bed early. By the next day, a red quarter sized circle appeared on my upper left arm. I expected that. Arm was a little sore (expected that). I went to work the next day. I tired very quickly, but I was able to do desk work. My co-workers thought I should have stayed home. But, I was not willing to get a demerit (point) for being absent for this. At that time I understood each person was a case by case basis. I wasn't willing to chance my case. Here is what I did NOT expect: the red circle on my upper left growing (bigger than an old silver dollar coin a few times) on my left upper arm that would come and go. My left arm being warm to the touch. Also, within a day or so after the shot, I felt a gel "pill" like circle IN my arm about an inch above my elbow. So, thinking the medicine needed help to move around, I started gently rubbing (massaging) my arm up and down. While the "gel" like substance disappeared, I started experiencing black and blue "bruising" in my left arm along with the redness. I would literally have red, black, and blue "come and go" spots on my arm. (I did NOT rub for long). This ended up causing a regression in my left arm among my tendons/ligaments that I thought was healed. (About a year or two ago, I had some tendon/ligament issues in that arm) I am not a happy camper. This went on for a few weeks. My co-workers told me I needed to get it checked out. (But I was still alive and able to function, so I guess that is what Moderna and the government would consider: success??!!) I (a person who believes in taking vaccines) was angry, frustrated, scared, and wished I had taken the JnJ or Pfizer vs Moderna. Then I decided NOT to take the second shot. This was ridiculous. I did go to my doctor, but for other issues. I did mention about getting my shot and what had happened. He glanced at my arm and said it appeared to be healing. I told him I may not be getting the second dose. I asked if we could see about how much antigen/antibiotic I had in my blood in a few weeks. We wanted to give this a little longer. Since then, my job is pressuring people to get the vaccine. I am very, very frustrated. I do have a Dr's appointment to see how I should proceed. A few times during these couple of months, when I would go back to do some general shopping, I would stop off at the Pharmacy to ask questions. I spoke with 3 different people in the pharmacy, explaining my experiences. 1 person mentioned that I should to the Vaers Safe Check-in and sign up (I did), 1 person mentioned they could never get through to Moderna to ask their questions (I'm thinking, but you are a pharmacy calling?!!!). Another person mentioned, they heard of another customer having the same effects I did. I left knowing I wasn't the only one. All would say, to seek medical attention if needed. Many times I was told, "That may be how YOUR body is reacting." I'm thinking, but there were TEST trials before the general public started taking it .... and some of my symptoms were NOT mentioned. As of August 19, 2021, I still have the shot injection mark on my upper left arm. I do not understand how this is still here. I get blood draws frequently, and my skin is penetrated to get the Remicaid in, yet those heal up fast (within 24 hours). The flu shot heals up fast (within 24 hours). This Moderna shot does NOT.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Palpitations
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Ligiment/Tendon problems I thought were healed b4 this.
- Vorgeschichte
- Rheumatoid Arthritis, High Blood Pressure, Leg Vein issues
- Andere Medikamente
- Remicaid (infusion every 8-10 weeks), Methotrexate (skipped do On the Methotrexate (2.5 mg, 5 tabs 1x weekly) I was told to skip a dose due to taking the Covid-19 vaccine. I did. Metoprolol Succ ER 50 MG Tab (1x PM) Lisinopril Tab 5 MG (1x
- Allergien
- Dust, Seasonal Sinus Allergies, Clavulanic Acid, Neosporin
- Vorherige Impfungen
- -
- Staat
- NM
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 18.08.2021
- Impfdatum
- 18.08.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Confusional state
Dizziness
Hyperhidrosis
Hypotension
Tachycardia
Tremor
Symptomtext
Severe Hypotension, Diaphoresis, Dizziness, Tachycardia, shaky, confusion From 1:45 to 2:30 when she left the building. o.3 mg Epinephrine injection auto injector to the right lateral thigh Activated AMR Epinephrine RX called into local pharmacy Hypotension and confusion, and dizziness and diaphoresis were resolved with epinephrine,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hypotension
- Hospital-Tage
- -
- Labordaten
- vital signs monitored until departure activated AMR
- Aktuelle Erkrankungen
- anxiety, depression, anaphylaxis
- Vorgeschichte
- unknown
- Andere Medikamente
- citalopram 40 mg oral daily clonazepam 0.5mg oral BID Lorazepam 0.5mg oral once tablet for sever anxiety lamotrigine 50mg oral once daily
- Allergien
- sliver, wool, morphine, Zofran, milk
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 12.08.2021
- Impfdatum
- 22.07.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19 pneumonia
Symptomtext
Received first covid vaccine on 7/22/21. Required admission to hospital for covid pneumonia on 8/12/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19 pneumonia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 12.08.2021
- Impfdatum
- 12.08.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Paraesthesia
Peripheral swelling
Symptomtext
Pharmacist reports that after administration of 1st dose of Moderna 08/12/2021, Pt. started to experience tingling and slight swelling in the right leg. Still continuing as Pt. left the facility.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Diabetic
- Andere Medikamente
- Unknown
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 12.08.2021
- Impfdatum
- 03.08.2021
- Beginn
- 03.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blindness
Dyspnoea
Fatigue
Headache
Irritability
Pain
Pain in extremity
Pulmonary pain
Symptomtext
Patient stated that an hour after she received the vaccination she felt a pain in her lungs. She had a hard time breathing for about 6 hours. She received a bad headache. Her vision started to go in and out of vision. She is tired all the time. She is sleeping for 3 or 4 hours in the day time. She said her body hurts to walk. Her arms are sore and she is very irritated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Lung Damage COPD Diabetes Osteopartis Depression
- Andere Medikamente
- Laminthaol Trazadone 150mg @ night Meloxicam Methazole Vitamin D3 Zinc Women's supplement Rescue inhaler Advair inhaler Takes one shot once a week Orzimpic
- Allergien
- Codeine Penicillin Rosati Seroquel
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 04.08.2021
- Impfdatum
- 01.07.2021
- Beginn
- 25.07.2021
- Tage bis Beginn
- 24,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthma
Condition aggravated
Cough
Exposure to SARS-CoV-2
Fatigue
SARS-CoV-2 test positive
Tension headache
Upper respiratory tract infection
Symptomtext
Cough Exposure to COVID-19 virus Fatigue, unspecified type Tension headache Suspected COVID-19 virus infection Mild intermittent asthma with acute exacerbation URI, acute
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Condition aggravated
- Hospital-Tage
- -
- Labordaten
- 07/31/21 1214 POCT COVID-19 PCR Collected: 07/31/21 1214 | Final result | Specimen: Swab from Nares POC COVID-19 PCR DetectedAbnormal Lot # 1000273439 Point of Care COVID-19 PCR Testing Method Cepheid Lot Expiration Date 06/26/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Respiratory Allergic rhinitis Moderate persistent asthma Reactive airway disease Musculoskeletal Intrinsic eczema Other SVD (spontaneous vaginal delivery)
- Andere Medikamente
- albuterol HFA (VENTOLIN HFA) 90 mcg/actuation inhaler copper (PARAGARD T 380A) 380 square mm IUD hydrocortisone 2.5 % ointment iron aspgly-C-B12-Ca-suc-stoma (MULTIGEN) 70 mg-150 mg-10 mcg-2 mg-75 mg tablet lidocaine (lidocaine) 2 % solutio
- Allergien
- AppleOther (document details in comments) Tree NutsOther (document details in comments)
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 30.07.2021
- Impfdatum
- 23.07.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest discomfort
Dyspnoea
Throat irritation
Symptomtext
Spoke with the patient Thursday (7-29-2021) who was concerned about side effects she had been experiencing after here Covid-19 vaccination. Upon questioning, the patient reported her throat felt coarse and she was having chest discomfort and difficulty breathing. She reported her chest discomfort was comparable to bad heartburn. She reported using her husbands albuterol inhaler due to her difficulty breathing. Patient also reported that it has been worsening since she received the vaccine on Friday (7-23-2021). Patient did not have a diagnosed history of Covid-19. I recommended the patient contact her primary care physician and seek treatment as soon as possible as these side effects seemed concerning. She understood and said she would follow through. I reported this to both her primary care physician and the standing order physician. A report was also filed with the FDA through VAERS. Patient was seen at PCP on 7-30-21 and was prescribed Doxycycline, Prednisone, and Benzonatate.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Crohn's Disease F39 (Unspecified mood [affective] disorder)
- Andere Medikamente
- Lamotrigine
- Allergien
- Penicillin
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 27.07.2021
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Hypoaesthesia
Paraesthesia
Symptomtext
Not too long after vaccine was given, she stated her ear, neck, and side of face felt tingly and numb. She was givne benadryl.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- She was given benadryl when she said she was having an reaction.
- Allergien
- Shrimp
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 25.07.2021
- Impfdatum
- 25.07.2021
- Beginn
- 25.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blood pressure increased
Chest pain
Musculoskeletal chest pain
Palpitations
Symptomtext
Within 1 minute, patient started experiencing Chest pains across the ribs, heart palpitations and I measured her BP and it spiked
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- N/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- N/a
- Andere Medikamente
- N/a
- Allergien
- N/a
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 18.07.2021
- Impfdatum
- 17.07.2021
- Beginn
- 18.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Dyspnoea
Headache
Pain
Pain in extremity
Pyrexia
Symptomtext
Patient called around 3:30 p.m. to report her side effects. All side effects were within expected range, except she also said it "may be difficult to breathe." This started a couple of hours ago. Other expected side effects included: headache, body aches, chills, fever, and sore arm. She said she took some Advil for her headache, which helped. She was reminded that all other reported side effects were to be expected and may last for up to a few days. She was told she may continue to take the oral pain reliever and use a cold compress for local side effects, but she was advised to seek medical attention if she is having difficulty breathing.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyspnoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- amoxicillin allergy reported
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 09.07.2021
- Impfdatum
- 08.07.2021
- Beginn
- 08.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Back pain
Fatigue
Headache
Injection site erythema
Injection site swelling
Injection site warmth
Mobility decreased
Neck pain
Pain in extremity
Painful respiration
Symptomtext
Left arm is in pain, unable to move left arm, large and red hot to the touch at the injection site... left side of neck is in pain,,, back pain... hurts taking in a deep breathe, Headache and very tired
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mobility decreased
- Hospital-Tage
- -
- Labordaten
- no
- Aktuelle Erkrankungen
- Interstitial Cyspitis
- Vorgeschichte
- Interstitial Cyspitis
- Andere Medikamente
- Elavil Klonopin Prilosec Zantac venlasaxine Ropinirole Tylenol /Cod 4
- Allergien
- Penicillin and Latex
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- -
- Geschlecht
- U
- Eingang
- 08.07.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest pain
Dyspnoea
Pain in extremity
Pyrexia
Rash
Symptomtext
chest pain, hard breathing, many rashes on skin, fever, and arm pain
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 18,0
- Geschlecht
- F
- Eingang
- 02.07.2021
- Impfdatum
- 29.06.2021
- Beginn
- 30.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Chest X-ray
Chest discomfort
Chest pain
Electrocardiogram
Full blood count
Symptomtext
Patient exhibited symptoms for myocarditis. She also had chest pains, and a crushing sensation in her chest. These symptoms began in the middle of the night on June 30, 2021. Worsened in the morning and patient went to E.R. Patient received toradol and i.v. fluids and was monitored. Symptoms resolve after approximately 4 hours. Today she is feeling fine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- EKG (6/30/21), CBC (6/30/21), x-ray of heart
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Allergies, migraines
- Andere Medikamente
- Fluoxetine, Nuvaring, Qvar inhaler, desloratadine 5mg, zolmitriptan 5mg, Astelin nasal spray 0.1%
- Allergien
- Cefdinir, peanuts, nuts
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 28.06.2021
- Impfdatum
- 25.06.2021
- Beginn
- 27.06.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dysphagia
Paraesthesia oral
Stomatitis
Tongue discomfort
Symptomtext
Patient woke up with red spots/sores on tongue (likened to "burnt spots when you drink something too hot"), and they continue to persist. Patient has had trouble eating or drinking, as that increases the burning/tingling feeling.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia oral
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 18.06.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Paraesthesia oral
Throat irritation
Symptomtext
Patient c/o tingling lips and throat irritation after receiving 2nd dose. Patient was taken to exam room for assessment and vital signs were taken. Patient was then evaluated by provider FNP and Benadryl 25mg IM was ordered and administered. Vitals taken again and patient was observed another 30 minutes and then released.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia oral
- Hospital-Tage
- -
- Labordaten
- Vital Signs: 09:50 - BP 115/76, P62, R16, T98.0, Ox 99% 10:00 - BP 114/74, P56, R16, T98.0, Ox 98% 10:10 - BP 125/87, P67, R16, T98.0, Ox 99%
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Epinephrine Auto-Injector, Testosterone Cypionate, Zyrtec
- Allergien
- Seafood
- Vorherige Impfungen
- Moderna Dose 1 - Same symptoms, per patient
- Staat
- MI
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 18.06.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Chest pain
Confusional state
Dyspnoea
Gait disturbance
Hyperhidrosis
Mental status changes
Nausea
Slow response to stimuli
Symptomtext
At end of 15 minute observation period, pt asked how is he feeling , pt slow to response and appeared confused, pt complained of nausea, unsteady gate noted, VS taking at 10:18 am Bp-200/140, P-86,o2-97% , pt complained of SOB and chest pains, at 10:23am 1mL of epinephrine given IM in right deltoid, 911 called. At 10:25am pt SPo2 decreased to 90% pt sweating profusly patient advised to deep breathe, mental status decreased set of vital signs taken at 10:32am Bp-168/138, P-86, 911 arrived at 10:33am Bp-201/147, Hr-82 patient left at 10:39am with EMS.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 10.06.2021
- Impfdatum
- 09.06.2021
- Beginn
- 09.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hypoaesthesia
Paraesthesia
Symptomtext
Left Arm Paresthesia, temporary about 5 minutes starting about 5-10 minutes after vaccine.... then tingling and back to normal by 15 minutes post-vaccine. Patient was able to feel me touching her around the shoulder, but not under. No pain. I called her on 06.10.21 at 4pm. She stated she has normal sensation. Reported general soreness due to vaccine admin.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Paraesthesia
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- HERPES LABIALIS
- Vorgeschichte
- NUMBNESS AND TINGLING IN THE LEFT ARM, PARESTHESIA OF LEFT FINGER
- Andere Medikamente
- LORATADINE, LOPERAMIDE
- Allergien
- NO KNOWN ALLERGIES
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 24.09.2022
- Impfdatum
- 01.06.2021
- Beginn
- 01.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Asthenia
Injection site pain
Limb discomfort
Muscular weakness
Symptomtext
Weakness; Weakness of arms; Arms felt heavy and dead; Injection site tenderness; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weakness), MUSCULAR WEAKNESS (Weakness of arms), LIMB DISCOMFORT (Arms felt heavy and dead) and INJECTION SITE PAIN (Injection site tenderness) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Crohn's disease. Previously administered products included for Product used for unknown indication: ZOLOFT (Zoloft allergy manifested by depression), CIPRO (Cipro allergy manifested by vomiting) and BACTRIM (Bactrim allergy manifested by vomiting). Past adverse reactions to the above products included Depression with ZOLOFT; and Vomiting with BACTRIM and CIPRO. Concurrent medical conditions included Smoker (About 20 cigarettes per day) since 2009, Alcohol use (A dhot of liquor once or twice a month), Perianal discomfort (Perianal disease), Crohn's aggravated (Crohn's flare up), Topical adhesive allergy (Adhesive allergy manifested by burning and itching on skin), Allergic reaction to antibiotics (Cipro allergy manifested by vomiting), Allergic reaction to antibiotics (Bactrim allergy manifested by vomiting) and Allergic reaction to drug (Zoloft allergy manifested by depression). Concomitant products included BUSPIRONE for Anxiety, PREDNISONE for Crohn's disease, PANTOPRAZOLE for Hyperacidity, BACLOFEN for Spasms. On 01-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 40 milligram. On 01-Jun-2021, the patient experienced ASTHENIA (Weakness), MUSCULAR WEAKNESS (Weakness of arms), LIMB DISCOMFORT (Arms felt heavy and dead) and INJECTION SITE PAIN (Injection site tenderness). On 04-Jun-2021, INJECTION SITE PAIN (Injection site tenderness) had resolved. In June 2021, ASTHENIA (Weakness), MUSCULAR WEAKNESS (Weakness of arms) and LIMB DISCOMFORT (Arms felt heavy and dead) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged. On 01-Jun-2021, the patient experienced weakness, injection site tenderness and arms felt heavy and dead. On 04-Jun-2021, the injection site tenderness was resolved. In Jun-2021, the weakness and arms felt heavy, and dead resolved. It was unknown if patient was enrolled in a COVID-19 Vaccine Trial. The reporter's causality for Humira 40mg/0.4ml (Adalimumab) for the events of injection site tenderness, arms felt heavy and dead, onset 01-Jun-2021 was not provided. Treatment information was not provided. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna mailbox were missed to be booked-in. This case was linked to MOD-2021-626111 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Alcohol use (A dhot of liquor once or twice a month); Allergic reaction to antibiotics (Cipro allergy manifested by vomiting); Allergic reaction to antibiotics (Bactrim allergy manifested by vomiting); Allergic reaction to drug (Zoloft allergy manifested by depression); Crohn's aggravated (Crohn's flare up); Perianal discomfort (Perianal disease); Smoker (About 20 cigarettes per day); Topical adhesive allergy (Adhesive allergy manifested by burning and itching on skin)
- Vorgeschichte
- -
- Andere Medikamente
- PREDNISONE; BUSPIRONE; PANTOPRAZOLE; BACLOFEN; HUMIRA
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 16.04.2022
- Impfdatum
- 04.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site urticaria
Urticaria
Symptomtext
Hives. I woke up the morning after receiving the Moderna booster dose with hives on my left deltoid which is where I got the shot. Since then, I have been suffering with hives everyday and now have to take cetirizine 40 mg/d to control them. I hope this doesn't go on much longer. I am eligible to get a 2nd booster dose and will do so next week, but I will choose the Pfizer vaccine since my initial 3 vaccines were Moderna. What is worse, chronic daily hives or Covid-19 infection? Probably Covid, but hives are definitely a form of torture!
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site urticaria
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Depression, chronic neck pain, HSV, menopausal hot flashes
- Andere Medikamente
- bupropion SR, climara patch, micronized progesterone, valacyclovir, meloxicam, multivitamin, sodium oxybate
- Allergien
- Amoxicillin causes a rash
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 29.03.2022
- Impfdatum
- 09.06.2021
- Beginn
- 25.03.2022
- Tage bis Beginn
- 289,0
- Dosis
- 2
- Route/Site
- UN / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: unbekannt
Cough
Nausea
Oropharyngeal pain
Rhinorrhoea
Vomiting
Symptomtext
cough, rhinorrhea and sore throat, n/v
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 05.03.2022
- Impfdatum
- 06.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Myalgia
Pyrexia
Symptomtext
myalgia; fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (myalgia) and PYREXIA (fever) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. Concomitant products included PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS FUMARATE;FOLIC ACID;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL ACETATE;RIBOFLAVIN;THIAMINE MONONITRATE;TOCOPHERYL ACETATE;ZINC OXIDE] for an unknown indication. On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Jul-2021, the patient experienced MYALGIA (myalgia) and PYREXIA (fever). The patient was treated with IBUPROFEN for Pain, at an unspecified dose and frequency. At the time of the report, MYALGIA (myalgia) and PYREXIA (fever) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Fever 101.3 degrees F This case was linked to MOD-2021-250232 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- PRENATAL VITAMINS [ASCORBIC ACID;BETACAROTENE;CALCIUM SULFATE;COLECALCIFEROL;CYANOCOBALAMIN;FERROUS
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 49,0
- Geschlecht
- M
- Eingang
- 04.03.2022
- Impfdatum
- 21.08.2021
- Beginn
- 22.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Testicular pain
Symptomtext
Patient stated he had testicular pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Testicular pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 23.07.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash macular
Symptomtext
20 spots on my back/new one on my wrist/and one on my leg; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (20 spots on my back/new one on my wrist/and one on my leg) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 (Covid in March and was hospitalized). Concurrent medical conditions included Heart rate irregular. Concomitant products included METOPROLOL and LISINOPRIL for Heart rate irregular. On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jul-2021, the patient experienced RASH MACULAR (20 spots on my back/new one on my wrist/and one on my leg). At the time of the report, RASH MACULAR (20 spots on my back/new one on my wrist/and one on my leg) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Prior to receiving vaccine patient had some spots on back, like insect bites, which continued to spread and patient thought of having bitten by a spider and now had a new one on wrist tonight which was just a bump right now, and one on leg. Patient has not taken any treatment for the events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash macular
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Heart rate irregular
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19 (Covid in March and was hospitalized)
- Andere Medikamente
- METOPROLOL; LISINOPRIL
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 29,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 12.06.2021
- Beginn
- 10.07.2021
- Tage bis Beginn
- 28,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Chills
Decreased appetite
Dizziness
Headache
Insomnia
Suspected COVID-19
Vaccination site discolouration
Vision blurred
Vomiting
Symptomtext
no appetite; blurry vision; nasty weakness; purple area around the injection site; vomit intensely; intense headache/like their head was going to explode/headache was really strong; felt like they were getting covid-19; could barely sleep; Chills; Dizziness; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizziness), SUSPECTED COVID-19 (felt like they were getting covid-19), INSOMNIA (could barely sleep), DECREASED APPETITE (no appetite) and VISION BLURRED (blurry vision) in a 29-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 12-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Jul-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced DIZZINESS (Dizziness). On 11-Jul-2021, the patient experienced SUSPECTED COVID-19 (felt like they were getting covid-19), INSOMNIA (could barely sleep) and CHILLS (Chills). On 14-Jul-2021, the patient experienced DECREASED APPETITE (no appetite), VISION BLURRED (blurry vision), ASTHENIA (nasty weakness), VACCINATION SITE DISCOLOURATION (purple area around the injection site), VOMITING (vomit intensely) and HEADACHE (intense headache/like their head was going to explode/headache was really strong). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form and IBUPROFEN at a dose of 600 mg. On 13-Jul-2021, SUSPECTED COVID-19 (felt like they were getting covid-19), INSOMNIA (could barely sleep) and CHILLS (Chills) had resolved. At the time of the report, DIZZINESS (Dizziness), DECREASED APPETITE (no appetite), VISION BLURRED (blurry vision), ASTHENIA (nasty weakness), VACCINATION SITE DISCOLOURATION (purple area around the injection site), VOMITING (vomit intensely) and HEADACHE (intense headache/like their head was going to explode/headache was really strong) had not resolved. Concomitants medication patient was on prenatal vitamins since last pregnancy. Patient states they have had very strong covid-19, that left the patient with asthma, that they did not have before. No lab data has been provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 11.06.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Body temperature
Cough
Headache
Myalgia
Pain in extremity
Pyrexia
Vaccination site erythema
Vaccination site swelling
Vaccination site warmth
Symptomtext
cough; Hot to touch; red spot at the injection site; Arm hurt couple of days; Swelling; body ache; excruciating headache; fever; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough), VACCINATION SITE WARMTH (Hot to touch), VACCINATION SITE ERYTHEMA (red spot at the injection site), PAIN IN EXTREMITY (Arm hurt couple of days) and VACCINATION SITE SWELLING (Swelling) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 047C21A and 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 11-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (cough), VACCINATION SITE WARMTH (Hot to touch), VACCINATION SITE ERYTHEMA (red spot at the injection site), PAIN IN EXTREMITY (Arm hurt couple of days), VACCINATION SITE SWELLING (Swelling), MYALGIA (body ache), HEADACHE (excruciating headache) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form every four hours. At the time of the report, COUGH (cough), VACCINATION SITE WARMTH (Hot to touch), VACCINATION SITE ERYTHEMA (red spot at the injection site), VACCINATION SITE SWELLING (Swelling), MYALGIA (body ache), HEADACHE (excruciating headache) and PYREXIA (fever) outcome was unknown and PAIN IN EXTREMITY (Arm hurt couple of days) had resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) Fever 102F for 2 days. No concomitant medications were reported. It was reported that she being in bed since 10-Jun-2021. she was so much pain. This case was linked to MOD-2021-254036 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- Test Name: Body Temperature; Result Unstructured Data: Fever 102F for 2 days
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Body temperature
Exposure via breast milk
Myalgia
Pyrexia
Symptomtext
myalgia; Fever; Vaccine exposure via breast milk; This spontaneous case was reported by a consumer and describes the occurrence of EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk), MYALGIA (myalgia) and PYREXIA ( Fever) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. Concurrent medical conditions included Maternal exposure during breast feeding. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication. On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jul-2021, the patient experienced EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk). On 07-Jul-2021, the patient experienced MYALGIA (myalgia) and PYREXIA ( Fever). On 06-Jul-2021, EXPOSURE VIA BREAST MILK (Vaccine exposure via breast milk) had resolved. At the time of the report, MYALGIA (myalgia) and PYREXIA ( Fever) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Jul-2021, Body temperature: 101.3 (abnormal) 101.3F. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Treatment details were not provided. This case was linked to MOD-2021-250376 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210707; Test Name: body temperature; Result Unstructured Data: 101.3F
- Aktuelle Erkrankungen
- Maternal exposure during breast feeding
- Vorgeschichte
- -
- Andere Medikamente
- PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 81,0
- Geschlecht
- F
- Eingang
- 15.01.2022
- Impfdatum
- 11.08.2021
- Beginn
- 08.01.2022
- Tage bis Beginn
- 150,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Cough
Hypoxia
Lethargy
Pyrexia
SARS-CoV-2 test negative
SARS-CoV-2 test positive
Urinary tract infection
Symptomtext
81 yr old female with pmh of dementia , parkinsons long term resident of assited living was sent to er for cough fever and hypxia . in er evaluation pt found to have uti , lethargy . pt is admitted for further treatment and close monitoring , including test for covid .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- 7,0
- Labordaten
- 01/08/2022 - Both SARS-COV-2 Antigen and PCR (-) 01/11/2022 SARS-CoV-2 PCR (++)
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Anxiety, hypertension, major depression, dementia, Parkinson's, schizophrenia.
- Andere Medikamente
- amantadine HCl 100 mg Capsule Directions: 1 capsule oral twice a day (Active) cholecalciferol (vitamin D3) 50 mcg (2,000 unit) Tablet Directions: 1 tablet oral daily (Active) docusate sodium (Colace) 100 mg Capsule Directions: 2 capsu
- Allergien
- Fish and shrimp
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 22.12.2021
- Impfdatum
- 10.06.2021
- Beginn
- 10.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bone pain
Pain in extremity
Sleep disorder
Symptomtext
Client reported pain to the arm that he states has increased in the six months since receiving his second dose. The client describes the pain as in his bone and in the last week is keeping him up at night.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bone pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- diabetes, elevated blood pressure, hypothyroidism
- Andere Medikamente
- Losartin, Metformin, levothyroxine
- Allergien
- latex
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 24.11.2021
- Impfdatum
- 15.06.2021
- Beginn
- 22.06.2021
- Tage bis Beginn
- 7,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Nipple pain
Symptomtext
Pt reports persistent Left nipple pain 1 week after receiving his second moderna shot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nipple pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Opioid dependence, Inguinal hernia, Acid reflux, Dysphagia, Erectile dysfunction, unspecified erectile dysfunction type, Benign liver cyst, Cigarette nicotine dependence , Lung nodule, Fatty liver, Hyperlipidemia, unspecified hyperlipidemia type, Migraine with aura and without status migrainosus, not intractable, COPD (chronic obstructive pulmonary disease) , Essential hypertension , Episodic tension-type headache, not intractable , Cluster headaches, Smoking greater than 30 pack years
- Andere Medikamente
- -
- Allergien
- no known drug allergies
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 23.11.2021
- Impfdatum
- 16.06.2021
- Beginn
- 16.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Urticaria
Symptomtext
Whelps appeared on his right arm and legs. They were large and very noticeable. He was treated in the Emergency department with a Medrol Dose pack, and steroid injection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Asthma
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 16.11.2021
- Impfdatum
- 24.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Arthritis
Gait disturbance
Pain in extremity
Symptomtext
After second shot all joints inflame; Arms and knees effected; Knees has become very painful to walk; The number 10 pain in shoulders has gone from a 10 to a 3; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRITIS (After second shot all joints inflame), PAIN IN EXTREMITY (Arms and knees effected), GAIT DISTURBANCE (Knees has become very painful to walk) and ARTHRALGIA (The number 10 pain in shoulders has gone from a 10 to a 3) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053E21A and 053C21A) for COVID-19 vaccination. Concurrent medical conditions included Hives, Hay fever, Fibromyalgia in 1985, Degenerative disc disease (The status was worse), Scoliosis (Scoliosis of spine 4 neck, the status was worse), Bell's palsy (The status was worse) and Ascites (The status was worse). Concomitant products included DEXAMETHASONE, NEOMYCIN, POLYMYXIN B (NEOPOLYDEX) from 11-Oct-2021 to an unknown date for Eye disorder, DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) from 2021 to an unknown date for Multiple allergies. On 24-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ARTHRITIS (After second shot all joints inflame), PAIN IN EXTREMITY (Arms and knees effected), GAIT DISTURBANCE (Knees has become very painful to walk) and ARTHRALGIA (The number 10 pain in shoulders has gone from a 10 to a 3). At the time of the report, ARTHRITIS (After second shot all joints inflame), PAIN IN EXTREMITY (Arms and knees effected), GAIT DISTURBANCE (Knees has become very painful to walk) and ARTHRALGIA (The number 10 pain in shoulders has gone from a 10 to a 3) had not resolved. Not Provided Treatment medications were not reported. Company comment- This case concerns a 73 year old female with relevant medical history of Fibromyalgia , Degenerative disc disease , Scoliosis, who experienced non-serious , unexpected , AESI event of Arthritis, which occurred 1 day after vaccination with the 1st dose of mRNA -1273 vaccine ( Moderna Covid 19 Vaccine ) The re-challenge for this case is not applicable since the events has not resolved yet at the time of the report. The medical condition of fibromyalgia , degenerative disc disease and scoliosis are confounders for this case. The benefit -risk relationship of mRNA-1273 vaccine (Moderna Covid 19 vaccine ) is not affected by this report. This case was linked to MOD-2021-278470 (Patient Link).; Sender's Comments: This case concerns a 73 year old female with relevant medical history of Fibromyalgia , Degenerative disc disease , Scoliosis, who experienced non-serious , unexpected , AESI event of Arthritis, which occurred 1 day after vaccination with the 1st dose of mRNA -1273 vaccine ( Moderna Covid 19 Vaccine ) The re-challenge for this case is not applicable since the events has not resolved yet at the time of the report. The medical condition of fibromyalgia , degenerative disc disease and scoliosis are confounders for this case. The benefit -risk relationship of mRNA-1273 vaccine (Moderna Covid 19 vaccine ) is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Ascites (The status was worse); Bell's palsy (The status was worse); Degenerative disc disease (The status was worse); Hay fever; Hives; Scoliosis (Scoliosis of spine 4 neck, the status was worse)
- Vorgeschichte
- Medical History/Concurrent Conditions: Fibromyalgia
- Andere Medikamente
- BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]; NEOPOLYDEX
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 73,0
- Geschlecht
- F
- Eingang
- 16.11.2021
- Impfdatum
- 24.07.2021
- Beginn
- 24.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Arthralgia
Erythema
Feeling abnormal
Myalgia
Pain in extremity
Rhinorrhoea
Sneezing
Symptomtext
red spot in her arm that keeps getting bigger,arm is all bright red; brain fog; joint pain; muscle pain; Sneezing; Runny nose; arm is hurting, sore; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (red spot in her arm that keeps getting bigger,arm is all bright red), PAIN IN EXTREMITY (arm is hurting, sore), FEELING ABNORMAL (brain fog), SNEEZING (Sneezing) and RHINORRHOEA (Runny nose) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 053E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included Joint pain (before getting the vaccine) and Muscle pain (before getting the vaccine). Concurrent medical conditions included Urticaria, Fibromyalgia since 1985, Degenerative disc disease (worse), Bell's palsy (worse), Hay fever and Ascites. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy, DEXAMETHASONE, NEOMYCIN, POLYMYXIN B (NEOPOLYDEX) from 10-Nov-2021 to an unknown date for Eye disorder, IBUPROFEN for an unknown indication. On 24-Jul-2021 at 3:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Aug-2021 at 3:00 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Jul-2021, the patient experienced PAIN IN EXTREMITY (arm is hurting, sore). On 25-Jul-2021, the patient experienced SNEEZING (Sneezing) and RHINORRHOEA (Runny nose). On an unknown date, the patient experienced ERYTHEMA (red spot in her arm that keeps getting bigger,arm is all bright red), FEELING ABNORMAL (brain fog), ARTHRALGIA (joint pain) and MYALGIA (muscle pain). On 26-Jul-2021, PAIN IN EXTREMITY (arm is hurting, sore) had resolved. At the time of the report, ERYTHEMA (red spot in her arm that keeps getting bigger,arm is all bright red), FEELING ABNORMAL (brain fog), SNEEZING (Sneezing), RHINORRHOEA (Runny nose), ARTHRALGIA (joint pain) and MYALGIA (muscle pain) outcome was unknown. Reported that patient took allergy medication. This case was linked to MOD-2021-378327 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 08-Nov-2021: Significant follow up received on 08-Nov-2021-Events, medical history and concomitant medications added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Ascites; Bell's palsy (worse); Degenerative disc disease (worse); Fibromyalgia; Hay fever; Urticaria
- Vorgeschichte
- Medical History/Concurrent Conditions: Joint pain (before getting the vaccine); Muscle pain (before getting the vaccine)
- Andere Medikamente
- IBUPROFEN; BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]; NEOPOLYDEX
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 74,0
- Geschlecht
- F
- Eingang
- 10.11.2021
- Impfdatum
- 05.11.2021
- Beginn
- 05.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site bruising
Symptomtext
Bruised above administration site remaining 5 days post administration, dark purple in color, 3-in width
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site bruising
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- History of stroke (last year) Asthma Hypothyroidism
- Andere Medikamente
- Prednisone Rosuvastatin Budesonide-Formoterol Duloxetine Levothyroxine Montelukast
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 06.10.2021
- Impfdatum
- 02.09.2021
- Beginn
- 03.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 3
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dermatitis contact
Feeling abnormal
Rash
Rash pruritic
Rash vesicular
Scar
Vaccination site warmth
Symptomtext
the next morning, it was very strange, there were places that looked like worms and round rashes on both arms and identical, from the palms up to the elbows on the inside. It looked like poison Ivy and with the blisters. Both itched, went to 2 doctor. the vaccinated area was round and hot to touch. Gave steroids and antibiotic. 9/3/2021 Urgent care and 9/7/2021 normal healthcare. Its gone but there are some scars.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- 9/3/2021 - no test, they took pictures gave steroids and cortisone cream, used Benadryl 9/7/2021 - no test. prednisone.
- Aktuelle Erkrankungen
- no
- Vorgeschichte
- grave's diseases
- Andere Medikamente
- amlodipine - 5milligram , amitrittyline - 10 milligram, zolpiden - 10 milligrams , hydrochloridhiaide - 12.5 milligram, ometrazole 0 40 milligrams, edsvenlasaxine - 90 milligrams, enalatril - 20 milligrams. tizanizine - 40 milligrams, xynth
- Allergien
- statins
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 20.08.2021
- Beginn
- 31.08.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site erythema
Injection site pruritus
Injection site rash
Injection site swelling
Injection site warmth
Oral mucosal roughening
Pruritus
Rash
Rash pruritic
Symptomtext
Same day and next day of injection - had some itchy, roughness on roof of mouth and lips. 11 days (8/31) after the injection had about a 3 inch oval around welt like spot at injection site that was red, puffy, warm and itchy. 4 days after that (15 after injection - 9/3) broke out in extremely itchy rash mostly on both arms but some on stomach and legs. The itchiness on roof of mouth and lips started again. Applied ice to injection site and took Benadryl - no immediate relief but went away after about 6 days. Rash - Benadryl did not help - applied rubbing alcohol for some itch relief. Still have rash on arms as of 9/22 but itchiness improved and starting to dry up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- Primary suggested I see an allergist. Saw allergy doctor on 9/15 who reviewed rash and pictures and recommended that I DO NOT receive second dose as the reaction could be worse. He suggested wait until I can get J and J once cross vaccination is approved. No testing was done.
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- High BP Diabetes
- Andere Medikamente
- Valsartan, atorvastatin, levothyroxine, metFORMIN, Vitamin D, Vitamin C, quercetin, zinc, Elderberry and Zyrtec (as needed)
- Allergien
- Shellfish Cefuroxime Kenalog injections
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 18.05.2021
- Beginn
- 15.07.2021
- Tage bis Beginn
- 58,0
- Dosis
- 2
- Route/Site
- IM / UN
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Oedema peripheral
Pain in extremity
Vertigo
Symptomtext
vertigo, leg and arm pain, lower extremity edema
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- anxiety,
- Andere Medikamente
- Celexa, Wellbutrin, birth control, vitamin d
- Allergien
- adhesive tape
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- -
- Geschlecht
- M
- Eingang
- 22.09.2021
- Impfdatum
- 20.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Fatigue
Muscular weakness
Pain
Symptomtext
Severe diarrhea; Both legs were weak that he find it hard to urinate standing; Pain in the entire body; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Severe diarrhea), MUSCULAR WEAKNESS (Both legs were weak that he find it hard to urinate standing), PAIN (Pain in the entire body) and FATIGUE (Fatigue) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. Concurrent medical conditions included Allergy to plants (Aloe vera rash). On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jul-2021, the patient experienced DIARRHOEA (Severe diarrhea), MUSCULAR WEAKNESS (Both legs were weak that he find it hard to urinate standing), PAIN (Pain in the entire body) and FATIGUE (Fatigue). At the time of the report, DIARRHOEA (Severe diarrhea), MUSCULAR WEAKNESS (Both legs were weak that he find it hard to urinate standing), PAIN (Pain in the entire body) and FATIGUE (Fatigue) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medication details was reported. No treatment medication details was reported. Most recent FOLLOW-UP information incorporated above includes: On 13-Sep-2021: Followup information received include second dose information added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy to plants (Aloe vera rash)
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 46,0
- Geschlecht
- F
- Eingang
- 21.09.2021
- Impfdatum
- 03.08.2021
- Beginn
- 06.08.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Erythema
Injection site discomfort
Injection site pruritus
Pruritus
Symptomtext
After reviewing the first injection of Moderna covid vaccine I begin to feeling itching and discomfort at the injection site but didn't get bothered much by it and considered as normal injection site symptom. A couple of days later, l noticed a red/ purplish in color circular itchy patch on the side of my breast then, more appeared in the chest area, then one on my right upper arm then another on the left side of my neck then two spots in the middle of my back. These spots had rapidly multiplied during the course of 2-3 weeks but mainly in the previous mentioned areas (chest back arms & neck. The second dose on 8/31 made them erupt more in the stomach and lower back area.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site discomfort
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 18.09.2021
- Impfdatum
- 18.09.2021
- Beginn
- 18.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 17.09.2021
- Impfdatum
- 22.07.2021
- Beginn
- 22.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- UN / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Diarrhoea
Nausea
Pain in extremity
Vomiting
Symptomtext
Diarrhea and vomiting after Dose 1. Sore arm, decreased energy, and queasy after Dose 2.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- N/a.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Diverticulitis; Atypical Chest Pain
- Andere Medikamente
- Aspirin 81 mg; Metoprolol 50mg; Claritin 10mg; Nitroglycerin 04.mg
- Allergien
- PCN
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 02.09.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Anger
Back pain
Extra dose administered
Headache
Interchange of vaccine products
Pain in extremity
Symptomtext
Patient was here for a third dose booster. They previously received 2 doses of Pfizer. This third dose they accidentally received a dose of Moderna. This error was noticed the next day. Our Medical Director called them on 9/7/21 to make sure that they were aware of what happened and to let them know that per the CDC they should be fine and should not repeat the dose. She reported: When I asked how he was today he responded "terrible." He explained that he's had significant back pain. He stated that he was advised to have surgery but he's heard bad things about that & is hesitant to do that. He has an appt tomorrow for a shot at a pain clinic. A pack with pills they gave prior helped only a little bit. He also intends to see a chiropracter. I extended my concern for his pain & encouraged him to keep his appt tomorrow with the pain clinic. I then advised him of the reason for my call He had previously received 2 pfizer vaccines. When he came in for the booster, he was given Moderna. Patient became very upset & began yelling & using profanity. He advised that since he & his brother had the shot that they've not felt right with headaches & arm soreness. "You messed us up." Was repeated several times He expressed concerns that we could have killed them. I apologized for the error and assured him that we were reviewing what happened in order to make a corrective action plan to prevent it from happening again. He advised it was already too late as it happened to him & his brother. I advised that per CDC guidance, it is not ideal to receive Moderna after receiving Pfizer, but it is possible & does not have to be re-boostered with Pfizer. Harm would also not be expected. He advised that he will be in contact with other groups for their opinion including his lawyer. I advised that headache & arm soreness is typical after the immunizations - both Pfizer & Moderna - & that after several shots, the reactions may be intensified since the immune system is already primed to fight the disease. He reiterated the above phrase with profanity. He then asked if I had another else to say because he had several phone calls to make. I offered to answer any questions he may have & again apologized that the mistake happened. He stated he did not have further questions & we would hear from his lawyer ...........
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 06.09.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Body temperature increased
Chills
Diarrhoea
Hyperhidrosis
Hypopnoea
Myalgia
Vomiting
Symptomtext
Vomiting, diarrhea, temp to 102, sweats and chills, muscular aches and pains, shallow breathing, inability to leave my bed 4 days after the first and 3 days after the second.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None. Just ride it out. Did not think I needed the hospital or doctor yet.
- Aktuelle Erkrankungen
- In May, slipped in bathroom. Three days later discovered a small vein had torn and I had retroperitoneal bleed resulting in the loss of 4 liters of blood that could not be reached to cauterize. Was hospitalized 2 separate weeks in ICU before stabilizing.
- Vorgeschichte
- Psoriatic and osteo arthritis, spondylosis, bulging and herniated disks, Factor 5 Leiden to include numerous clots below the knee and a major clot resulting in lung clotting since the age of 25, pernicious anemia, hypothyroidism.
- Andere Medikamente
- Eliquis, B-12 injections 2x mo, Humira, levothyroxine, tolterdodine, folic acid, iron, Vit D prescription strength, krill oil, Vitamin C, cymbalta
- Allergien
- No food allergies. Avelox- more it makes me deathly sick to my stomach than a true allergy.
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 03.09.2021
- Impfdatum
- 22.07.2021
- Beginn
- 22.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Asthenia
Chills
Contusion
Joint stiffness
Lethargy
Miliaria
Myalgia
Pain
Pyrexia
Rash
Skin warm
Somnolence
Vaccination site pain
Symptomtext
pain; joint stiffness; Heat rash; rash on chest; On and off chills; aches; fever; Pain at injection site; Skin feeling warm; Bottom of his feet started feeling bruised; slept most of the day and through the night; lethargic; No energy; This spontaneous case was reported by a consumer and describes the occurrence of SKIN WARM (Skin feeling warm), CONTUSION (Bottom of his feet started feeling bruised), SOMNOLENCE (slept most of the day and through the night), PAIN (pain) and JOINT STIFFNESS (joint stiffness) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 22-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jul-2021, the patient experienced SKIN WARM (Skin feeling warm), CONTUSION (Bottom of his feet started feeling bruised), SOMNOLENCE (slept most of the day and through the night), LETHARGY (lethargic), ASTHENIA (No energy) and VACCINATION SITE PAIN (Pain at injection site). On 23-Jul-2021, the patient experienced PYREXIA (fever) and MYALGIA (aches). On 24-Jul-2021, the patient experienced PAIN (pain), JOINT STIFFNESS (joint stiffness), MILIARIA (Heat rash), RASH (rash on chest) and CHILLS (On and off chills). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 23-Jul-2021, SOMNOLENCE (slept most of the day and through the night) had resolved. On 10-Aug-2021, PAIN (pain), JOINT STIFFNESS (joint stiffness), MILIARIA (Heat rash), LETHARGY (lethargic), RASH (rash on chest), PYREXIA (fever), CHILLS (On and off chills) and MYALGIA (aches) had resolved. At the time of the report, SKIN WARM (Skin feeling warm), ASTHENIA (No energy) and VACCINATION SITE PAIN (Pain at injection site) had not resolved and CONTUSION (Bottom of his feet started feeling bruised) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No concomitant medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 21-Aug-2021: Follow up received on 21-AUG-2021 contains Patient Demographic details, Vaccine Facility Information and Added events and Events outcome.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 02.09.2021
- Impfdatum
- 26.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 3,0
- Dosis
- 1
- Route/Site
- ID / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash erythematous
Rash morbilliform
Rash pruritic
Skin discolouration
Skin induration
Symptomtext
Measle like itchy red bumps that turn into hard skin colored bumps.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash erythematous
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Autoimmune
- Andere Medikamente
- Oxycodone, lyrica
- Allergien
- Sulfa, CT scan dye
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 29.08.2021
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Abdominal pain
Feeling abnormal
Headache
Muscle spasms
Symptomtext
Awkward headaches- fuzzy/ foggy sensation lasting minutes to an hour- comes and goes, abdominal pain like cramps- not stomach cramps but all the muscles around the stomach- lasts a few hours, comes and goes. Pharmacist said would disappear after 24 hrs but it hasn?t. Both symptoms have been recurring since I received my first dose 4 1/2 weeks ago.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal pain
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Diabetes
- Andere Medikamente
- Naproxen
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 28.08.2021
- Impfdatum
- 13.08.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Fatigue
Feeling abnormal
Myalgia
Vaccination site pain
Symptomtext
sore arm the first day; tired for about four hours; soreness at injection site; last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back; This spontaneous case was reported by a patient and describes the occurrence of MYALGIA (sore arm the first day), FATIGUE (tired for about four hours), VACCINATION SITE PAIN (soreness at injection site) and FEELING ABNORMAL (last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. Concurrent medical conditions included Drug allergy, Allergy to antibiotic and Milk protein allergy. On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MYALGIA (sore arm the first day) (seriousness criterion medically significant), FATIGUE (tired for about four hours) (seriousness criterion medically significant), VACCINATION SITE PAIN (soreness at injection site) (seriousness criterion medically significant) and FEELING ABNORMAL (last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back) (seriousness criterion medically significant). At the time of the report, MYALGIA (sore arm the first day), FATIGUE (tired for about four hours), VACCINATION SITE PAIN (soreness at injection site) and FEELING ABNORMAL (last night/night before he can feel his heart beat in the middle of stomach/happens when he lies on his back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Company comment: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Allergy to antibiotic; Drug allergy; Milk protein allergy
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 13.07.2021
- Beginn
- 09.08.2021
- Tage bis Beginn
- 27,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Body temperature
Feeling abnormal
Headache
Nausea
Pyrexia
Symptomtext
Feels bad; Big Headache; Fever up to 102 degrees; Feels nauseous; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feels bad), HEADACHE (Big Headache), PYREXIA (Fever up to 102 degrees) and NAUSEA (Feels nauseous) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 939902) for COVID-19 vaccination. No Medical History information was reported. On 13-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Aug-2021, the patient experienced FEELING ABNORMAL (Feels bad), HEADACHE (Big Headache), PYREXIA (Fever up to 102 degrees) and NAUSEA (Feels nauseous). At the time of the report, FEELING ABNORMAL (Feels bad), HEADACHE (Big Headache), PYREXIA (Fever up to 102 degrees) and NAUSEA (Feels nauseous) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 09-Aug-2021, Body temperature: 102 degrees (High) 102 degrees. Concomitant product use was not provided by the reporter. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- Test Date: 20210809; Test Name: Body temperature; Result Unstructured Data: 102 degrees
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 27.08.2021
- Impfdatum
- 17.06.2021
- Beginn
- 17.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dysstasia
Influenza
Myalgia
Symptomtext
she is struggling to get up; she feels like she has the flu.; body aches, her whole body hurts, pain; This spontaneous case was reported by a patient and describes the occurrence of DYSSTASIA (she is struggling to get up), INFLUENZA (she feels like she has the flu.) and MYALGIA (body aches, her whole body hurts, pain) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. Concomitant products included IBUPROFEN (ADVIL [IBUPROFEN]), VITAMINS NOS and VITAMIN C [ASCORBIC ACID] for an unknown indication. On 17-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Jun-2021, the patient experienced DYSSTASIA (she is struggling to get up), INFLUENZA (she feels like she has the flu.) and MYALGIA (body aches, her whole body hurts, pain). At the time of the report, DYSSTASIA (she is struggling to get up), INFLUENZA (she feels like she has the flu.) and MYALGIA (body aches, her whole body hurts, pain) outcome was unknown. Concomitant medication unspecified OTC Heartburn medication and unspecified Anti Anxiety medication. Treatment information were not Advil provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Myalgia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ADVIL [IBUPROFEN]; VITAMINS NOS; VITAMIN C [ASCORBIC ACID.]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 26.08.2021
- Impfdatum
- 18.08.2021
- Beginn
- 18.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Dizziness
Ear pain
Fatigue
Feeling hot
Headache
Heart rate increased
Hyperhidrosis
Injection site pain
Nausea
Oropharyngeal pain
Pain
Pyrexia
Respiratory tract congestion
Upper-airway cough syndrome
Symptomtext
1 hour after: feeling faint and dizzy, pain at injection site 4 hours after: previous symptoms with additional symptoms: fever (103.7), body aches, chills, horrible headache, fatigue, nausea, increased resting heart rate and non-resting heart rate (see below), Post-nasal drip, sore throat, congestion, ear ache, increased sweating All above symptoms lasted for 48 hours. After 48 hours fever and aches subsided , but increased feeling of being hot and increased heart rate continued. Sore throat and post nasal drip also continued. Still persisting today - 8/26/21 Heart rate - before receiving 2nd covid shot, resting heart rate was 40s - 50s bpm, now resting heart rate is in the 70s bpm. Heart rate is increasing to 120s from very simple activities, like walking across the yard. No history of heart conditions, very healthy, regularly exercise. 5?6? 115lbs Scheduling a follow up with primary care for increased heart rate on 9/1/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- Unknown - follow up with primary care will occur on 9/1/21 for increased heart rate
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Hypothyroidism Asthma
- Andere Medikamente
- Synthroid, pulmicort
- Allergien
- Tavist D Polyhistine D Amoxicillin Cipro Keflex Phenergain Nablecon E-mycin (erythromycin)
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 56,0
- Geschlecht
- F
- Eingang
- 24.08.2021
- Impfdatum
- 16.08.2021
- Beginn
- 16.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pruritus
Urticaria
Symptomtext
Itching on left arm, elbow down to wrist on both arms had hives, took Benadryl and hives cleared.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None.
- Vorgeschichte
- Kidney disease.
- Andere Medikamente
- None.
- Allergien
- Morphin.
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 16.08.2021
- Impfdatum
- 30.07.2021
- Beginn
- 10.08.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- - / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Crying
Pain
Pain in extremity
Symptomtext
PATIENT CALLED AND REPORTED THAT SHE HAS PAIN IN THE RIGHT ARM THAT IS RADIATING, SHE WAS CRYING. SHE REPORTS THAT SHE WENT TO THE EMERGENCY ROOM LAST TUESDAY BUT THEY REFUSED TO TREAT HER. SUGGESTED THAT PATIENT USE ICE PACKS, TYLENOL, IBUPROFEN, AND SEE PHYSICIAN.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- NONE
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 11.08.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Decreased appetite
Dizziness
Fatigue
Injection site pain
Nausea
Symptomtext
About 5 hours after administration: light headedness- 2 episodes about a day apart, chills- intermittent for about 24 hours, fatigue- about 2 days, nausea and inappetance- about 2 days, injection site pain- about 3 days
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- Terbinafine
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 10.08.2021
- Impfdatum
- 30.06.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood pressure abnormal
Dizziness
Malaise
Muscular weakness
Neurological examination normal
Symptomtext
Since 2nd shot, pt got very ill for about a week, but after the week continued have issues with dizziness, weakness in the legs, and blood pressure issues that were not present before hand.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- Hospital visit and having examination for stroke, date unknown, but stroke negative.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- -
- Andere Medikamente
- Daily maintenance medications
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 09.08.2021
- Impfdatum
- 07.07.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
Pt reports developing a rash on the skin days after 1st dose of covid vaccine Moderna. Per PCP pre-medicate pt with diphenhydramine 20-30 min before vaccination with 30min obs.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- No Known Allergies
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 08.08.2021
- Impfdatum
- 09.07.2021
- Beginn
- 17.07.2021
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Injection site erythema
Injection site pain
Injection site swelling
Vaccination complication
Symptomtext
Patient experienced localized arm redness, swelling and pain at injection site starting approximately 1 week post vaccination - "covid arm". Lasted a few days before going away completely on it's own.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- na
- Aktuelle Erkrankungen
- na
- Vorgeschichte
- na
- Andere Medikamente
- na
- Allergien
- na
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 07.08.2021
- Impfdatum
- 29.07.2021
- Beginn
- 06.08.2021
- Tage bis Beginn
- 8,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site reaction
Rash erythematous
Rash macular
Rash papular
Rash pruritic
Symptomtext
itchy puffy red blotchy rash about 4 inches across on left shoulder at site of injection which appeared 8 days after the vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site reaction
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- None
- Allergien
- Sulfa
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 05.08.2021
- Impfdatum
- 11.06.2021
- Beginn
- 11.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immediate post-injection reaction
Neuralgia
Pain in extremity
Symptomtext
Immediate pain shot down arm to thumb and index finger lasting 2 weeks for each shot. Residual nerve pain in thumb and index finger 2 months post shot.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain in extremity
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- acid reflux
- Andere Medikamente
- pantoprazole 40mg
- Allergien
- n/a
- Vorherige Impfungen
- Initial COVID 1st dose on 5/14/21
- Staat
- MN
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 30.07.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Scab
Urticaria
Symptomtext
Patient reports hives started 48 hours after receiving the vaccine. Today they are starting to scab over.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- depression, PTSD
- Andere Medikamente
- atorvaSTATin (LIPITOR) 20 mg tablet, oral, daily sertraline (ZOLOFT) 100 mg tablet, oral, daily
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 03.08.2021
- Impfdatum
- 28.06.2021
- Beginn
- 29.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blister
Diarrhoea
Headache
Herpes zoster
Nausea
Pyrexia
Vomiting
Symptomtext
The day after vaccination, the patient had a fever of 102.2 and blisters on her hands. She took Tylenol. She then developed a headache, nausea, vomiting, and diarrhea the next day. Blisters spread to leg and torso. The doctor diagnosed her with shingles. She was given Acyclovir 800 mg for 1 week. She continued to have fevers on and off for 1 week. Shingles has resolved.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 02.08.2021
- Impfdatum
- 30.07.2021
- Beginn
- 31.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Cough
Headache
Oropharyngeal pain
Pyrexia
Symptomtext
Headache, fever, chills, mild sore throat, mild dry cough
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- Buspirone, mirtazapine, L-methylfolate, daily multivitamin, loteprednol, vitamin D, beta carotene, allergy medication
- Allergien
- -
- Vorherige Impfungen
- Unknown age, date, or name of vaccine
- Staat
- MO
- Alter
- 40,0
- Geschlecht
- F
- Eingang
- 02.08.2021
- Impfdatum
- 22.07.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Fatigue
Feeling cold
Hot flush
Insomnia
Musculoskeletal stiffness
Pain
Pyrexia
Symptomtext
C/O chills, hot and cold flahses, bodyaches, stiff arm, insomnia, fever and fatigue
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 30.07.2021
- Impfdatum
- 29.07.2021
- Beginn
- 30.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Rash erythematous
Rash pruritic
Swelling
Symptomtext
Red, swollen, itchy rash all over her body the morning/day after vaccination. Pt reports this also happened after first dose, but much milder. Pt had not treated with anything yet, recommended Benadryl and hydrocortisone applied to the reddest/itchiest areas.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None Known.
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- She circled 'No' on the immunization form, but her medication history suggests rheumatoid arthritis.
- Andere Medikamente
- Prescriptions for this patient were transferred out 12/29/2020. at that time included Methotrexate 2.5mg, 8 tabs once a week, Colestipol 1g 2bid, Tizanidine 4mg at hs, Omeprazole 20mg daily, Hydroxychloroquine 200mg bid, Folic acid 1mg dai
- Allergien
- NKDA
- Vorherige Impfungen
- Similar to this, but more delayed and more minor to 1st moderna covid 19 dose
- Staat
- IL
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 30.07.2021
- Impfdatum
- 23.07.2021
- Beginn
- 24.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site rash
Injection site swelling
Pain
Pyrexia
Symptomtext
Patient reported a rash and swelling on her left arm where she received the vaccine. She reported a low grade fever and aches as well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site rash
- Hospital-Tage
- -
- Labordaten
- Contacted her primary care physician to report the rash.
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- Ulcerative colitis
- Andere Medikamente
- mesalamine, bupropion
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 29.07.2021
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pruritus
Symptomtext
Patient received second dose of Moderna and had an itchy mouth/jaw area for about five minutes until it subsided
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 28.07.2021
- Impfdatum
- 18.07.2021
- Beginn
- 19.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Rash
Rash morbilliform
Rash pruritic
Symptomtext
Patient states that she had a rash develop over most of her body (cheeks on face to top of feet) Patient states that it looked like a morbilliform rash when looking at pictures. States it did itch, but no pain.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- None, did not seek medical attention
- Aktuelle Erkrankungen
- nothing
- Vorgeschichte
- nothing
- Andere Medikamente
- Buspar 10mg Pristiq 100mg
- Allergien
- Shrimp, red food coloring, sulfa drugs, penicillin, and oxycodone
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 30,0
- Geschlecht
- M
- Eingang
- 28.07.2021
- Impfdatum
- 13.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 14,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Erythema
Injection site vesicles
Symptomtext
The day after vaccination the patient broke out with blisters just about 2in below the injection site and goes down the whole arm. The blisters are red. Caller went to the DR on 7/28/2021 and received a cream. If spots does not clear up patient has to go back to the Dr.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site vesicles
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- High Blood pressure Anxiety Auto immune diffencicy
- Andere Medikamente
- lisinopril 10mg Escitaopram 20mg
- Allergien
- Morphine Loratab
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 27.07.2021
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Injection site erythema
Injection site pruritus
Injection site swelling
Symptomtext
Site of injection became red, swollen & patient reported itchiness within 5 minutes of administration of vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 30,0
- Geschlecht
- F
- Eingang
- 27.07.2021
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Pruritus
Symptomtext
On 7/27/21 I administered the Moderna Covid 19 vaccine to patient about 9:40am. On her form she indicated that she had allergies to latex (topical reaction), shellfish, whitefish, tree nuts (muscle aches, tongue swelling, itchy reactions), chicken and coffee (same but milder reaction as listed before), cabbage, mustard, ginger (upset stomach reactions). She informed me she had no issues with medications but does get dizzy after vaccines at times due to her fear of needles. About 945am she came to me saying her arms, legs and face felt itchy, so I gave her 25mg of diphenhydramine. She asked to hold off on the second dose of 25mg due to the side effect of drowsiness. The first dose helped but about 25 minutes later she felt she was getting itchy again and asked for the second 25mg dose of diphenhydramine. I had the patient wait about 15-20 minutes at which point she was feeling better, and the itching had again subsided. At that point the patient asked to head home and I advised her if any symptoms arise after the diphenhydramine wears off to take another dose. If things seem to be worse, she may need to consider going to the ED.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pruritus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- latex (topical reaction), shellfish, whitefish, tree nuts (muscle aches, tongue swelling, itchy reactions), chicken and coffee (same but milder reaction as listed before), cabbage, mustard, ginger (upset stomach reactions).
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 19,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fall
Pallor
Symptomtext
patient became light headed after the shot, remained conscious, but slid to floor after the shot after walking and turned white. After he ate and drank something, he reported to be fine and in good health
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none known
- Vorgeschichte
- none known
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- passed out previously to vaccines
- Staat
- ND
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Expired product administered
Fatigue
Pain
Pain in extremity
Symptomtext
This patient received an expired vaccination. It had been taken out of the fridge on 4/28/21 so it should've been used by 5/28/21. The expiration on the bottle was 11/09/21. This patient experienced sore arm, body aches, fatigue, and chills.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 26.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Fatigue
Pain
Pain in extremity
Product storage error
Symptomtext
This patient received an expired vaccination. It had been taken out of the fridge on 4/28/21 so it should've been used by 5/28/21. The expiration on the bottle was 11/09/21. This patient experienced sore arm, body aches, fatigue, and chills.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Chills
Expired product administered
Fatigue
Myalgia
Symptomtext
This patient received a vaccine that was expired. It had been put in the fridge on 4/28/21 so it was good until 5/28/21, with the expiration of 11/09/21. They received it on 7/20/21. The patient reported chills, muscle aches, and fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NKA
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Fatigue
Myalgia
Pain in extremity
Symptomtext
This patient received an expired vaccination. It was taken out of the freezer and put in the fridge on 4/28/21 so it expired on 5/28/21. The expiration was 11/09/21 but was in the fridge for too long. The patient experienced a sore arm, fatigue, and muscle aches.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Fatigue
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 24.07.2021
- Impfdatum
- 23.07.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: ja
Eye pruritus
Eye swelling
Oral pruritus
Pharyngeal swelling
Pruritus
Urticaria
Symptomtext
Pt received vaccination at pharmacy at approx 9:25am. Waited 15 minutes at pharmacy without incident. At about 1:00pm same day pt reports began itching on arms, neck and face. Eyes and mouth soon began to itch and hives developed over arms, neck, face and chest. Eyes also swelled. When throat began swelling pt went to the ER at approx 3:00pm. Pt was treated with Solu-Medrol and given prescriptions for Prednisone and Famotidine to take upon discharge.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Eye pruritus
- Hospital-Tage
- -
- Labordaten
- unknown as do not have records from ER visit.
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- HTN, Factor V Leiden disorder, fatty liver disease, fibromyalgia
- Andere Medikamente
- hydrochlorothiazide, Tylenol #3,
- Allergien
- ceftin
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 58,0
- Geschlecht
- F
- Eingang
- 23.07.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chills
Inappropriate schedule of product administration
Injection site pain
Symptomtext
The first vaccine date (07/07/2021) was overlooked, and pt was given the Moderna COVID Vaccine #2 too early. Pt was oberved in clinic >15 mins, pt tolerated the shot and left clinic stable. 07/22/2021, pt was contacted. She reported pain to injection site and some chills but improved with tylenol. Pt to follow up with primary care provider on 07/26/2021 or sooner if needed.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- Diabetes, hypertension
- Andere Medikamente
- None
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 22.07.2021
- Impfdatum
- 22.07.2021
- Beginn
- 22.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dizziness
Malaise
Symptomtext
patient felt light headed and did not feel right after the vaccine. she works and went over there after the vaccine and called to say she wasnt feeling well. we advised her to sit down with her head between her knees and call another associate to cover for her. when we went over an checked on her the facility was closed. we are being told she went to the er
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- went to the er
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- NO
- Andere Medikamente
- XANAX
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 22.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Bone pain
Chills
Dizziness
Fatigue
Feeding disorder
Feeling cold
Headache
Pain in extremity
Symptomtext
Right after the shot had a severe headache, chills, dizzy, lightheaded, arm was very sore, bones was hurting extremely, couldn't eat, and was always cold and she was always tired.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Bone pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- Codeine
- Vorherige Impfungen
- -
- Staat
- MS
- Alter
- 32,0
- Geschlecht
- F
- Eingang
- 20.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Fall
Hyperhidrosis
Symptomtext
Patient received the vaccination and was told to sit down in a waiting chair to be observed for adverse reaction for 15 minutes. Patient fainted and fell off the chair but remained conscious. Patient felt lightheaded and was sweating.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Patient had diarrhea due to eating certain types of food.
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 20.07.2021
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Nausea
Rash
Rash macular
Vomiting
Symptomtext
BLOTCHY CHEST RASH, NAUSEA/VOMITING
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- LATEX, BUT NO REACTION TO ANY VACCINE IN THE PAST
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 16.07.2021
- Impfdatum
- 12.07.2021
- Beginn
- 12.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Pain
Symptomtext
On 7/12/2021 patient was given Moderna 1 ml instead of 0.5 ml. Outcome: Follow up call on 7/16/2021. Patient stated she had bodyaches on 7/12/2021 after the injection. She took Ibuprofen 600 mg and rested. No symptoms the following day. No need for an ER visit. Doing well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- On 06/24/2021 Pt c/o cough, sore throat, onset 06/14/2021. Denies sick contact, covid-19 no exposure.
- Vorgeschichte
- J31.0 Rhinitis K29.70 Gastritis E55.9 Low vitamin D level J45.909 Asthma E89.0 Status post thyroidectomy Z68.33 BMI 33.0-33.9,adult F25.0 Schizo affective schizophrenia E78.5 Hyperlipidemia D50.9 Microcytic anemia R41.3 Memory problem H52.4 Presbyopia
- Andere Medikamente
- Fluticasone Propionate 50 mcg/inh spray 1 spray(s) intranasally once a day ZyrTEC 10 mg tablet 1 tab(s) orally once a day Lipitor 20 mg tablet 1 tab(s) orally once a day ferrous sulfate 325 mg tablet 1 tab(s) orally 3 times a day
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 16.07.2021
- Impfdatum
- 12.07.2021
- Beginn
- 12.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Incorrect dose administered
Pyrexia
Symptomtext
Patient was given Moderna 1 ml instead of 0.5 ml on 7/12/2021. Outcome: Patient experienced a fever on 7/13/2021, took Tylenol, symptoms resolved. No other symptoms, no need for ER visit.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- 1. Type 2 diabetes mellitus without complication, without long-term current use of insulin - E11.9 (Primary) 2. Hyperlipidemia, unspecified hyperlipidemia type - E78.5 3. Right knee pain - M25.561
- Andere Medikamente
- metFORMIN 1000 mg tablet 1 tab(s) orally 2 times a day glimepiride 2 mg tablet 1 tab(s) orally BID, stop date 08/16/2021 Atorvastatin Calcium 10 mg tablet 1 tab(s) orally once a day, stop date 08/16/2021
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 43,0
- Geschlecht
- F
- Eingang
- 16.07.2021
- Impfdatum
- 15.07.2021
- Beginn
- 15.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
generalized urticaria
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Cystitis
- Vorgeschichte
- -
- Andere Medikamente
- Cephalexin 500 mg po qid
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 14.07.2021
- Impfdatum
- 13.07.2021
- Beginn
- 13.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Product administered to patient of inappropriate age
Symptomtext
Patient, aged 17, was inappropriately given Moderna COVID19 vaccine, not recommended under the age of 18. Pharmacy attempted to contact patient immediately upon realization, roughly 3 hours after vaccination. Pharmacy finally reached patient's mother the next morning, and she was informed of the error. Patient's mother will monitor patient, and in accordance with CDC recommendation, the pharmacy will plan to administer the second dose of Moderna to the patient at the appropriate time. Patient's mother agrees with this plan. At the time of contact, patient had only developed mild soreness at the injection site.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 13.07.2021
- Impfdatum
- 13.07.2021
- Beginn
- 13.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 6
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Vomiting
Symptomtext
Pt stated dizziness within 5 min of administration. bp checked and informed provider. pt vitals monitored. Pt had vomiting at 12:06 and informed provider Fair. Pt sx improved at 12:30 and released after informing provider. 11:42am- o2- 98, Pulse- 82 bp 129/82 in left arm, sitting, auto 11:45am- BP 132/86 manual in left arm lying down 12:07- BP 132/86 Manual right arm sitting
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- GI reflux
- Andere Medikamente
- Famotidine 20mg Cyclobenzaprine 10mg ProAir HFA
- Allergien
- Acetaminophen ASA Cipro Hydrocodone Naproxen PCN
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 13.07.2021
- Impfdatum
- 01.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 5,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Urticaria
Symptomtext
Moderna COVID-19 Vaccine EUA\ hives over body. primarily back of neck, back, stomach & legs. quantity total: ~40
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Urticaria
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- asthma
- Andere Medikamente
- albuterol (asthma inhaler)
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- SD
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 09.07.2021
- Impfdatum
- 07.07.2021
- Beginn
- 08.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- UN / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Dizziness
Dysstasia
Gait disturbance
Hypoacusis
Pyrexia
Tinnitus
Symptomtext
Fever of 105 started during the night and could not stand or walk without assistance. Extreme dizziness. In the morning started suffering from tinnitus and her hearing became very muffled.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hepatitis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NJ
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 08.07.2021
- Impfdatum
- 07.07.2021
- Beginn
- 08.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Injection site swelling
Pain
Symptomtext
Patient is having arm pain and swelling at injections site. he is experiencing shooting and burning sensations from injection to the elbow recommended tylenol, cold pack and talk in primary md
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- NE
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 02.07.2021
- Impfdatum
- 01.06.2021
- Beginn
- 02.07.2021
- Tage bis Beginn
- 31,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Arthralgia
Dizziness
Fatigue
Injection site rash
Injection site swelling
Rash erythematous
Symptomtext
Approximately five and a half hours after the moderna vaccine number two, taken on July 2nd 2021, this patient (self) experience a red, swollen rash on the left arm below the injection site north of hand. Dizziness, joint pain, extreme fatigue.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Arthralgia
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA NOTE: This report refers to THE SECOND Moderns COVID-19 VACCINE.
- Andere Medikamente
- Over the counter antihistamine generic Zyrtec
- Allergien
- Zulfa
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 02.07.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood test
Dysarthria
Eye swelling
Headache
Hypoaesthesia
Vaccination complication
Symptomtext
eye was swollen that night, left side of head , left side of neck, back and shoulder were numb and slurring of speech. bad headache, covid arm.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- blood draw,
- Aktuelle Erkrankungen
- asym flutter, congestive heart failure, emphysema , copd , hbp, chemo for hep c , reoccurring kidney stone, bilateral
- Vorgeschichte
- asym flutter, congestive heart failure, emphysema , copd , hbp, chemo for hep c , reoccurring kidney stone, bilateral
- Andere Medikamente
- Albuterol Eliquis Carvedilol Diltiazem Furosemide Lisinopril Spirolacpone Symbicort
- Allergien
- ampicillin
- Vorherige Impfungen
- ampicillin
- Staat
- CT
- Alter
- 13,0
- Geschlecht
- M
- Eingang
- 30.06.2021
- Impfdatum
- 25.06.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Headache
Interchange of vaccine products
Pain in extremity
Product administered to patient of inappropriate age
Symptomtext
Vaccine recipient had received a dose of Pfizer vaccine about 3 weeks ago at a clinic. Recipient present to this clinic with his mother on 6/25/21 for his second dose of Pfizer vaccine. The nurse discussed the Pfizer vaccine and accidentally grabbed a Moderna. She vaccinated the child with 0.5mL of Moderna vaccine IM. Immediately after the recipient was vaccinated, the nurse realized she had given the Moderna instead of the Pfizer. The mother was notified immediately, vitals were taken and the child observed for 30 minutes post vaccination. Child had no ill effects and was sent home with clinic phone number in case of any issues. A nurse from this facility contacted the parent on 6/26/21 to check on the child, mother reported that child had "a slight headache and his arm is a little sore". A nurse from this facility contacted the parent on 6/28/21 again to check on the child, mother reported no complaints of headache arm soreness, or any other complaints.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 30.06.2021
- Impfdatum
- 19.06.2021
- Beginn
- 20.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Hot flush
Hyperhidrosis
Malaise
Pain
Pain in extremity
Pyrexia
Symptomtext
24 hours after second dose I started feeling sick with, fever, chills, hot/cold flashes, body aches, very sore arm. Except for my arm, the chills, intense body aches and hot/cold flashes with sweating have continued, now at day 10 after 2nd injection.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None yet, going to contact my doctor tomorrow.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Advanced degenerate disc disease. Mitral valve prolapse, allergic rhinitis, IBS, heart murmur.
- Andere Medikamente
- Paroxetine, levothyroxine, vitamins
- Allergien
- Vistaril, amitriptalyne, Luvox, Zoloft, fentanyl, morphine, plastic tape
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 29.06.2021
- Impfdatum
- 22.06.2021
- Beginn
- 27.06.2021
- Tage bis Beginn
- 5,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Cough
Diarrhoea
Fatigue
Pain in extremity
Pyrexia
Sinus congestion
Sneezing
Vomiting
Symptomtext
Sore arm, sinus congestion, diahera, vomitting, coughing, sneezing, fever-101 degrees, fatigue, chills
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 28.06.2021
- Impfdatum
- 26.06.2021
- Beginn
- 28.06.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Chills
Headache
Heart rate increased
Pyrexia
Symptomtext
very fast heart beat, fever, chills, headache.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- -
- Andere Medikamente
- Xanax prazosin hydroxyzine fluvoxamine
- Allergien
- penicillin
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 26.06.2021
- Impfdatum
- 11.06.2021
- Beginn
- 12.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Back pain
Burning sensation
Herpes zoster
Rash
Symptomtext
Patient developed back pain the following day, along with a buring sensation that wrapped around to her abdomen. 4 days later a rash developed. Patient sough out medical care and was diagnosed with shingles on 6/26/21
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Back pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- HTN
- Andere Medikamente
- Lisinopril
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 25.06.2021
- Impfdatum
- 24.06.2021
- Beginn
- 24.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Decreased appetite
Diarrhoea
Fatigue
Haematochezia
Hot flush
Hyperhidrosis
Hypoaesthesia
Peripheral swelling
Tenderness
Symptomtext
Pt states day of 06/24/2021 after vaccination about 8:30 experiencing hot flashes, sweating, fatigued, loose stool, numbness in the leg, swollen feet tenderness. 06/25/2021 morning bloody stool, low appetite, very fatigued. States Monday 06/28/2021 plans to make an appt. with Primary.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- Common Cold
- Vorgeschichte
- N/A
- Andere Medikamente
- Anastiovole 1mg, Calcium +D, Vitamin D, Codeine
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 24.06.2021
- Impfdatum
- 24.06.2021
- Beginn
- 24.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Blood pressure increased
Muscle tightness
Nausea
Vomiting
Symptomtext
Pt presented for 1st dose Moderna Vaccine. Reviewed and completed required documentation prior to administration. Around 5 min. post immunization pt exhibited N/V, supervisor informed. pt vitals were taken, informed provider CRNP. instructed oral nausea medication. pt refused EMT at that time. Pt given Zofran 4mg PO. Pt was unable to keep down. Vitals were taken every 10 min. with elevated bp. Informed Dr. of situation and urged pt to go to ER. Pt agreed, EMT was contacted and arrived around 20 min. after. Prior to EMT arrival pt C/O left jaw tightness. EMT arrived and transported pt to Hospital
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Nausea
- Hospital-Tage
- -
- Labordaten
- 2:50pm -bp 226/142 pulse 88
- Aktuelle Erkrankungen
- Elevated Blood pressure, Nausea, Vomiting, Jaw tightness
- Vorgeschichte
- none reported
- Andere Medikamente
- pt reported taking Vit. D and B otc
- Allergien
- NKDA reported
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 22.06.2021
- Impfdatum
- 21.06.2021
- Beginn
- 22.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Diarrhoea
Pyrexia
Vomiting
Symptomtext
Vomiting, diarrhea, fever since waking this morning. Unable to eat or drink anything but water.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Diarrhoea
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 20.06.2021
- Impfdatum
- 19.06.2021
- Beginn
- 20.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- UNK
- Route/Site
- SYR / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Pyrexia
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pyrexia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- None
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 18.06.2021
- Impfdatum
- 16.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site swelling
Injection site warmth
Symptomtext
PATIENT REPORTED VIA TELEPHONE THAT HER ARM STARTED SWELLING BELOW THE INJECTION SITE, BUT ABOVE THE ELBOW, ON 6/18/21. IT IS ALSO VERY WARM TO THE TOUCH. PATIENT WAS ADVISED TO SELF-MONITOR AND TO SEEK MEDICAL TREATMENT IF THE SWELLING PROGRESSED. PATIENT WAS ADVISED TO USE OTC AND SELF-CARE REMEDIES IN THE MEAN TIME. PATIENT WAS NOT ASSESSED IN-PERSON BY PHARMACIST.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site swelling
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- UNKNOWN
- Vorgeschichte
- UNKNOWN
- Andere Medikamente
- UNKNOWN, NO PRESCRIPTION HISTORY AT PHARMACY
- Allergien
- UNKNOWN
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 18.06.2021
- Impfdatum
- 16.06.2021
- Beginn
- 16.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Rash
Symptomtext
Pt had second Moderna vaccination on 6/16/2021. Later that evening he noticed a red rash on his legs and arms. Denies any itching, easy bleeding pain, or other concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Rash
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 28,0
- Geschlecht
- M
- Eingang
- 18.06.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Headache
Symptomtext
Pt complained of severe headache, pt took a 500mg Tylenol from a coworker, VS taking at 9:02am Bp-140/98, P-79, res-13, o2-97%, nursing staff offered snacks and water, patient stated he has not eating in 3 days, patient refused snacks and water, patient advised to go home, staff advised pt not to drive, pt states "i'm fine to drive" second set of vital signs taken at 9:17am Bp135/80, p-72 o2-96% Res-13 patient left at 10:10am.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 17.06.2021
- Impfdatum
- 17.06.2021
- Beginn
- 17.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Dizziness
Symptomtext
5 minutes after administration patient reported light-headedness. Had patient lie flat on mat, advised to loosen tight clothing and maintain open airway. Provided cold compress for patient to use on neck. Kept under close observation x 2 hours until symptoms resolved. Had nurse at facility check and assist in getting client a cab home.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- BP: 126/100, HR: 85, Temp: 98.6-99.1 deg F.
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- MDD, GERD, anxiety, COPD, alcohol abuse, BPH
- Andere Medikamente
- COVID-19 Moderna vaccine
- Allergien
- Bees, mushrooms, seasonal allergies
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 09.06.2021
- Impfdatum
- 06.06.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Injection site erythema
Injection site inflammation
Injection site pain
Symptomtext
red, inflamed, left deltoid with pain. pt applied cold compress and swelling went down. Used tylenol.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 08.06.2021
- Impfdatum
- 08.06.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Dizziness
Nausea
Vomiting
Symptomtext
Pt states she felt dizzy along with n/v.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dizziness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 60,0
- Geschlecht
- M
- Eingang
- 07.08.2023
- Impfdatum
- 06.06.2021
- Beginn
- 16.10.2022
- Tage bis Beginn
- 497,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Breakthrough COVID-19
SARS-CoV-2 test positive
Symptomtext
Breakthrough case admission after 2 vaccines Moderna 5/19/21 lot# 041C21A Moderna 6/6/21 lot# 053C21A
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Breakthrough COVID-19
- Hospital-Tage
- -
- Labordaten
- COVID +
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 01.02.2023
- Impfdatum
- 28.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 01-Jul-2021. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added. Case narrative updated.; Sender's Comments: MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 01.02.2023
- Impfdatum
- 28.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 01-Jul-2021. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added. Case narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 01.02.2023
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date/lot 042J21A should have been reported with a BUD of Feb 17, 2022) and NO ADVERSE EVENT (No adverse event) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. Concomitant medication was not provided. It was reported that there was a mistake given during my phone call regarding lot 012H21B. That lot was not affected, but lot 042J21A should have been reported with a BUD of Feb 17, 2022. Treatment information was not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 01.02.2023
- Impfdatum
- 28.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042J21A and 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medications were reported. Patient received Moderna vaccine beyond the 30 days beyond use date. Beyond use date for lot 053C21A was 01-Jul-2021 (Vaccine received on 28-Jul-2021) and for lot 042J21A was 17-Feb-2022 (vaccine received on 02-Mar-2022). No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non significant Follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 69,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 07.07.2021
- Beginn
- 29.12.2022
- Tage bis Beginn
- 540,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
COVID-19
SARS-CoV-2 RNA
SARS-CoV-2 test positive
Symptomtext
HOSPITALIZATION RELATED TO COVID-19 FOLLOWING COMPLETION OF PRIMARY COVID VACCINE SERIES
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 6,0
- Labordaten
- SARS-COV-2 RNA DETECTED 12/29/22
- Aktuelle Erkrankungen
- NONE KNOWN
- Vorgeschichte
- ABNORMAL LIVER ENZYMES DYSLIPIDEMIA ESOPHAGEAL REFLUX FACET ARTHROPATHY, CERVICAL HEADACHES HYPERTENSION HYPOHTYROIDISM OBSTRUCTIVE SLEEP APNEA OVERWEIGHT SPINAL STENOSIS VERTIGO
- Andere Medikamente
- AMLODIPINE BESYLATE DAILY ASPIRIN DAILY BENEFIBER DAILY CALCIUM WITH VITAMIN D DAILY FISH OIL DAILY HYDROCHLOROTHIAZIDE DAILY LEVOTHYROXINE DAILY MAGNESIUM DAILY MULTIVITAMIN DAILY PANTOPRAZOLE DAILY PROBIOTIC DAILY RIZATRIPTAN BENZOATE AS
- Allergien
- TOPAMAX ZOLOFT IMITREX PEANUTS
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 79,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 79-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 042J21A and 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Jul-2021, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) 1 dosage form. On 25-Feb-2022, received third dose of mRNA-1273 (Spikevax) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Spikevax) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant Follow up received; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). Concomitant medication was not reported. Patient received Moderna vaccine beyond the 30 day beyond use date. Beyond use date for lot was 01-Jul-2021 and patient received vaccine on 28-Jul-2021. Treatment medication was not reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non-significant follow up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.) and NO ADVERSE EVENT (No adverse event) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient was administered with the Moderna vaccine which was beyond the 30-day use by date of 21-Jul-2021.). Concomitant product use was not provided by the reporter. Pharmacist reported that, they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The beyond use by date for lot number 053C21A was 01-Jul-2021. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up document received includes no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 01-Jul-2021. No treatment medications details were reported. NDC number was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added. Case narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 01-Jul-2021. No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added. Case narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 64,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date. They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). Concomitant products were not provided. Treatment medication were not reported. It was reported that there was a mistake given during phone call regarding lot 012H21B. That lot was not affected, but lot 042J21A should have been reported with a BUD of Feb 17, 2022. This case was linked to MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Nonsignificant Follow up; Sender's Comments: MODERNATX, INC.-MOD-2023-704416: Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of the first episode of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), the second episode of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced the first episode of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced the second episode of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, last episode of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). Concomitant products were not provided. Treatment medication were not reported. It was reported that there was a mistake given during phone call regarding lot 012H21B. That lot was not affected, but lot 042J21A should have been reported with a BUD of Feb 17, 2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up contains no new information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Non significant Follow up received; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (vaccine used which were beyond the 30-Day beyond use date). Concomitant products were not reported. It was reported that 30 day beyond use date of lot 053c21a was 01-Jul-2021. Treatment medications were not reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date) and NO ADVERSE EVENT (No adverse event) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date). No concomitant medication was reported. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant Follow-up received; Patient information and vaccinations details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date) and NO ADVERSE EVENT (No adverse event) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patients had been administered with the Moderna vaccine (more or less 170 monovalent) which were beyond the 30 days beyond use date). No concomitant medication was reported. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 monovalent and 20 bivalent) which were beyond the 30 days beyond use date. No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Significant Follow-up received; Patient information and vaccinations details updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 44,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medication information was provided. The vaccine BUD was reported as 1Jul2021. Treatment medication information was not provided. This case was linked to MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant follow up received.; Sender's Comments: MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 07.07.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053c21a and 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medication information was provided. The vaccine BUD was reported as 1Jul2021. Treatment medication information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant follow up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 52,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 12.08.2021
- Beginn
- 12.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 52-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 12-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medication information was provided. The vaccine BUD was reported as 1Jul2021. Treatment medication information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant live follow up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Product storage error
Symptomtext
They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.), PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and PRODUCT STORAGE ERROR (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant drug information was provided. The BUD of the vaccine was provided was 1Jul2021. No treatment medication information was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date; his spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date). Concomitant product use was not provided by the reporter. Patients administered Moderna vaccine monovalent beyond the 30 day beyond use date. Batch number 053C21A (BUD- 01Jul2021). No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 days beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30 day beyond use date.). Most recent FOLLOW-UP information incorporated above includes:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 04.08.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date). Concomitant product use was not provided by the reporter. Patients administered Moderna vaccine monovalent beyond the 30 day beyond use date. Batch number 053C21A (BUD- 01Jul2021). No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Live Follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 76,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053c21a and 042J21A) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient administered with the Moderna vaccine, which were beyond the 30day beyond use date). Concomitant product use was not provided by the reporter. Patients administered Moderna vaccine monovalent beyond the 30 day beyond use date. Batch number 053C21A (BUD- 01 Jul 2021). No treatment information was provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (inked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant Follow up Appended; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use) and NO ADVERSE EVENT (No adverse event) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Aug-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use). No concomitant medications were reported. Pharmacist reported that they had more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. It was reported lot 042J21A should had been reported with a BUD of 17-Feb-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live significant Follow-up contains narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 73,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use) and NO ADVERSE EVENT (No adverse event) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use). No concomitant medications were reported. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 days beyond use date. The lot number for the monovalent vaccines with their corresponding BUD dates were 027C21A (BUD - 21-May-2021), 053C21A (BUD - 01-Jul-2021), 939902 (BUD - 02-Sep-2021), 011F21A (BUD - 04-Nov-2021), 012H21B (BUD - 23-Dec-2021), 056M21A (BUD - 12-May-2022), 082B22A (BUD - 08-Sep-2022). The lot numbers for the bivalent vaccines with their corresponding BUD dates and the interval period of administration. 052D22A (BUD - 17-Nov-2022), dates of administration 18-Nov-2022 to 28-Nov-2022, 023H22A, (BUD - 15-Dec-2022), dates of administration 16-Dec-2022 to 20-Dec-2022. It was reported lot 042J21A should have been reported with a BUD of 17-Feb-2022. No treatment medications were reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: The live significant follow-up contains narrative updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 07.07.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053c21a and 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). Concomitant medications details were not reported by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date. Treatment details were not reported by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Expired vaccine used; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). Concomitant medications details were not reported by the reporter. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date. Treatment details were not reported by the reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up document contains no additional information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). No concomitant medication were reported. Pharmacist reported that they have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30 day beyond use date. No treatment medication were reported. Most recent FOLLOW-UP information incorporated above includes:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 68,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 04.08.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Inappropriate schedule of product administration
No adverse event
Symptomtext
No adverse event; 1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021) and NO ADVERSE EVENT (No adverse event) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042J21A, 939902 and 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On 15-Sep-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date), INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (1st dose on 04 Aug 2021 and 2nd dose on 15 Sep 2021). No concomitant medication was reported. No treatment medication was reported. Patients had been administered with the 3 Moderna vaccines which were beyond the 30 day beyond use date. For lot 053C21A (dose 1)was 01-Jul-2021, for lot 939902 (dose 2) was 02-Sep-2021 and for lot 042J21A (dose 3)was 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053c21a and 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Aug-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 07-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patient had been administered with the 2 Moderna vaccine which were beyond the 30 day beyond use date. For lot 053C21A (dose 1 and 2) BUD was 01-Jul-2021. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received contains non-significant information.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 45,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 45-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 042J21A and 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 28-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 - monovalent and 20 bivalent) which were beyond the 30 day beyond use date). No concomitant medication was reported. No treatment medication was reported. Patient had been administered with the Moderna vaccine which were beyond the 30 day beyond use date. Patient received dose 1 from lot 053C21A with BUD 01-Jul-2021 and dose 3 from lot 042J21A with BUD 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (E2B Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live follow-up received: Narrative was updated.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 71,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had been administered with the Moderna vaccine which were beyond the 30day beyond use date). No concomitant medication was reported. No treatment medication was reported. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant follow up received.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medications details were reported. Patient received vaccine at Pharmacy. Beyond use date of the vaccine was 01-Jul-2021 No treatment medications details were reported. NDC number was reported as 80777-273-10. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Follow-up received wherein patient and vaccination details added.; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medicine were reported. No treatment medicine were reported. lot 042J21A should have been reported with a BUD of 17-Feb-2022. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 21-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. No concomitant medicine were reported. No treatment medicine were reported. Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 31.01.2023
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 14-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less 192 patients who had been administered with the Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medication was provided by reporter. No treatment medication was provided by reporter. NDC- 80777-273-10 This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live non significant follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; They have more or less a170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (They have more or less a170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (They have more or less a170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (They have more or less a170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (They have more or less a170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). No concomitant medication was provided by reporter. No treatment medication was provided by reporter. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Non significant live follow up; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 31.01.2023
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
No adverse event
Symptomtext
No adverse event; Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053c21a) for COVID-19 prophylaxis. No Medical History information was reported. On 07-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Moderna vaccine (more or less 170 -monovalent and 20 bivalent) which were beyond the 30day beyond use date.). Concomitant product use was not provided by the reporter. lot 053C21A should have been reported with a BUD of 1-Jul-2021. Treatment information was not provided. This case was linked to US-MODERNATX, INC.-MOD-2023-704416 (Linked Report). Most recent FOLLOW-UP information incorporated above includes: On 24-Jan-2023: Live Follow up consists of Non significant information; Sender's Comments: US-MODERNATX, INC.-MOD-2023-704416:Master case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 25.01.2023
- Impfdatum
- 26.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Menstrual disorder
Symptomtext
Patient's mother says that her daughter used to have regular periods. After getting her vaccination she did not have a period for at least 3 months. She then had a couple of periods. Now she goes many months without a period.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Menstrual disorder
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- has down syndrome
- Andere Medikamente
- levothyroxine
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 27,0
- Geschlecht
- F
- Eingang
- 20.09.2022
- Impfdatum
- 20.07.2021
- Beginn
- 18.09.2022
- Tage bis Beginn
- 425,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
covid vaccine breakthrough case
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- covid+ test on 9/14/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 76,0
- Geschlecht
- M
- Eingang
- 09.09.2022
- Impfdatum
- 20.05.2021
- Beginn
- 20.08.2022
- Tage bis Beginn
- 457,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: ja
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
Decreased appetite
SARS-CoV-2 test positive
Symptomtext
LOSS OF APPETITE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- 3,0
- Labordaten
- POSITIVE COVID TEST 8/20/2022
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- CKD (chronic kidney disease) stage 3 Dementia DJD (degenerative joint disease) GERD (gastroesophageal reflux disease) HTN (hypertension) Hyperlipidemia Kidney stones Prediabetes
- Andere Medikamente
- Hydrochlorothiazide 12.5 Mg Oral Tablet Metoprolol Tartrate (Lopressor) 25 Mg Oral Tablet Pantoprazole (Protonix) 40 Mg Oral Delayed Release Tablet Quetiapine (Seroquel) 25 Mg Oral Tablet Trazodone (Desyrel) 50 Mg Oral Tablet
- Allergien
- Amoxicillin Celebrex [Celecoxib]
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 08.09.2022
- Impfdatum
- 10.06.2021
- Beginn
- 24.08.2021
- Tage bis Beginn
- 75,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Anaemia
Asymptomatic COVID-19
Maternal exposure before pregnancy
SARS-CoV-2 test positive
Symptomtext
Patient presented to the hospital 37 weeks pregnant on 8/24/22 due to anemia. Tested for COVID as part of routine process and was found to be positive. No symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anaemia
- Hospital-Tage
- -
- Labordaten
- COVID+ by PCR on 8/24/22
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 67,0
- Geschlecht
- M
- Eingang
- 29.08.2022
- Impfdatum
- 16.09.2021
- Beginn
- 16.08.2022
- Tage bis Beginn
- 334,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
Unevaluable event
Symptomtext
patient hospitalized
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- 13,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CO
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 20.05.2022
- Impfdatum
- 04.08.2021
- Beginn
- 07.03.2022
- Tage bis Beginn
- 215,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022; The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 084J21A, 048C21A and 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 04-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2022, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Mar-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 11-Jan-2022 and was administered on 07-Mar-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant product use was reported. The date the vial initially stored in the refrigerator was 11-Jan-2022 which means that all doses administered more than 30 days after 11-Jan-2022 were not in accordance with the Reportedly, the vial didn't undergo any temperature excursions. The patient had not reported adverse reaction to the reporter's knowledge. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 11.05.2022
- Impfdatum
- 12.05.2021
- Beginn
- 18.02.2022
- Tage bis Beginn
- 282,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Ankle fracture
Device failure
External fixation of fracture
Fall
Incisional drainage
Open reduction of fracture
Osteomyelitis
Wound closure
Symptomtext
02/18/22 direct admit "for drainage from her LLE Taylor spatial frame with concerns for sepsis". PMHx of "anxiety, depression, COPD, OSA, HTN, HLD, morbd obesity, T2DM, and fall with left ankle fracture 10/2021 s/p ORIF at OSH c/b osteomyelitis and hardware failure s/p Ex-fix and multiple I&Ds and wound vac placements"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Ankle fracture
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.05.2022
- Impfdatum
- 17.01.2022
- Beginn
- 17.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Product storage error
Symptomtext
Continuously stored in stable FREEZER environment. Only stored in fridge on date of administration for thaw period; 1 Expired Dose Administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (1 Expired Dose Administered) and PRODUCT STORAGE ERROR (Continuously stored in stable FREEZER environment. Only stored in fridge on date of administration for thaw period) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (1 Expired Dose Administered). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Continuously stored in stable FREEZER environment. Only stored in fridge on date of administration for thaw period). At the time of the report, EXPIRED PRODUCT ADMINISTERED (1 Expired Dose Administered) and PRODUCT STORAGE ERROR (Continuously stored in stable FREEZER environment. Only stored in fridge on date of administration for thaw period) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided by the reporter. No treatment information was provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 13.04.2022
- Impfdatum
- 16.04.2021
- Beginn
- 16.04.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Mouth swelling
Pharyngeal swelling
Symptomtext
swelling at the back of my mouth and top of my thoart lasted abot ten minutes saw the Dr on monday was okay at that time
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Mouth swelling
- Hospital-Tage
- -
- Labordaten
- nonej ust checkec out was okay then
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- diabetic, Asthma-allergies
- Andere Medikamente
- Vit c, b-12, b com,Iron,Folic acid, aspirin, zyrtec, tylenol; Naprox-naprosyn,Plaquenil Hydroxchoxchoroquine,Muli-vit,Morphine, Kelflex, levaquin, rhinocort, meloxican, suifa
- Allergien
- penicillin,motrin, cytotec, Amoxicillin, deciofena,vollaren, d
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 79,0
- Geschlecht
- F
- Eingang
- 21.03.2022
- Impfdatum
- 22.06.2021
- Beginn
- 05.07.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Femur fracture
Fracture displacement
Symptomtext
Patient hospitalized for displaced intertrochanteric fracture of right femur. Initial encounter for closed fracture within 6 weeks of receiving the COVID-19 vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Femur fracture
- Hospital-Tage
- 7,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Dose administered after more than 30 days in refrigerator; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 30 days in refrigerator) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 30 days in refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Dose administered after more than 30 days in refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant medication information was not reported. Treatment information was not reported. This case was linked to MOD-2021-267672 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
All patients who received the vaccine between 7/16/21 and 7/28/21 received the vaccine after 30 days BUD; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (All patients who received the vaccine between 7/16/21 and 7/28/21 received the vaccine after 30 days BUD) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (All patients who received the vaccine between 7/16/21 and 7/28/21 received the vaccine after 30 days BUD). At the time of the report, EXPIRED PRODUCT ADMINISTERED (All patients who received the vaccine between 7/16/21 and 7/28/21 received the vaccine after 30 days BUD) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. there were 100 vials (1000 doses) received and kept at appropriate refrigeration temp 2C-8C since the morning of 6/15/21. Unfortunately, at 30 days after the storage in appropriate refrigeration temp, the vials continued to be used in the clinic and administered to patients. There were no temperature excursions from 6/15/21 through 7/28/21, but all patients who received the vaccine between 7/16/21 and 7/28/21 received the vaccine after 30 days. The vials were removed from refrigeration after each day of use, and were administered or wasted within 8 hours at room temp (21C-22C). No concomitant medications were reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 07.07.2021
- Beginn
- 30.07.2021
- Tage bis Beginn
- 23,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Product administration error
Symptomtext
patient got total of three doses of Moderna Vaccine; patient received two doses of Moderna vaccine half hour apart in addition to a first vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXTRA DOSE ADMINISTERED (patient received two doses of Moderna vaccine half hour apart in addition to a first vaccine) and PRODUCT ADMINISTRATION ERROR (patient got total of three doses of Moderna Vaccine) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 048C21A and 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 07-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jul-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXTRA DOSE ADMINISTERED (patient received two doses of Moderna vaccine half hour apart in addition to a first vaccine). On an unknown date, the patient experienced PRODUCT ADMINISTRATION ERROR (patient got total of three doses of Moderna Vaccine). On 30-Jul-2021, EXTRA DOSE ADMINISTERED (patient received two doses of Moderna vaccine half hour apart in addition to a first vaccine) had resolved. At the time of the report, PRODUCT ADMINISTRATION ERROR (patient got total of three doses of Moderna Vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was provided. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OK
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
vaccinated from a vial which was first punctured 22 hours before the vaccination; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccinated from a vial which was first punctured 22 hours before the vaccination) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 immunisation. No Medical History information was reported. On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccinated from a vial which was first punctured 22 hours before the vaccination). On 27-Jul-2021, EXPIRED PRODUCT ADMINISTERED (vaccinated from a vial which was first punctured 22 hours before the vaccination) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No Concomitant medications were provided It was reported that the patient had not developed any side effects. No treatment medications were provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- -
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
expired dose administered; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 26-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 26-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered). On 26-Jul-2021, EXPIRED PRODUCT ADMINISTERED (expired dose administered) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Expired dose of the vaccine was administered on 26JUL2021 as 2nd doses. The lot number for the vaccine was 053C21A (expiration date on vial 09Nov2021). The date the vial was moved from freezer to refrigerator was 24Jun2021. The date the vial expired was 23Jul2021. The administration of the doses was 3 days after the vial expired. This case was linked to MOD-2021-277219 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 26.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
expired product administered; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (vaccine was administered from a vial that was first punctured and left at room temperature around 9:15am on 23Jul2021.This would far exceed both the allowed time at room temperature exposure and allowed time of a punctured vaccine vial) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The patient's past medical history included No adverse reaction. On 26-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 26-Jul-2021, the patient experienced PRODUCT STORAGE ERROR (vaccine was administered from a vial that was first punctured and left at room temperature around 9:15am on 23Jul2021.This would far exceed both the allowed time at room temperature exposure and allowed time of a punctured vaccine vial). At the time of the report, PRODUCT STORAGE ERROR (vaccine was administered from a vial that was first punctured and left at room temperature around 9:15am on 23Jul2021.This would far exceed both the allowed time at room temperature exposure and allowed time of a punctured vaccine vial) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Reporter did not allow further contact
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Administered Moderna Vaccine that is beyond recommended 12 hour period; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered Moderna Vaccine that is beyond recommended 12 hour period) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. Concurrent medical conditions included Pain in thumb since 28-Apr-2021. On 21-Jul-2021 at 4:35 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered Moderna Vaccine that is beyond recommended 12 hour period). On 21-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Administered Moderna Vaccine that is beyond recommended 12 hour period) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported that Patient was administered with a vial which was opened on 20-JUL-2021 10:46AM. He was realized that he was given expired vaccine after discharged from the clinic. During follow up he was contacted multiple times but no response, messages left on patients voicemail to contact clinic. No Concomitant medications were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 26-Jul-2021: Follow up received contains Patient demographic details, Medical History and Vaccine information. On 26-Jul-2021: Follow up received has other patient information linked to this case.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Pain in thumb
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm) in a 13-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 20-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm). On 20-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (a 13-year-old who received the Moderna vaccine 1st dose today 20Jul2021 on her right arm) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 21-Jul-2021: Follow-up received included no new significant information. Reporter information updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 09.07.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Expired Vaccine Administered to patient; This spontaneous prospective pregnancy case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered to patient) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 09-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Administered to patient) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Nurse is calling to report that they have 80 doses of the Moderna COVID-19 Vaccine. Lot No: 053C21A & MFG Date: 04/09/2021 sitting in the refrigerator since 07JUN2021. 2 doses were administered, 32 days after storage in the refrigerator began Administered on 09JUL2021. Caller has limited information regarding the patients: She states that It was their First Doses. A 77-year-old and A 22-year-old non-pregnant individual were vaccinated with expired vaccine, 2 days past refrigeration expiration date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 09.07.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Expired Vaccine Used; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Vaccine Used) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use not provided. Treatment information not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 22.06.2021
- Beginn
- 13.07.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 053C21A and 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jul-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Jul-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early). On 13-Jul-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Given the shot one week early to a patient/received 2nd Moderna dose at 21 days/ one week early) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. No Treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 19-Jul-2021: Follow-up received on 19-Jul-2021 contains significant information. The second dose start date of the Moderna vaccine was added. The event was updated. On 20-Jul-2021: Follow-up received on 20-Jul-2021 contains significant information. The patient demographics (Patient's initials, DOB) were added. The start date and Lot no. of first and second Moderna vaccine was added. The expiry date of the second dose was added.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ID
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- 12.07.2021
- Beginn
- 12.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patients received vaccine from vial that was punctured for almost 48hs; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received vaccine from vial that was punctured for almost 48hs) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 12-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received vaccine from vial that was punctured for almost 48hs). On 12-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patients received vaccine from vial that was punctured for almost 48hs) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Treatment information was unknown.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 26.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product storage error
Product temperature excursion issue
Symptomtext
This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Administered vaccine that went through repeated excursion in the freezer, at various dates) and PRODUCT TEMPERATURE EXCURSION ISSUE (Administered vaccine that went through repeated excursion in the freezer, at various dates) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. In 2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that went through repeated excursion in the freezer, at various dates) and PRODUCT TEMPERATURE EXCURSION ISSUE (Administered vaccine that went through repeated excursion in the freezer, at various dates). In 2021, PRODUCT STORAGE ERROR (Administered vaccine that went through repeated excursion in the freezer, at various dates) and PRODUCT TEMPERATURE EXCURSION ISSUE (Administered vaccine that went through repeated excursion in the freezer, at various dates) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant and no treatment medication were informed. Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up received on 09-JUL-2021, contains non - significant information.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient received an expired dose of the Moderna COVID-19 vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jul-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021). On 06-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired dose of the Moderna COVID-19 vaccine from a previously unpunctured vial that had been in their refrigerator since 04 Jun 2021) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Patient received a vaccine that was 17 years old; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received a vaccine that was 17 years old) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 06-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received a vaccine that was 17 years old). On 06-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Patient received a vaccine that was 17 years old) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. No treatment information was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine) in a 14-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine). On 01-Jul-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Gave a patient a first dose on 1Jul2021 Patient was 14 years old come in and take a dose of vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. concomitant medications were not provided. Treatment medication was not provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received expired vaccine as a 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine as a 1st dose) in a 56-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine as a 1st dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine as a 1st dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 26.02.2022
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received an expired vaccine as a 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. No treatment medication was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Patient received an expired vaccine as a 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose). On 01-Jul-2021, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. No treatment drug details was reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 26.02.2022
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Patient received an expired vaccine as a 1st dose; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 01-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received an expired vaccine as a 1st dose) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Treatment information was not provided by the reporter.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 02.02.2022
- Impfdatum
- 13.08.2021
- Beginn
- 15.01.2022
- Tage bis Beginn
- 155,0
- Dosis
- UNK
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
SARS-CoV-2 test positive
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 27.01.2022
- Impfdatum
- 16.08.2021
- Beginn
- 16.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Vasodilatation
Symptomtext
she had excessive dilation of blood vessels on the right arm injection site all the way down to the fingers; This spontaneous case was reported by a consumer and describes the occurrence of VASODILATATION (she had excessive dilation of blood vessels on the right arm injection site all the way down to the fingers) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The patient's past medical history included Anaphylaxis. On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Aug-2021, the patient experienced VASODILATATION (she had excessive dilation of blood vessels on the right arm injection site all the way down to the fingers). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 20-Aug-2021, VASODILATATION (she had excessive dilation of blood vessels on the right arm injection site all the way down to the fingers) had resolved. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitant medications were not reported. Company comment: This is a spontaneous case concerning a 78-year-old, female patient with no relevant medical history, who experienced the unexpected non-serious event of vasodilation (excessive dilation of blood vessels on the right arm injection site all the way down to the fingers). The event vasodilation (excessive dilation of blood vessels on the right arm injection site all the way down to the fingers) occurred the same day after the first dose of mRNA-1273 vaccine administration with approximately 4 days duration. No reported treatment information. The outcome of the event vasodilation (excessive dilation of blood vessels on the right arm injection site all the way down to the fingers) was resolved from the time of last observation. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report. This case was linked to MOD-2022-455229 (Patient Link).; Sender's Comments: This is a spontaneous case concerning a 78-year-old, female patient with no relevant medical history, who experienced the unexpected non-serious event of vasodilation (excessive dilation of blood vessels on the right arm injection site all the way down to the fingers). The event vasodilation (excessive dilation of blood vessels on the right arm injection site all the way down to the fingers) occurred the same day after the first dose of mRNA-1273 vaccine administration with approximately 4 days duration. No reported treatment information. The outcome of the event vasodilation (excessive dilation of blood vessels on the right arm injection site all the way down to the fingers) was resolved from the time of last observation. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vasodilatation
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Anaphylaxis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 24,0
- Geschlecht
- F
- Eingang
- 21.01.2022
- Impfdatum
- 26.08.2021
- Beginn
- 20.01.2022
- Tage bis Beginn
- 147,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
COVID-19
Chest X-ray
SARS-CoV-2 test positive
Symptomtext
1/20/22- 25-year-old female who presents to the emergency department after being diagnosed with COVID-19 on 1/20. She reports that she has had symptoms for the last 3 to 4 days. She reports diffuse myalgias, headache, fatigue, intermittent fevers and lightheadedness. She does report her P.O. intake has been decreased. She had COVID-19 1 year ago and had been diagnosed with reactive airway disease, bronchitis after this. She reports that symptoms feel similar. ROS: Constitutional: Fever, chills. Eyes: Does not report eye redness or discharge. HENT: Nasal congestion, sore throat. Respiratory: Cough. Cardiovascular: Does not report chest pain or palpitations. GI: Does not report abdominal pain, nausea, vomiting or diarrhea. GU: Does not report dysuria or change in urinary habits. Musculoskeletal: Myalgias. Integument: Does not report rash or bruises. Neurologic: Headache. All other systems reviewed and negative
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- 1/20/22- COVID Result IPOC PCR Detected Abnormal. FINDINGS: Chest X-ray-A single AP upright portable view of the chest shows adequate lung volumes, without infiltrates or pleural effusions. The pulmonary vascularity and cardiac silhouette are within normal limits. IMPRESSION: No acute cardiac or pulmonary process.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Chronic left-sided low back pain with left-sided sciatica 1/30/2017, Depression, History of COVID-19, Irregular menses 10/10/2016, Obesity (BMI 30-39.9) 7/6/2016, PCOS (polycystic ovarian syndrome), Seasonal allergies
- Andere Medikamente
- busPIRone (BUSPAR) 5 MG tablet Take 1 tablet by mouth 3 (three) times daily as needed (anxiety). cetirizine (ZYRTEC) 10 MG tablet Take 1 tablet by mouth daily as needed for Allergies or Rhinitis. citalopram (CELEXA) 10 MG tablet Take 1 tabl
- Allergien
- No known allergies
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 78,0
- Geschlecht
- F
- Eingang
- 20.01.2022
- Impfdatum
- 16.08.2021
- Beginn
- 24.09.2021
- Tage bis Beginn
- 39,0
- Dosis
- 1
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Received the 2nd shot 6 weeks & 4 days after first shot/first shot on 16 Aug and 2nd shot on 24 sep; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd shot 6 weeks & 4 days after first shot/first shot on 16 Aug and 2nd shot on 24 sep) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 053C21A) for COVID-19 vaccination. The patient's past medical history included Anaphylaxis. On 16-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Sep-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd shot 6 weeks & 4 days after first shot/first shot on 16 Aug and 2nd shot on 24 sep). On 24-Sep-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Received the 2nd shot 6 weeks & 4 days after first shot/first shot on 16 Aug and 2nd shot on 24 sep) had resolved. No concomitant medications reported by reporter No treatment medications provided by the reporter. This case was linked to MOD-2022-455222 (Patient Link).
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Medical History/Concurrent Conditions: Anaphylaxis
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 18.01.2022
- Impfdatum
- 26.05.2021
- Beginn
- 30.12.2021
- Tage bis Beginn
- 218,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Abdominal wall infection
COVID-19
SARS-CoV-2 test positive
Symptomtext
12/30/21 presents to ED for "infection of her abdominal wall". PMHx of "insulin dependent diabetes"
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal wall infection
- Hospital-Tage
- -
- Labordaten
- 12/30/21 SARS-CoV-2 (COVID-19) by NAA detected
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- KY
- Alter
- 83,0
- Geschlecht
- M
- Eingang
- 14.01.2022
- Impfdatum
- 30.09.2021
- Beginn
- 11.01.2022
- Tage bis Beginn
- 103,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Asthenia
Brain natriuretic peptide increased
COVID-19
Cerebral infarction
Chest X-ray abnormal
Computerised tomogram head abnormal
Mental status changes
SARS-CoV-2 test positive
Troponin increased
Urinary incontinence
Symptomtext
Per history and physical on 1/11/2022: An 84-year-old male with PMH significant for DM 2, HTN, HLD, CAD s/p CABG, atrial fibrillation (on Xarelto), CHF, CVA, carotid disease, hypothyroid and GERD, presented to the ED with complaint of altered mental status and weakness. Per EMS report, family stated he began to have urinary incontinence yesterday and was leaning to the left. He had no obvious facial droop and grips were equal and round. Patient has known dementia at baseline. He is unable to contribute to HPI. Family is unable to contacted. Both phone numbers listed go directly to voicemail. Upon arrival to the ED, he is noted to have elevated troponin and BNP. CXR is concerning for LLL infiltrate and found to be COVID-19 positive. Per medical record, he is vaccinated x3. CT head notes old infarct.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 12.01.2022
- Impfdatum
- 23.07.2021
- Beginn
- 10.01.2022
- Tage bis Beginn
- 171,0
- Dosis
- 2
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Gastrointestinal haemorrhage
SARS-CoV-2 test positive
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- SARS-COV-2 (COVID-19) by NAA, Micro-DETECTED
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Bronchitis ? Diabetes (CMS/HCC) ? Hypertension ? MVA (motor vehicle accident) ? Paraplegia (CMS/HCC) 04/17/2021 2/2 SCI (struck by vehicle) ? Pedestrian injured in traffic accident 04/17/2021 Struck by a vehicle sustaining multiple traumatic injuries, requiring multiple surgeries. ? Pelvic fracture (CMS/HCC) ? R hemopneumothorax 4/17/2021 ? Renal disorder ? Spinal cord injury, C1-C7 ? TBI (traumatic brain injury) 04/17/2021 ? Urinary retention
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 10.01.2022
- Impfdatum
- 21.06.2021
- Beginn
- 05.01.2022
- Tage bis Beginn
- 198,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: nein
COVID-19
SARS-CoV-2 test positive
Vaccine breakthrough infection
Symptomtext
covid vaccine breakthrough
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- covid+ test
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 28.12.2021
- Impfdatum
- 10.06.2021
- Beginn
- 21.12.2021
- Tage bis Beginn
- 194,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
COVID-19
SARS-CoV-2 test positive
Symptomtext
DIAGNOSED WITH COVID-19 AFTER BINAX NOW TEST ON 12/21/2021
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- BINAX NOW DETECTED COVID 19
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- RHINITIS, DEPRESSIVE DISORDER
- Andere Medikamente
- -
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- PR
- Alter
- 35,0
- Geschlecht
- M
- Eingang
- 24.12.2021
- Impfdatum
- 02.08.2021
- Beginn
- 01.10.2021
- Tage bis Beginn
- 60,0
- Dosis
- 2
- Route/Site
- SYR / RL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Dyskinesia
Tinnitus
Symptomtext
I NEVER HAVE PROBLEMS WITH MY MUSCLES OR MY EARS, SINCE THE VACCINATION I STAR PRESENTING AND FEELING VOICES CLOSE TO MY EARS AND MY MUSCLES MOVE INVOLUNTARY.( I NEVER HAVE PROBLEMS WITH MY MUSCLE)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Dyskinesia
- Hospital-Tage
- -
- Labordaten
- THERE IS NO TEST FOR THE EFFECTS, IS JUST HAPPENS FROM NO WHERE. SINCE THE (AI - ARTIFICIAL INTELLIGENCE WENT OUT IN 2020 EVERYTHING CHANGE!! WE DONT WANT AI!!!
- Aktuelle Erkrankungen
- none HIV SINCE 2011, BUT NEVER HAVE SIDE EFFECTS IN MY MUSCLES. ONLY HAPPENS AFTER THE COVID-19 VACCINATION.
- Vorgeschichte
- N/A
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 23,0
- Geschlecht
- M
- Eingang
- 14.12.2021
- Impfdatum
- 09.12.2021
- Beginn
- 09.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Accidental underdose
Symptomtext
0.25ml given as first dose; This spontaneous case was reported by an other health care professional and describes the occurrence of ACCIDENTAL UNDERDOSE (0.25ml given as first dose) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .25 milliliter. On 09-Dec-2021, the patient experienced ACCIDENTAL UNDERDOSE (0.25ml given as first dose). On 09-Dec-2021, ACCIDENTAL UNDERDOSE (0.25ml given as first dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No adverse reaction observed. No pre existing medical condition. No concomitant medication were given. No treatment information were given.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental underdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OR
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 06.12.2021
- Impfdatum
- 03.12.2021
- Beginn
- 03.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Event occurred at the school district event on 12/3/21. This RN is entering in system on 12/6/2021. RN is inputting event and realizes that patient received her 2nd dose of Moderna vaccine 7 days too early. Patient received 1st dose on 11/12/21 and second dose on 12/3/21. RN confers with team and they remember that patient was told she was not eligible for vaccine at registration table. She was there with son and proceeded to go through the process with her son. This RN is unsure of how she proceed to receive vaccination but VAR was completed with time stamp and sticker signifying that she did receive the dose. This RN will complete VAERs report, submit to incident portal, and forward to PCP?s team for further recommendations. CDC says to ?Repeat dose after invalid dose by the minimum interval.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 60,0
- Geschlecht
- F
- Eingang
- 06.12.2021
- Impfdatum
- 03.12.2021
- Beginn
- 03.12.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Anxiety
Interchange of vaccine products
Neoplasm malignant
Nervousness
No adverse event
Symptomtext
12/3/21 - Event occurred at the school district event at School. This RN was in hallway when patient walks out and was mildly upset. RN walks with to cafeteria which is the observation area. Patient relays information to RN that she was there for Pfizer booster but was accidentally given a Moderna shot. RN walks patient to observation provider. Patient then decides she does not want to wait in cafeteria due to lots of noise and leaves to go outside. Provider asks RN to catch up with patient to get name and DOB. RN catches up to patient and speak to her outside of school. Patient verbalized she was not upset about the wrong shot but instead that she was upset because she was nervous about the safety of the event. Patient had tears in eyes and relayed to RN that she also has cancer and anxiety and was having a hard day already. She thanks RN for speaking with her. Patient says she will go home to relax and calm down. At the time of entering this incident, does not show that the vaccine has been entered yet nor which nurse gave the vaccine. No adverse reactions occurred but it was a vaccine administration error which is why this RN is reporting it.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Anxiety
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 01.12.2021
- Impfdatum
- 25.06.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Wrong product administered
Symptomtext
Pt was given the wrong COVID vaccine. Since he was not 18 yr at the time of the first administration, he should have gotten pfizer, but was mistakenly given the Moderna. Pt/parent was notified. Provider also notified and told us since he got the 1st dose of Moderna to given him the @nd dose on 08/04/2021. Pt did not have any adverse reactions to either of the 2 moderna injections,.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Asthma
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.11.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Product storage error
Symptomtext
multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days; multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days) and PRODUCT STORAGE ERROR (multiple patients received a Moderna dose from a vial that had been stored in the refrigerator for more than 30 days) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported No treatment medications were reported Doses were administered on and after 14Sep2021 Most recent FOLLOW-UP information incorporated above includes: On 02-Nov-2021: Follow-up received on 03-Nov-2021 contains no new information. On 04-Nov-2021: Follow up received includes Batch number added and narrative was updated.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 10.11.2021
- Impfdatum
- 27.09.2021
- Beginn
- 28.09.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: ja
Erholt: ja
Computerised tomogram head normal
Dysarthria
International normalised ratio increased
Ultrasound Doppler
Symptomtext
Patient developed slurred speech one day after. She went to ER after 2 days. She had a negative Ct of her head and negative for carotid thrombosis. She was well anticoagulated at INR 3.0 on 9/27/21 the date of her vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Computerised tomogram head normal
- Hospital-Tage
- 1,0
- Labordaten
- Ct brain 9/30/21 and cartoid US duplex extracranial arteries
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Artifical heart valve, hypertension, diabetes type 2, anxiety, neuropathy hyperlipidmia
- Andere Medikamente
- Coumadin, atorvastatin, enalpril, furosemide, gabapentin, invokana, levemir , novolog
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 35,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 36,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 55,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BEYOND USE DATE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 41,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 29.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BEYOND USE DATE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BEYOND USE DATE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 20,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 7,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST Beyond Use Date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 23,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product storage error
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 02.11.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
NO ADVERSE EVENT OCCURED. VACCINE ADMINSTERED PAST BUD
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 25,0
- Geschlecht
- F
- Eingang
- 28.10.2021
- Impfdatum
- 28.10.2021
- Beginn
- 28.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Symptomtext
Patient was administered a Moderna second dose and was due to receive a Pfizer second dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- none reported
- Andere Medikamente
- n/a
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 31,0
- Geschlecht
- M
- Eingang
- 13.10.2021
- Impfdatum
- 06.08.2021
- Beginn
- 15.08.2021
- Tage bis Beginn
- 9,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
COVID-19
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- COVID-19
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- -
- Geschlecht
- U
- Eingang
- 11.10.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product storage error
Symptomtext
received frozen Moderna covid-19 vaccine that was stored in a freezer which did not have a separate freezer door; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a physician and describes the occurrence of PRODUCT STORAGE ERROR (received frozen Moderna covid-19 vaccine that was stored in a freezer which did not have a separate freezer door) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT STORAGE ERROR (received frozen Moderna covid-19 vaccine that was stored in a freezer which did not have a separate freezer door). At the time of the report, PRODUCT STORAGE ERROR (received frozen Moderna covid-19 vaccine that was stored in a freezer which did not have a separate freezer door) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication were reported. No treatment information was reported. Reporter did not allow further contact
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 39,0
- Geschlecht
- F
- Eingang
- 09.10.2021
- Impfdatum
- 20.05.2021
- Beginn
- 08.09.2021
- Tage bis Beginn
- 111,0
- Dosis
- 2
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Exposure during pregnancy
Foetal heart rate abnormal
Labour induction
Stillbirth
Ultrasound antenatal screen abnormal
Symptomtext
In April, I became pregnant with my second child. After heavy advising, I recieved the first dose of the covid vaccine in May, my first month of being pregnant. I received the second dose in June, my second month of pregnancy. On Sept 8th, during a routine scheduled ultrasound, the fetus was found to have no heartbeat. Which resulted in an emergency induction of labor. I had a stillbirth delivery the next day, Sept 9th.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Exposure during pregnancy
- Hospital-Tage
- 3,0
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 59,0
- Geschlecht
- M
- Eingang
- 08.10.2021
- Impfdatum
- 07.10.2021
- Beginn
- 07.10.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Interchange of vaccine products
No adverse event
Symptomtext
Patient received a Vaccine 6/18/21 MODERNA, then came to and received a 2nd dose of PFIZER on 10/07/2021. Patient had no ASE's.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- not reported
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 06.10.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Moderna vaccine that was punctured last evening at 530pm was administered to a patient at 11:15am this morning.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna vaccine that was punctured last evening at 530pm was administered to a patient at 11:15am this morning.) in a 21-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna vaccine that was punctured last evening at 530pm was administered to a patient at 11:15am this morning.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna vaccine that was punctured last evening at 530pm was administered to a patient at 11:15am this morning.) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment drugs were reported .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 34,0
- Geschlecht
- M
- Eingang
- 01.10.2021
- Impfdatum
- 30.09.2021
- Beginn
- 30.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Interchange of vaccine products
No adverse event
Symptomtext
Patient received Janssen vaccine 5/27/21. Patient presented to offsite vaccine clinic 9/23/21 and received a Moderna shot. Patient indiciated on vaccine questionnaire he had not yet been vaccinated. Patient presented to offsite vaccine clinic 9/30/21 and indicated on vaccine questionnaire he had not yet been vaccinated and received a Janssen vaccine. Patient exhibited no adverse effects from vaccines per post vaccine observation. Vaccine clinics offered incentives and most likely the reason patient presented for vaccines. VPN access to to EHR was not functioning properly either time so medical record could not be reviewed to confirm previous covid vaccinations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- F
- Eingang
- 22.09.2021
- Impfdatum
- 27.08.2021
- Beginn
- 27.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Vaccine experienced excursion in the transport container / Excursion duration: 3-5 minutes; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine experienced excursion in the transport container / Excursion duration: 3-5 minutes) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 27-Aug-2021 at 11:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine experienced excursion in the transport container / Excursion duration: 3-5 minutes). On 27-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Vaccine experienced excursion in the transport container / Excursion duration: 3-5 minutes) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Most recent FOLLOW-UP information incorporated above includes: On 17-Sep-2021: Followup received: Patient details received
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 87,0
- Geschlecht
- M
- Eingang
- 12.09.2021
- Impfdatum
- 01.08.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient was inadvertently given a third dose of moderna per his request, pt has memory loss it has been learned.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 64,0
- Geschlecht
- M
- Eingang
- 10.09.2021
- Impfdatum
- 09.09.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient was mistakenly scheduled for, and received his second dose of the Moderna vaccine series 22 days following his first dose, outside of the recommended 28 days and 4 day grace period per CDC. Patient notified of error on 9/10/21. Per CDC, patient does not need to repeat doses or series.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 10.09.2021
- Impfdatum
- 09.09.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient was mistakenly scheduled for, and received her second dose of the Moderna vaccine series 22 days following her first dose, earlier than the recommended 28 days and 4 day grace period per CDC. Called patient 9/9/21 immediately after mistake was realized and explained situation. Per CDC, patient does not need to repeat dose or series.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MD
- Alter
- 59,0
- Geschlecht
- F
- Eingang
- 10.09.2021
- Impfdatum
- 09.09.2021
- Beginn
- 09.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient was mistakenly scheduled for, and received her second dose of the Moderna vaccine series 22 days following her first dose, outside of the recommended 28 days and 4 day grace period per CDC. Attempted to notify patient of mistake, multiple calls made without success. Will continue to try to get in contact with patient. Per CDC, patient does not need to repeat dose or series.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 08.09.2021
- Impfdatum
- 02.09.2021
- Beginn
- 02.09.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Symptomtext
Patient has received 2 doses of Pfizer. Came to for a third booster and accidentally received a dose of Moderna instead. This mistake was realized the next day. Our Medical Director reached out to inform them of the mistake and that per the CDC they were probably find but that the CDC recommends not to repeat the dose. She reported: Reached out to patient again Was able to speak with him this time. He was already aware of the error from his brother calling him. He advised me that he and his brother have side effects of arm soreness, headache and generally not feeling well. He advised that they did not have any side effects after the pfizer vaccines. He was upset stating "this should have never happened" and "this is just messed up." I agreed that it should not have happened and apologized for it. I assured him that we were looking into the incident and trying to determine why it occured and take action from preventing it in the future. He advised me that he and his brother both showed the nurse their cards prior to getting the vaccine so he again could not understand how it happened. I thanked him for sharing that information as it is important for us to understand what occured while we investigate the problem. I advised that the CDC does not recommend mixing the Moderna and Pfizer vaccines but that it was a possibilty previously when Pfizer was on shortage and that no significant ill side effect would be anticipated. He advised that he and his brother were ill with side effects as above. I explained that the side effects they are experiencing are those anticipated with both vaccines and are likely to be intensified after having already received 2 shots from the immune system being primed to fight the disease. He stated that he is upset that they are having any symptoms at all as they did not with pfizer and then hung up.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 08.09.2021
- Impfdatum
- 28.05.2021
- Beginn
- 30.06.2021
- Tage bis Beginn
- 33,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Interchange of vaccine products
No adverse event
Symptomtext
On 5/28/21 patient received a dose of the J&J Covid-19 vaccine incorrectly. The patient had asked for the Moderna Covid-19 vaccine, signed a consent form for a Moderna Covid-29 vaccine, and received a card that stated she received a Moderna shot. However in her chart it was entered that she received a J&J Covid-19 vaccine with a J&J lot number of 202A21A. Thinking she had received Moderna, the patient came back on 6/30/21 and received an actual dose of the Moderna Covid-19 vaccine. She thought that this was her second shot. We realized on 7/9/21 while looking through our records that there was an error. We spoke to all staff involved to understand what happened. Once we were able to piece together what happened the patient was informed on 8/2/21. Our Medical Director, spoke with her and reported the following: Reviewed that J and J is a solitary dose and did not require a booster. Advised that I would not anticipate any harm from receiving both especially as we are now 5-6 weeks past the administration, but since the vaccines are under EUA and this would be a rare circumstance, there is not data about such. Patient received information well. Stated that the J and J was a "doozy" and she had side effects for 3 days. Stated she did not have any side effects after the Moderna vaccine. Stated she has been feeling good - went out of state and quarantined for 2 weeks after given the high rate of CoVID there. She actually stated " I feel even better having had 2 shots now with this variant." She told me she would be ready for her third shot whenever booster are advised. She is requesting appointments for her oldest 2 children to receive the vaccine. I will send that information to the vaccine scheduler. She also needed an appt for her oldest to have a sports physical - I made that appointment. She expressed concerns about her younger children being in school and unvaccinated and I empathized with her on the subject. She did not have any questions or questions at the end of the conversation
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MO
- Alter
- 37,0
- Geschlecht
- M
- Eingang
- 05.09.2021
- Impfdatum
- 22.07.2021
- Beginn
- 22.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Immediate post-injection reaction
Peripheral swelling
Symptomtext
Left arm swell to a golf ball size within a minute of vaccine administration.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immediate post-injection reaction
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- GA
- Alter
- 46,0
- Geschlecht
- M
- Eingang
- 31.08.2021
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / AR
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Interchange of vaccine products
Symptomtext
Pt came in and stated he had not received a covid vaccine- that this would be his first. We only had moderna at the time so we gave him the Moderna vaccine and scheduled him for his 2nd appt. When our report came up of patients that missed their 2nd dose, we looked on the website to make sure he had not received the 2nd dose at another pharmacy. It then showed us he supposedly received a Pfizer vaccine on July 1. We called the wife and she said she knows nothing about another covid vaccine and she should have been notified because he is disabled. She is checking with the hospital tomorrow to see if they gave him one because she had not taken him anywhere else for the vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- na
- Aktuelle Erkrankungen
- na
- Vorgeschichte
- na
- Andere Medikamente
- na
- Allergien
- na
- Vorherige Impfungen
- -
- Staat
- TN
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 31.08.2021
- Impfdatum
- 17.08.2021
- Beginn
- 17.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Accidental overdose
Symptomtext
Patient received 1ml instead of .5ml; This spontaneous case was reported by a pharmacist and describes the occurrence of ACCIDENTAL OVERDOSE (Patient received 1ml instead of .5ml) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 17-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 milliliter. On 17-Aug-2021, the patient experienced ACCIDENTAL OVERDOSE (Patient received 1ml instead of .5ml). On 17-Aug-2021, ACCIDENTAL OVERDOSE (Patient received 1ml instead of .5ml) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 30.08.2021
- Impfdatum
- 27.08.2021
- Beginn
- 27.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Received request for Moderna vaccines for family member of an employee. They filled out the required forms. Employee family member filled out the form with wrong birthday. Administered shot in right deltoid. No concerns. Monitored for 15 minutes after dose. No concerns.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 38,0
- Geschlecht
- M
- Eingang
- 28.08.2021
- Impfdatum
- 29.06.2021
- Beginn
- 29.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
dose administered after vial was opened for 12 hours; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered after vial was opened for 12 hours) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 29-Jun-2021 at 1:00 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient started (unknown route) at an unspecified dose. On 29-Jun-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered after vial was opened for 12 hours). On 29-Jun-2021, EXPIRED PRODUCT ADMINISTERED (dose administered after vial was opened for 12 hours) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitants medications were not reported. Treatments medications was not reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jun-2021: updated primary reporter,
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 28.08.2021
- Impfdatum
- 25.06.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
An unauthorized age group patient received 1st dose of moderna vaccine instead of Pfizer vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An unauthorized age group patient received 1st dose of moderna vaccine instead of Pfizer vaccine) in a 12-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jun-2021 at 8:53 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jun-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An unauthorized age group patient received 1st dose of moderna vaccine instead of Pfizer vaccine). On 25-Jun-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (An unauthorized age group patient received 1st dose of moderna vaccine instead of Pfizer vaccine) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant medication was reported. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 29-Jul-2021: Non significant follow up appended
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 75,0
- Geschlecht
- M
- Eingang
- 28.08.2021
- Impfdatum
- 22.06.2021
- Beginn
- 23.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Erythema
Feeling hot
Vaccination site erythema
Symptomtext
It has spread ever since but has not quite reached the elbow; Warm to the touch; That was developing some redness where shot was injected. It has spread ever since but has not quite reached the elbow; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (It has spread ever since but has not quite reached the elbow), FEELING HOT (Warm to the touch) and VACCINATION SITE ERYTHEMA (That was developing some redness where shot was injected. It has spread ever since but has not quite reached the elbow) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. The patient's past medical history included COVID-19 on 26-Feb-2021. Concurrent medical conditions included Lymphoma. Concomitant products included IBRUTINIB (IMBRUVICA), FUROSEMIDE, WARFARIN, VITAMIN D3 and VITAMIN B COMPLEX (B COMPLEX [VITAMIN B COMPLEX]) for an unknown indication. On 22-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Jun-2021, the patient experienced ERYTHEMA (It has spread ever since but has not quite reached the elbow), FEELING HOT (Warm to the touch) and VACCINATION SITE ERYTHEMA (That was developing some redness where shot was injected. It has spread ever since but has not quite reached the elbow). At the time of the report, ERYTHEMA (It has spread ever since but has not quite reached the elbow) and VACCINATION SITE ERYTHEMA (That was developing some redness where shot was injected. It has spread ever since but has not quite reached the elbow) had resolved and FEELING HOT (Warm to the touch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications also included two heart medications. Patient received antibodies on 27-FEB-2021 No treatment medications were taken by the patient. Most recent FOLLOW-UP information incorporated above includes: On 25-Jul-2021: Follow up information received, included event (Redness recovered in 7-8 days) outcome was updated to recovered.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Lymphoma
- Vorgeschichte
- Medical History/Concurrent Conditions: COVID-19
- Andere Medikamente
- IMBRUVICA; FUROSEMIDE; WARFARIN; VITAMIN D3; B COMPLEX [VITAMIN B COMPLEX]
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 25.08.2021
- Impfdatum
- 25.05.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Gave Moderna Covid Vaccine IM Right Deltoid, Was Told Patent under 18 yrs of age Cannot get Vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 24.08.2021
- Impfdatum
- 25.07.2021
- Beginn
- 26.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Tinnitus
Symptomtext
hearing sounds in her head
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Tinnitus
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- ambien lorazaphen
- Allergien
- bananas avocado peanuts tomato pineapple
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 24.08.2021
- Impfdatum
- 09.06.2021
- Beginn
- 09.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Accidental overdose
Symptomtext
1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 053C21A) for COVID-19 vaccination. No Medical History information was reported. On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced ACCIDENTAL OVERDOSE (1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine). On 09-Jun-2021, ACCIDENTAL OVERDOSE (1st dose of Moderna COVID-19 vaccine was accidentally administered to a patient who had already been vaccinated with 2 doses of Pfizer COVID-19 vaccine) had resolved. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant products were reported. No treatment information was provided.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Accidental overdose
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 72,0
- Geschlecht
- F
- Eingang
- 23.08.2021
- Impfdatum
- 26.07.2021
- Beginn
- 23.08.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abdominal distension
Erythema
Inflammation
Peripheral swelling
Symptomtext
The patient stated that their left arm became very inflamed and red, that their arm was 'bloated' and bigger than usual afterwards.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abdominal distension
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- Cipro, Simvastatin,Tramadol, Zolpidem,
- Allergien
- Sulfa Antibiotics
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 26,0
- Geschlecht
- F
- Eingang
- 15.08.2021
- Impfdatum
- 14.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 4,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Heavy menstrual bleeding
Symptomtext
Heavy period that lasted for two days following second dose of COVID vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Heavy menstrual bleeding
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 47,0
- Geschlecht
- F
- Eingang
- 15.08.2021
- Impfdatum
- 18.07.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 14,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Joint swelling
Skin tightness
Symptomtext
patient came in for 2nd dose of moderna vaccine and stated that about 10-14 days after first dose her knee became swollen. She states she had knee surgery on that knee about a year ago. She had a tissue expander put in. She states the knee is getting worse. She says it feels tight like there is fluid inside. I did inspect the knee and it was swollen around the knee cap and above the knee. Visibly more swollen than other knee. I told her to contact her knee doctor for further guidance.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Joint swelling
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- SC
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 13.08.2021
- Impfdatum
- 13.08.2021
- Beginn
- 13.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
The Moderna COVID-19 shot was given to a 16 year old. This is an adverse event because it is only approved for those 18 years and older right now.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 12.08.2021
- Impfdatum
- 07.08.2021
- Beginn
- 09.08.2021
- Tage bis Beginn
- 2,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cheilitis
Symptomtext
inflamed upper lip, she didn't do anything but wait, resolved after 16-20 hours
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cheilitis
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Hypertension, hypothyroidism, GERD, Migraine, Contraception, Allergic Rhinitis
- Andere Medikamente
- Lisinopril, Levothyroxine, Hydrochlorothiazide, pantoprazole, Sumatriptan Succinate, Trivora, Bupropion XL, Claritin-D
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 12.08.2021
- Impfdatum
- 08.07.2021
- Beginn
- 05.08.2021
- Tage bis Beginn
- 28,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Interchange of vaccine products
No adverse event
Symptomtext
patient got 1 does of janssen then came and got 1 dose of Moderna. initially lied about status of COVID vaccination. Patient had no side effects/symptoms to report
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none listed
- Vorgeschichte
- none listed
- Andere Medikamente
- none known
- Allergien
- none known
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 39,0
- Geschlecht
- M
- Eingang
- 11.08.2021
- Impfdatum
- 12.07.2021
- Beginn
- 12.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
No adverse event
Symptomtext
No adverse event happened. patient tolerated the injection well. The injection was five days early.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- Epinephrine 0.3 mg injector auto
- Allergien
- bee venom
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 29,0
- Geschlecht
- M
- Eingang
- 11.08.2021
- Impfdatum
- 28.07.2021
- Beginn
- 29.07.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Visual impairment
Xanthopsia
Symptomtext
Patient described altered vision, "like looking through yellow glasses" for approximately 12 hours the following day.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Visual impairment
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Celiac disease
- Andere Medikamente
- Lamotrigine 100mg BID, Asmanex inhaler
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 52,0
- Geschlecht
- F
- Eingang
- 10.08.2021
- Impfdatum
- 22.07.2021
- Beginn
- 04.08.2021
- Tage bis Beginn
- 13,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Inappropriate schedule of product administration
Symptomtext
Pt received her Moderna Covid 19 vaccine 6 days prior to the 28th day that it was due.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- HTN, HIV, Asthma
- Vorgeschichte
- Pancreatitis, arthritis right knee, gastric bypass.
- Andere Medikamente
- Amlodipine, Biktarvy 50-200-25, Ondansetron, Baclofen, Ventolin HFA,
- Allergien
- Keflex, Prednisone, Ibuprofen, Pen V, Clindamycin, ASA, Levofloxacin.
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 28,0
- Geschlecht
- F
- Eingang
- 10.08.2021
- Impfdatum
- 14.06.2021
- Beginn
- 05.07.2021
- Tage bis Beginn
- 21,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: ja
Disable: unbekannt
ER: unbekannt
Erholt: ja
Abortion spontaneous
Exposure during pregnancy
Symptomtext
Patient reported during second dose that she miscarried at 4 months pregnant. Patient reported receiving another vaccination as well, not given at our facility. She did not blame the vaccine, but thought it was worth mentioning. Other vaccine not reported to IMPACTSISS, vaccine likely to be Tdap booster.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Abortion spontaneous
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NK
- Vorgeschichte
- IV drug use recovery
- Andere Medikamente
- unknown
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 09.08.2021
- Impfdatum
- 06.08.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Interchange of vaccine products
Symptomtext
Patient accidentally received a 3rd COVID19 vaccine with Moderna. He originally received the Pfizer COVID19 vaccine on 2/24/21 and 3/17/21. Our office identified the error after the patient already received the third dose. Follow-up with patient was completed 3 days after the 3rd dose was given. Patient denied any adverse events from the vaccine and had no concerns. He confirmed the administration of the Pfizer vaccine in February/March and scheduled for another dose because he wanted the $100 gift card from his insurance. Our practice is implementing procedures to prevent this error in the future.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 33,0
- Geschlecht
- F
- Eingang
- 05.08.2021
- Impfdatum
- 16.07.2021
- Beginn
- 16.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
No adverse event
Symptomtext
Patient received 1st dose of Moderna Covid 19 Vaccine on 06/24/2021, Follow up appointment made for 2nd dose of Moderna Covid 19 vaccine on 07/22/2021 but Patient presented too early for her second dose on 07/16/21 which was not caught. Patient received 2nd dose of Moderna Covid Vaccine on 06/16/2021. No apparent injury or adverse reaction noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- No adverse reaction noted.
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 05.08.2021
- Impfdatum
- 04.08.2021
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Symptomtext
Patient received Pfzier Vaccination on 4/10/2021 at the health center. Patient came to clinic on 08/04/2021 for his 1st Covid vaccination and had chosen the Moderna vaccine. Patient stated that this will be the 1st Covid shot he had gotten. Looked into database and noticed that patient has received the Pfizer in April 2021. Patient was contacted to inform him that he doesn't need to get another Moderna vaccination.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 44,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 23.06.2021
- Beginn
- 23.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received their 2nd dose of Moderna after only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 04.08.2021
- Impfdatum
- 23.06.2021
- Beginn
- 23.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / OT
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received a 2nd dose of Moderna only 22 days after the 1st dose. 1st dose on 6/1/21 and 2nd dose on 6/23/21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- F
- Eingang
- 04.08.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received their 2nd dose of Moderna only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 77,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received their 2nd dose of Moderna only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 70,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received their 2nd dose of Moderna only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 65,0
- Geschlecht
- F
- Eingang
- 04.08.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received their 2nd dose of Moderna only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 04.08.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received their 2nd dose of Moderna only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 04.08.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received their 2nd dose of Moderna only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 82,0
- Geschlecht
- F
- Eingang
- 04.08.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
Symptomtext
Patient received a 2nd dose of Moderna only 22 days after their 1st dose.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 03.08.2021
- Impfdatum
- 03.08.2021
- Beginn
- 03.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
Patient received 3 total Moderna COVID-19 injections. Patient received 2 injections from Pharmacy on 7/1/2021 and 8/3/2021. Patient indicated on the initial COVID-19 Vaccine Immunization Administration Record on 7/1/2021 that she had not received a COVID 19 vaccine, and returned for her second vaccine on 8/3/2021, stating she lost her vaccine record card and needed a new card as well. Patient did receive an initial injection on 5/27/2021. This was not determined that the patient received her third injection until insurance was processed on 8/3/2021 and the insurance rejected, stating 2 injections in a 300 day period, prompting a check of the website to determine an initial injection was given 5/27/2021. Upon discussion with the patient, she was aware she was getting 3 injections, as she stated the initial injection "did not feel right", due to an adverse reaction, and wanted to go to another facility. She also stated she heard about a third being necessary
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- No known illness
- Vorgeschichte
- No known health conditions
- Andere Medikamente
- No medications
- Allergien
- Shrimp
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 50,0
- Geschlecht
- M
- Eingang
- 03.08.2021
- Impfdatum
- 02.08.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Symptomtext
The patient was supposed to get second dose of Pfizer vaccine and I gave him a Moderna vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- Patient had a cold, runny nose a week before vaccine.
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 56,0
- Geschlecht
- M
- Eingang
- 03.08.2021
- Impfdatum
- 31.07.2021
- Beginn
- 01.08.2021
- Tage bis Beginn
- 1,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Peripheral swelling
Symptomtext
Patient reports that the next morning after receiving his second dose his legs and feet were swollen. This condition has worsened over the last 2 days and I advised him to contact his PCP. His right calf is extremely swollen and both feet as well.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Peripheral swelling
- Hospital-Tage
- -
- Labordaten
- none yet
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- diabetes
- Andere Medikamente
- Insulin
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MT
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 03.08.2021
- Impfdatum
- 02.08.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Patient 14 years old and received Moderna covid vaccine which is only indicated for 18 and older. No adverse reactions to vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 02.08.2021
- Impfdatum
- 02.08.2021
- Beginn
- 02.08.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
NONE-Patient received Moderna vaccine that has not been approved by age group.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 81,0
- Geschlecht
- M
- Eingang
- 30.07.2021
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 30.07.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Blindness
Hallucination
Hallucination, auditory
Symptomtext
Hearing voices, hallucinations, mild degree of vision loss
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blindness
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- None
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 28.07.2021
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Hyperhidrosis
Pallor
Symptomtext
After patient was given vaccine he sat in waiting area for observation. He started to sweat and turn pale. He was given cool water and ice pack. He said he always has this happen after he sees a needle or gets a shot. He recovered after 5 minutes.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Hyperhidrosis
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 31,0
- Geschlecht
- F
- Eingang
- 28.07.2021
- Impfdatum
- 28.07.2021
- Beginn
- 28.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Chest discomfort
Erythema
Symptomtext
Patient complained of chest tightness and was observed to be red in the face arms, chest, and neck.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chest discomfort
- Hospital-Tage
- -
- Labordaten
- Vital Signs, Nurse respiratory assessment- 7/28/2021
- Aktuelle Erkrankungen
- Chronic Asthma, Long Term Benzodiazepine Use, PTSD
- Vorgeschichte
- PTSD, Asthma
- Andere Medikamente
- Deltasone 10mg, Xopenex HFA, Xopenex Neb 1.25/3mL, Tenex 1mg, Zoloft 100mg, Protonix 40mg EC, Breo-Ellipta 200/25mcg, Flonase, Singulair 10mg, Epi-PEN 0.3mg/0.3mL, Vitamin C 500mg, Zyrtec 10mg, Vitamin D3 25mcg, 1000u
- Allergien
- MMR Vaccination, Codeine, Shellfish, Sulfa, Silicone, Wasp Venom
- Vorherige Impfungen
- Anaphylactic, Age 13, MMR Vaccination 9/3/19 Merck
- Staat
- ID
- Alter
- 48,0
- Geschlecht
- F
- Eingang
- 28.07.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Inappropriate schedule of product administration
No adverse event
Symptomtext
Pt had no adverse reaction. Shot was just given on day 14 and not 24 or higher.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 27.07.2021
- Impfdatum
- 27.07.2021
- Beginn
- 27.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Patient inadvertently given Moderna COVID-19 vaccine despite being 17 years old. No allergic reaction noted during waiting period after administration. Scheduled for 2nd Moderna vaccine in 4 weeks per CDC guidelines.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- DC
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 26.07.2021
- Impfdatum
- 23.07.2021
- Beginn
- 23.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Asthenia
Fall
Hemiplegia
Symptomtext
Patient was informed she will be monitored for 30 minutes after vaccination due to previous reaction. after vaccination, Patient was accompanied to the waiting room by a staff and her husband, Patient fell on her way to the waiting room , she stated that she felt weak and gently lowered herself to the floor. Patient was alert and responsive and coherent, no physical injury noted, but she was unable to . unable to move her right side, Emergency team was called immediately., V/S was stable, 911 called Patient was transferred to the Hospital via Ambulance around 4.40PM.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Asthenia
- Hospital-Tage
- -
- Labordaten
- Vital signs monitored.
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- Food Intolerance, Low Vitamin D level
- Andere Medikamente
- None
- Allergien
- Lambs Quarters, Alcohol
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 24.07.2021
- Beginn
- 24.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Pt was under 18 years of age
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 47,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 19.07.2021
- Beginn
- 19.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
No adverse event
Symptomtext
Vaccine was given 7 days early. No side effects reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NA
- Vorgeschichte
- NA
- Andere Medikamente
- NA
- Allergien
- NA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 26.07.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Interchange of vaccine products
Symptomtext
Patient was injected with moderna instead of pfizer
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 26.07.2021
- Impfdatum
- 14.07.2021
- Beginn
- 14.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Unevaluable event
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Unevaluable event
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 57,0
- Geschlecht
- F
- Eingang
- 26.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
This patient received an expired vaccination. It had been taken out of the fridge on 4/28/21 so it should've been used by 5/28/21. The expiration on the bottle was 11/09/21. This patient did not report any adverse effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- ND
- Alter
- 70,0
- Geschlecht
- F
- Eingang
- 26.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
This patient received an expired vaccination. It had been taken out of the fridge on 4/28/21 so it should've been used by 5/28/21. The expiration on the bottle was 11/09/21. This patient did not experience any adverse effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 25,0
- Geschlecht
- M
- Eingang
- 23.07.2021
- Impfdatum
- 21.07.2021
- Beginn
- 21.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
The patient received his first dose of the Moderna COVID Vaccine in clinic on 07/21/2021. It was after he was discharged that it was realized the dose that was given to him was from a vial that has beyond use date (vial was opened 07/20/2021 10:46 AM) Patient was contacted multiple times but no reponse, messages left on pt's voicemail to contact clinic.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- lef thumb pain - concern for fracture
- Vorgeschichte
- -
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- FL
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 22.07.2021
- Impfdatum
- 19.07.2021
- Beginn
- 19.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
VACCINE GIVEN TO PATIENT UNDER 18 YEARS OF AGE
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- IA
- Alter
- 53,0
- Geschlecht
- F
- Eingang
- 22.07.2021
- Impfdatum
- 14.06.2021
- Beginn
- 22.07.2021
- Tage bis Beginn
- 38,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Symptomtext
PATIENT RECEIVED TWO DOSES OF PFIZER COVID VACCINE (2-19-21 AND 3-12-21). WE WERE NOTIFIED TODAY 7-22-21. I CALLED PATIENT TO DISCUSS ANY POTENTIAL ADVERSE EFFECTS BUT NO ANSWER/NO RESPONSE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- UNKNOWN
- Allergien
- NONE
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 21.07.2021
- Impfdatum
- 20.07.2021
- Beginn
- 20.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
13yr old patient was administered Moderna COVID Vaccines instead of Pfizer COVID Vaccine. CDC is currently not recommending Moderna for patients under 18 years of age. Spoke to patient mother on 07/21/2021 and stated patient is currently not having any adverse reactions or any major symptoms if any at all.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- NONE
- Vorgeschichte
- NONE
- Andere Medikamente
- None
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 77,0
- Geschlecht
- F
- Eingang
- 19.07.2021
- Impfdatum
- 09.07.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine given beyond- use date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- Yes
- Andere Medikamente
- No
- Allergien
- Beestings
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 32,0
- Geschlecht
- M
- Eingang
- 19.07.2021
- Impfdatum
- 09.07.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine given beyond-use date
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 22,0
- Geschlecht
- F
- Eingang
- 19.07.2021
- Impfdatum
- 09.07.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
Symptomtext
Vaccine given beyond-use date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- No
- Vorgeschichte
- No
- Andere Medikamente
- No
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 19.07.2021
- Impfdatum
- 08.07.2021
- Beginn
- 08.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Patient is only 17 and received a dose of Moderna, which is currently only approved for patients 18 years of age and older.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- OH
- Alter
- 49,0
- Geschlecht
- F
- Eingang
- 16.07.2021
- Impfdatum
- 16.07.2021
- Beginn
- 16.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
Inappropriate schedule of product administration
Interchange of vaccine products
No adverse event
Symptomtext
no adverse event but discovered when billing a rejection by insurance. Checked impactsis and discovered patient had already received J and J vaccine on 6-8-21 and Moderna on 4-15-21 and 5-28-21 and then received a moderna series from us on 6-18 and today 7-16-21.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 71,0
- Geschlecht
- M
- Eingang
- 15.07.2021
- Impfdatum
- 13.07.2021
- Beginn
- 13.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
RPH GAVE VACCINE ON THE 3RD WEEK INSTEAD OF GIVING IT 4 WEEKS AFTER THE 1ST DOSE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- FEVER
- Staat
- SD
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 14.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Blindness transient
Symptomtext
Approximately 5 minutes after dose was administered reported loss of vision for 3 minutes and then vision returned. He denied feeling light headed or dizzy. Blood pressure was 119/62 from left arm. No report of double vision.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Blindness transient
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none reported
- Vorgeschichte
- unknown
- Andere Medikamente
- unknown
- Allergien
- no known allergies
- Vorherige Impfungen
- -
- Staat
- LA
- Alter
- 42,0
- Geschlecht
- F
- Eingang
- 12.07.2021
- Impfdatum
- 30.06.2021
- Beginn
- 30.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Cough
Feeling hot
Flushing
Sensation of foreign body
Symptomtext
WITHIN 15-20 MINUTES OF RECEIVING THE SECOND VACCINATION, SHE BECAME "HOT", FLUSHED IN THE FACE, AND FELT LIKE SHE HAD A "LUMP" IN HER THROAT. SHE DID HAVE SOME COUGHING WITH REPEATED ATTEMPTS TO CLEAR HER THROAT. A NURSE AND FELT IT BEST TO USE AN INHALER THAT WAS SUPPLIED IN THE ANAPHYLAXIS KIT BROUGHT TO THE CLINIC WITH THE VACCINES. SHE DID 2 PUFFS OF A VENTOLIN INHALER AND TOOK BENADRYL 25MG BY MOUTH. THE SYMPTOMS DID NOT WORSEN AND SHE SAID SHE FELT BETTER WITHIN AN HOUR OF TAKING THE MEDICATIONS. THE ONLY COMPLAINT THAT SHE HAD WAS EXCESSIVE DROWSINESS SECONDARY TO THE BENADRYL.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- HTN, HLP
- Vorgeschichte
- HTN, HLP
- Andere Medikamente
- LOSARTAN LIPITOR CELEXA
- Allergien
- SHELLFISH IODINE DILAUDID
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 17,0
- Geschlecht
- M
- Eingang
- 09.07.2021
- Impfdatum
- 30.06.2021
- Beginn
- 30.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Product administered to patient of inappropriate age
Symptomtext
Moderna vaccine given to a patient who it was not indicated for since patient was only 17 years of age at the time of the vaccine. No adverse events reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CT
- Alter
- 15,0
- Geschlecht
- M
- Eingang
- 09.07.2021
- Impfdatum
- 09.07.2021
- Beginn
- 09.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Product administered to patient of inappropriate age
Symptomtext
Pt given vaccine age only 15 years old not 18.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- AR
- Alter
- 14,0
- Geschlecht
- F
- Eingang
- 08.07.2021
- Impfdatum
- 19.05.2021
- Beginn
- 19.05.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Vaccine given to pt outside of age recommedations for vaccine. Pt denies any complications at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 54,0
- Geschlecht
- M
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administration error
Symptomtext
Vaccine administration errors, not associated with an adverse event. Manufacture was contacted Moderna is not provide any specific recommendations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 18,0
- Geschlecht
- M
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administration error
Symptomtext
Vaccine administration errors, not associated with an adverse event Manufacture was contacted Moderna is not provide any specific recommendations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- n/a
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- M
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Vaccination error
Symptomtext
Vaccine administration errors, not associated with an adverse event Manufacture was contacted Moderna is not provide any specific recommendations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 21,0
- Geschlecht
- M
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Vaccination error
Symptomtext
Vaccine administration errors, not associated with an adverse event, Manufacture was contacted Moderna is not providing any specific recommendations at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 90,0
- Geschlecht
- M
- Eingang
- 07.07.2021
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Inappropriate schedule of product administration
Symptomtext
Resident received a TST Mantoux on 7/2/21 and then received COVID Vaccine 7/7/21. There was not a 4 week time frame between the two administrations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Inappropriate schedule of product administration
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 53,0
- Geschlecht
- M
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administration error
Symptomtext
Vaccine administration errors, not associated with an adverse event Manufacture was contacted Moderna is not provide any specific recommendations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- - / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Vaccination error
Symptomtext
Vaccine administration errors, not associated with an adverse event. manufacture Moderna was contacted and does not provide any specific recommendations.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Vaccination error
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- Penicillin, amphetamine, dextroamphetamine
- Vorherige Impfungen
- -
- Staat
- KS
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Moderna given to a 17 year old. No reaction noted
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- none
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 51,0
- Geschlecht
- F
- Eingang
- 07.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administration error
Symptomtext
Vaccine administration error of Moderna, not associated with an adverse event manufacture has been contacted no recommendations given at this time.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 19,0
- Geschlecht
- F
- Eingang
- 07.07.2021
- Impfdatum
- 07.07.2021
- Beginn
- 07.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Pharyngeal hypoaesthesia
Pharyngeal swelling
Symptomtext
The patient called an hour after receiving the shot stating she could feel her throat swelling slightly and having a feeling of numbness throughout her throat and tongue. She said she had no trouble breathing, swallowing fluids or any chest pain. It was recommended to take 2 benadryl tablets now (4:45pm) and 2 tablets before she goes to bed. I had the father get on the phone as well, tell educate him on monitoring her breathing. She was urged to see a doctor or call 911 if breathing issues start or swelling gets worse. I asked her to call the store first thing tomorrow morning when we open to see if there was any relief from the benadryl or if symptoms got worse.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pharyngeal hypoaesthesia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 15,0
- Geschlecht
- F
- Eingang
- 06.07.2021
- Impfdatum
- 06.07.2021
- Beginn
- 06.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- N/A
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Product administered to patient of inappropriate age
Symptomtext
A 15 yr old female adolescent came in for second dose COVID vaccine, after failing to appear for appointment on 07/01/2021 where she was suppose to recieve second dose of Pfizer. The patient stated she was here for a second dose of Moderna on 07/06/2021, and was mistakenly administered the Moderna dose. Patient should have recieved second dose of Pfizer.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- N/A
- Aktuelle Erkrankungen
- N/A
- Vorgeschichte
- N/A
- Andere Medikamente
- N/A
- Allergien
- N/A
- Vorherige Impfungen
- -
- Staat
- AL
- Alter
- 86,0
- Geschlecht
- F
- Eingang
- 05.07.2021
- Impfdatum
- 22.06.2021
- Beginn
- 22.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Interchange of vaccine products
Symptomtext
NURSING HOME WAS NOT INFORMED THE RESIDENT HAD A PREVIOUS VACCINE BEFORE ENTERING FACILITY. THEREFORE THE RESIDENT RECIEVED #2 DOSES OF MODERNA VACCINE AND PREVIOUS DOSE OF PFIZER. PHARMACY FOUND OUT WHILE ENTERING IT INTO THE VACCINE SYSTEM. INFORMED HOME BUT PATIENT WAS DOING FINE.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- NONE
- Aktuelle Erkrankungen
- UNK
- Vorgeschichte
- NO
- Andere Medikamente
- UNK
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- UT
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 02.07.2021
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- 1
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product administered to patient of inappropriate age
Symptomtext
Provided underage child with moderna vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product administered to patient of inappropriate age
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- None
- Andere Medikamente
- None.
- Allergien
- None.
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 57,0
- Geschlecht
- M
- Eingang
- 01.07.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Expired product administered
No adverse event
Symptomtext
Vaccine administered on July 1 may have been opened on Tuesday May 29, which is outside of the 12 hour allotted time window. Certified Pharmacy Technician administered vaccine assuming another pharmacist had already opened vial that was in refrigerator. Pharmacist does not recall opening a vial on July1. It could have been remainder of doses from 6-29-21. Vial was discarded and new vial was opened for subsequent doses in the day. Patient waited in the pharmacy for 30 minutes and noted no adverse events.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- F
- Eingang
- 01.07.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Immune system disorder
Symptomtext
Health care professional administered an expired dose of vaccine in the patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immune system disorder
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- Unknown
- Vorgeschichte
- Weakened immune system cause unknown
- Andere Medikamente
- Unknown
- Allergien
- Unknown
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 66,0
- Geschlecht
- M
- Eingang
- 01.07.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Expired product administered
Symptomtext
Health care professional gave this patient an expired dose of vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- Acute and Chronic respiratory failure Hypertension Chronic heart failure Pre Diabetes Hyperlipidemia
- Andere Medikamente
- Metformin 500mg daily Gabapentin 100mg daily Nitrostat .4 mg as needed Mucinex 600mg as needed
- Allergien
- none
- Vorherige Impfungen
- -
- Staat
- NC
- Alter
- 42,0
- Geschlecht
- M
- Eingang
- 01.07.2021
- Impfdatum
- 01.07.2021
- Beginn
- 01.07.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Expired product administered
Symptomtext
Healthcare professional called to report giving an expired dose to patient.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Expired product administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- unknown
- Vorgeschichte
- none
- Andere Medikamente
- unknown
- Allergien
- unknown
- Vorherige Impfungen
- -
- Staat
- PA
- Alter
- 36,0
- Geschlecht
- F
- Eingang
- 29.06.2021
- Impfdatum
- 19.06.2021
- Beginn
- 20.06.2021
- Tage bis Beginn
- 1,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Erythema
Oedema
Skin warm
Symptomtext
RED HOT LUMP, DID NOT HURT . AFTER FEW WEEKS OF NOT GOING AWAY WENT TO EMERGENCY WHERE THEY PRESCRIBED CEPHALEXIN FOR CELLLULITIS SAID WILL HEAL IN FEW DAYS
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Erythema
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- NONE
- Andere Medikamente
- LEVOTHYROXINE,
- Allergien
- SEASONAL ALLERGIES
- Vorherige Impfungen
- -
- Staat
- RI
- Alter
- 12,0
- Geschlecht
- F
- Eingang
- 28.06.2021
- Impfdatum
- 25.06.2021
- Beginn
- 25.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
No adverse event
Product administered to patient of inappropriate age
Symptomtext
Pt was observed for 30 min after administration of Moderna vaccine. No adverse reaction noted or reported.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- n/a
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 62,0
- Geschlecht
- M
- Eingang
- 27.06.2021
- Impfdatum
- 24.06.2021
- Beginn
- 24.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Interchange of vaccine products
No adverse event
Symptomtext
The patient came to pharmacy and asked to get the Covid-19 vaccine. He answered the pre-vaccination checklist for covid-19 vaccine form and stated this is his first time getting the vaccine. Pharmacist gave him Moderna Covid-19 vaccine on 06/24/2021. After the patient left, pharmacist entered his immunization record to immunization registry and found that pt already received 2 doses of Pfizer(second dose:02/01/2021) Patient was informed by pharmacist and he admitted that he did not tell pharmacist about his historical covid-19 vaccine because he lost his CDC immunization card. He is planning to travel and decided to revaccinate to get another CDC card Pharmacist apologized to the pt for the mistake of not checking the record before giving him the vaccine. pharmacist followed up with COVID-19 vaccine team for advise about this case on 06/24/21 and was told to call the organization who gave him the vaccine to verify if this is the correct pt However, pharmacist could not contact them ( Facility is pt medical group and the doctor at facility only helped the pt to entered to registry when pt came for visit ; according to the pt he got the vaccine) Pt is doing fine, no side effect as of 06/27/2021 Pharmacist will reach out to COVID team 06/28/21 for further guidance
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- ASTHMA, HIGH CHOLESTEROL
- Andere Medikamente
- don't know
- Allergien
- NO
- Vorherige Impfungen
- -
- Staat
- HI
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 25.06.2021
- Impfdatum
- 04.06.2021
- Beginn
- 04.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
No adverse event
Symptomtext
Patient received one dose of Moderna and one dose of Johnson and Johnson's Janssen vaccine. Patient did not report any adverse reactions/side effects.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 16,0
- Geschlecht
- M
- Eingang
- 25.06.2021
- Impfdatum
- 24.06.2021
- Beginn
- 24.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Interchange of vaccine products
Product administered to patient of inappropriate age
Symptomtext
Client was given a Moderna instead of Pzifer Covid Vaccine and the client was 16 years which is too ypung.Pfizer can be given at 16 years and Moderna is 18 years old .
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- none
- Andere Medikamente
- No
- Allergien
- no
- Vorherige Impfungen
- -
- Staat
- MN
- Alter
- 20,0
- Geschlecht
- F
- Eingang
- 21.06.2021
- Impfdatum
- 21.06.2021
- Beginn
- 21.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Glossodynia
Swollen tongue
Throat irritation
Symptomtext
patient went back to work and about an hour and so after receiving shot, pt felt like her tongue was swollen and painful and had an itchy throat. Her work EMT gave her Benadryl tablets and monitored her for a while. She said this took care of the effects
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Glossodynia
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- WA
- Alter
- 34,0
- Geschlecht
- F
- Eingang
- 21.06.2021
- Impfdatum
- 17.06.2021
- Beginn
- 19.06.2021
- Tage bis Beginn
- 2,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Cough
Symptomtext
Cough, Dry non productive, lasts throughout the day, has been constant since 2 days after vaccine
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Cough
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- Asthma, Recently pregnant
- Andere Medikamente
- -
- Allergien
- PROTON PUMP INHIBITORS/OMEPRAZOLE 10 MG., MEPERIDINE RELATED/MEPERIDINE HCL
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 18.06.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
This patient received his first Moderna vaccine today, 6/18, however, it was discovered after administration of the vaccine that she is under the age of 18. The patient was observed for a total of 15 minutes post-vaccination and there were no reactions, complaints, or complications. For Item 20 - I entered unknown as there was no adverse drug reaction prior to her departure from the vaccine event at Safer Foundation.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None Reported
- Vorgeschichte
- None Reported
- Andere Medikamente
- None Reported
- Allergien
- None Reported
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 14,0
- Geschlecht
- M
- Eingang
- 18.06.2021
- Impfdatum
- 18.06.2021
- Beginn
- 18.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product administered to patient of inappropriate age
Symptomtext
This patient received his first Moderna vaccine today, 6/18, however, it was discovered after administration of the vaccine that he is under the age of 18. The patient was observed for a total of 15 minutes post-vaccination and there were no reactions, complaints, or complications. For Item 20 - I entered unknown as there was no adverse drug reaction prior to his departure from the vaccine event which was offsite.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None Reported
- Vorgeschichte
- None Reported
- Andere Medikamente
- None Reported
- Allergien
- None Report
- Vorherige Impfungen
- -
- Staat
- AZ
- Alter
- 40,0
- Geschlecht
- M
- Eingang
- 16.06.2021
- Impfdatum
- 16.06.2021
- Beginn
- 16.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- SYR / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Interchange of vaccine products
No adverse event
Symptomtext
Patient was given Moderna instead of Pfizer for his second dose in the series. There were no side effects or difficulties. Patient requested "Moderna" and if was given - then when we went to document on his card, it showed that Pfizer had been given for his first dose. We notified our vaccination team at our organization, the medical director and annotated in the patients chart. No adverse effects noted.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- None
- Aktuelle Erkrankungen
- none
- Vorgeschichte
- CHTN
- Andere Medikamente
- HCTZ, Losartan, Clotrimazole
- Allergien
- NKMA
- Vorherige Impfungen
- -
- Staat
- MI
- Alter
- 55,0
- Geschlecht
- F
- Eingang
- 16.06.2021
- Impfdatum
- 11.06.2021
- Beginn
- 11.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Extra dose administered
Symptomtext
The patient received a third dose of Moderna Vaccine.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 63,0
- Geschlecht
- M
- Eingang
- 15.06.2021
- Impfdatum
- 15.06.2021
- Beginn
- 15.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- - / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Product storage error
Symptomtext
Patient was given a dose of the Moderna Covid vaccine serum morning after the day it was opened ( Vial opened on 6/14/2021, Vaccine given 6/15/2021 8:30am)
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Product storage error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- cardiomyopathy I42.9 Cardiomyopathy, unspecified heart murmur history of rheumatic fever hyperlipidemia E78.5 Hyperlipidemia, unspecified interventricular cardiac septal hypertrophy pain in thumb (Left) M79.645 Pain in left finger(s) sleep disorder tachycardia Type 2 diabetes mellitus without complication E11.9 Type 2 diabetes mellitus without complications ventricular fibrillation ventricular hypertrophy
- Andere Medikamente
- atorvastatin 40 mg tablet TAKE 1 TABLET AT BEDTIME (NEED LAB WORK BEFORE REFILLS) cyclobenzaprine 10 mg tablet TAKE 1 TABLET THREE TIMES A DAY AS NEEDED Diltiazem HCl CR 240 mg capsule,extended release Take 1 capsule every day by oral r
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 11.06.2021
- Impfdatum
- 11.06.2021
- Beginn
- 01.06.2021
- Tage bis Beginn
- -
- Dosis
- 2
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Interchange of vaccine products
Symptomtext
Patient received #1 dose Pfizer Covid vaccine on 5/21/2021 and inadvertently received #2 dose of Moderna Covid vaccine today.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- n/a
- Andere Medikamente
- levonorgestrel 0.15mg daily Vit D3 1250mg once weekly
- Allergien
- NKDA
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 21,0
- Geschlecht
- F
- Eingang
- 11.06.2021
- Impfdatum
- 10.06.2021
- Beginn
- 10.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Interchange of vaccine products
Symptomtext
The patient had previously received the Janssen Covid vaccine on 4/6/21 at another pharmacy and did not disclose this information beforehand. The patient has not notified us of any adverse reactions, but was advised to sign up with vSafe.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- CA
- Alter
- 17,0
- Geschlecht
- F
- Eingang
- 08.06.2021
- Impfdatum
- 08.06.2021
- Beginn
- 08.06.2021
- Tage bis Beginn
- 0,0
- Dosis
- 2
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Immunisation
Interchange of vaccine products
Symptomtext
Patient accidentally received Moderna instead of Pfizer. Per CDC guidelines, administered second dose Moderna to finish out series, informed patient and mother of incident and provided education on when to reach out to PCP.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Immunisation
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -